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Abstract 
Paralogs are present during ribosome biogenesis as well as in mature ribosomes in form 
of ribosomal proteins, and are commonly believed to play redundant functions within the cell. 
Two previously identified paralogs are the protein pair Ssf1 and Ssf2 (94% homologous). Ssf2 
is believed to replace Ssf1 in case of its absence from cells, and depletion of both proteins 
leads to severely impaired cell growth. Results reveal that, under normal conditions, the Ssf 
paralogs associate with similar sets of proteins but with varying stabilities. Moreover, 
disruption of their pre-rRNP particles using high stringency buffers revealed that at least three 
proteins, possibly Dbp9, Drs1 and Nog1, are strongly associated with each Ssf protein under 
these conditions, and most likely represent a distinct subcomplex. In this study, depletion 
phenotypes obtained upon altering Nop7, Ssf1 and/or Ssf2 protein levels revealed that the Ssf 
paralogs cannot fully compensate for the depletion of one another because they are both, 
independently, required along parallel pathways that are dependent on the levels of availability 
of specific ribosome biogenesis proteins. Finally, this work provides evidence that, in yeast, 
Nop7 is genetically linked with both Ssf proteins. 
 
Keywords: Ribosome biogenesis, parallel pathways, paralogs, Ssf, Ssf2, subcomplex, 
Nop7, genetic interactions 
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Résumé 
Les paralogues sont présents lors de la biogenèse des ribosomes ainsi que dans les 
ribosomes matures sous forme de protéines ribosomiques, et sont généralement censées jouer 
des fonctions redondantes dans la cellule. Deux paralogues précédemment identifiées sont la 
paire de protéines Ssf1 et Ssf2 (94 % d'homologie). Ssf2 remplacerait Ssf1 en cas d’absence 
du dernier dans la cellule, et l’absence des deux protéines diminue la croissance cellulaire. Nos 
résultats révèlent que, dans des conditions normales, les paralogues Ssf s’associent à des 
ensembles de protéines similaires, mais avec différentes stabilités. De plus, la perturbation de 
leurs particules pré-rRNP à l’aide de tampons de haute stringence a révélé qu'au moins trois 
protéines, probablement Dbp9, Drs1 et Nog1, sont fortement associées à chaque protéine Ssf 
dans ces conditions, et très probablement représentent des sous-complexes distincts. Dans 
cette étude, les phénotypes cellulaires observés lors de la déplétion des protéines Nop7, Ssf1 
et/ou Ssf2 ont révélé que les paralogues Ssf ne peuvent pas compenser entièrement pour la 
diminution de l'autre, car ils sont, indépendamment l’un de l’autre, nécessaires le long de voies 
de biogénèse ribosomale parallèles qui dépendent des niveaux de protéines impliqués dans la 
biogénèse des ribosomes disponibles. Enfin, ce travail fournit des preuves que, dans la levure, 
Nop7 est génétiquement lié aux deux protéines Ssf. 
 
Mots-clés: Biogénèse ribosomale, voies parallèles, paralogues, Ssf, Ssf2, sous-complexe, 
Nop7, interactions génétiques 
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1 Introduction 
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1.1 Ribosome biogenesis  
It is known that ribosomes are essential to every growing cell from Archaea to 
Animalia, including homo sapiens. As for the yeast Saccharomyces.cerevisiae, cells have to 
meet a minimal size requirement before they are able to divide and this is intimately linked to 
the number of ribosomes available in the cell (1, 2). Ribosomes are large ribonucleoprotein 
(RNP) machines made of a large and a small subunit (LSU and SSU), 78 ribosomal proteins 
(Rps) and four rRNAs (ribosomal RNAs), the active component of the ribosome that is 
responsible for mRNA (messenger RNA) translation. Making a ribosome involves ~200 
trans-acting factors that mediate ribosome biogenesis (RiBi), which entails pre-rRNA 
processing and modification as well as its hierarchical, complex assembly with Rps.  
 
1.1.1 Pre-rRNA processing  
A single cell’s genome has about 120 rDNA polycistronic tandem repeats in 
chromosome XII, a highly transcribed region (Fig 1.1) (3).  Each resulting polycistronic 
transcript contains 18S, 5.8S and 25S pre-rRNA which are flanked by external transcribed 
spacers I and II (ETS) and separated by internal transcribed spacers I and II (ITS).  
The earliest event is ETS2 processing by the endoribonuclease Rnt1, a protein which 
dimerizes and recognises tetraloop structures (4). Cleavage of the primary transcript at site B0 
by Rnt1 gives rise to the 35S pre-rRNA.  
 
1.1.1.1 35S to 32S processing:  ETS1 and ITS1 
The ETS1 region is highly structured and requires stem loops for correct A0 and A1 
endonucleolytic cleavages to occur (4). The 33S pre-rRNA is obtained through A0 processing, 
which can be performed by many endonucleases, including Rnt1 and RNase MRP (4-6). The 
released 5’ETS portion of the transcript is degraded by the exosome (3’→5’ exonuclease, 
Rrp6) or by Rat1/Rai1 (5’→3’ exonuclease Rat1) (4). A1 endonucleolytic cleavage can be 
performed by various endonucleases, including RNase MRP, yields 32S pre-rRNA and the 
exosome degrades the A0-A1 fragment (4, 6). 
3Figure 1.1 : The pre-rRNA processing pathway in yeast 
In dividing cells, about half of the rDNA repeats are in an open chromatin state, ready for transcription. A single rDNA 
repeat is simultaneously transcribed by many RNA polymerase  I, each resulting in a polycistronic primary transcript 
which is cotranscriptionnally processed by early RiBi factors. RiBi particles appear as decorations in an inverted 
Christmas tree, the base being rDNA associated with polymerases and the branches being the pre-rRNA transcripts. 
Each primary transcript contains 18S, 5.8S and 25S pre-rRNA flanked by transcribed spacers (External: ETS1, ETS2 
and Internal: ITS1, ITS2) which are sequentially cleaved and processed. Detailed in section 1.1.1. Figure modified from 
(3, 7). 
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ITS1 processing occurs almost simultaneous to A1 processing; A2 endonucleolytic 
cleavage can be performed by Rcl1, RNase MRP or Rnt1 (4, 6, 8). Interestingly, a delay A0 and 
A1 processing is not deleterious to the cell (4). U3 snoRNA, is a special class of box C/D 
snoRNP  believed to stabilise pre-rRNA and facilitate A0, A1 and A2 processing by its RNA 
basepairing to the 5’ETS of 35S pre-rRNA (just upstream of cleavage site A0), at least two 
regions within ITS1 and the 5’ coding region of 18S (9). 
 
1.1.1.2 Processing of 20S pre-rRNA in the cytoplasm 
A predominant cleavage at site A2 separates 20S from 27SA2 pre-rRNA processing, 
and thus maturation of 40S from that of 60S pre-ribosomal subunits. In a minor pathway, 
however, cleavage at site A3 occurs prior to those at sites A0, A1 and A2, which generates 23S 
pre-rRNA. This precursor is then sequentially processed at A0 (A0-A3=22S), A1 (A1-A3=21S) 
and A2 (A1-A2=20S) by the usual processing factors (10). In all cases, 20S pre-rRNA is already 
fully processed at its 5’. Its 3’ will be partially trimmed (3’→5’) by Xrn1 before the final 
maturation event through endoribonuclease cleavage by Nob1at site D in the cytoplasm (8). 
 
1.1.1.3 27S precursor maturation: ITS1/ETS2 processing 
At the stage of 27SA precursors, the 3’-end of ITS1 pairs with the 5’-end of 5.8S 
rRNA (11, 12). Concomitantly, ETS2 is completely removed by B0-B2 processing through the 
action of a yet unidentified protein, generating the mature 3’-end of the 25S (4).  
A3-cleavage within ITS1 is performed endonucleolytically by RNase MRP, prior to 
exonucleolytic digest of the resulting A2-A3 fragment, as well as processing of 27SA3 pre-
rRNA from site A3 by the 5’→3’ exonucleases Xrn1, Rat1 or Rrp17. This will generate the 
mature 5' end of 5.8SS (27SBS pre-rRNA) (7, 13). 27SBL pre-rRNA is presumably obtained 
through an endonucleolytic cleavage after cleavage at A3, however, the enzyme responsible 
for this event is still unknown (12).   
Both 27SB pre-rRNAs are subsequently processed within ITS2 by apparently identical 
pathways to generate the mature 25S rRNA and the mature 3’ ends of either 5.8SS or 5.8SL 
5 
rRNAs. 5.8SS-containing ribosomes are five times more abundant than 5.8SL-containing 
ribosomes.  
 
1.1.1.4 Processing events within ITS2  
After ITS1 removal, the pre-rRNA adopts another intermediate structure in which the 
5' of 25S interacts with the 3' of the 5.8S rRNA and forms a stem loop structure that is critical 
for processing and which is conserved in the mature ribosome (14). During its processing, ITS2 
switches from an open ‘ring’ to a closed hairpin structure (14). The closed hairpin structure can 
form spontaneously and its formation is prevented by RiBi factors (12). 
Unlike ITS1, ITS2 sequences are not recognised by RiBi proteins of distantly related 
organisms (15). However, the secondary structures adopted by the pre-rRNAs are similar and 
the important nucleotides required for correct processing are conserved (15). It has been 
proposed that correct ITS2 processing requires RiBi factors recognising specific secondary 
structures, specific sequences, or both (14).  
Cleavage at site C2 by an unidentified endonuclease within ITS2 generates the 7S and 
26S pre-rRNAs. Following C2 cleavage, the 3’ of 7S pre-rRNA is exonucleolytically 
processed, first by the exosome followed by fine trimming through Rrp6, Rex1 or Rex2 to 
first generate a stable precursor, the 6S, and then finally the mature 5.8S rRNA.  
The 5’ processing of 26S pre-rRNA is performed by Xrn1, Rat1 or Rrp17 and 
generates first 25S’ (C2 to C1’ processing), and then, after further fine trimming, mature 25S 
rRNA. 
 
1.1.2 Assembly with ribosomal proteins 
As pre-rRNA is processed in the compartments of the nucleolus, some RiBi factors 
will mediate its assembly with ribosomal proteins of the large subunit (Rpl). This is the case 
with the ribosomal-like proteins (Rlp), which interact with RiBi factors and are believe to 
mimic the structure of Rpls, inducing proper folding and conformational changes of the pre-
rRNA structure prior to the entry of the corresponding Rpl protein (16). For instance, Rlp7 has 
been reported to bind to two regions. It binds to the ITS2, very close to the 5.8S coding region 
6 
and also to the 5’ of the 25S coding region, a region forming  the proximal stem loop where 
Rpl7 is found in the mature ribosome (16). Therefore, some RiBi proteins are required to 
correctly fold pre-rRNA so that accommodation of the Rpl protein is possible, while other 
RiBi factors are required to recruit the Rpl proteins into the pre-rRNP particle. In the case of 
Rpl5 and Rpl11, they are recruited along with 5S rRNA as a module through interactions with 
LSU RiBi factors Rpf2 and Rrs1 (17). The import of ribosomal proteins into the nucleus is 
predominantly mediated by Kap123, an importin (18). 
 
1.1.3 The RiBi pathway 
Most RiBi proteins have been identified and are highly conserved in higher 
eukaryotes. They can be classified according to their function or to their entrance into the 
maturing pre-RNP particle (early, intermediate or late factors). However, even if most of their 
roles can be predicted, their exact function(s), substrates and physical interactions within the 
dynamic pre-rRNP particles remain elusive.  
In the dense fibrillar compartment (DFC) of the nucleolus, ribosome biogenesis is 
dependent on chromatin remodelling and RNA polymerase (pol) I regulation  (19-23). Co-
transcriptionally, snoRNPs will modify pre-rRNA (2'-O-ribose methylation and 
pseudourydilation) and early RiBi factors will be recruited onto the nascent transcript to form 
the pre-90S particle (3, 24, 25). As the particle transitions towards the granular compartment 
(GC) of the nucleolus, the primary transcript is separated in two by the A2 cleavage and 
distinct RiBi factors bind pre-rRNA, forming pre-60S and pre-40S particles. Within pre-60S 
maturation, several LSU RiBi proteins are required to ensure ribosome biogenesis, including 
Nop7 and the paralog pair Ssf1 and Ssf2 (Fig. 1.2). 
7Figure 1.2: RiBi pathway of the LSU 
Ribosome biogenesis involves 200 non-ribosomal proteins (RiBi) that modify, cleave, fold and correctly associates pre-rRNA with the 
ribosomal proteins (Rps). As the LSU matures, it moves from the dense fibrillar compartment (DFC) and granular compartment (GC) of the 
nucleolus to the nucleoplasm and its maturation is completed once it is in the cytoplasm. Here, the estimated time of entry and of exit of 
some RiBi proteins involved in the LSU maturation are shown. In red: some of the Brix/Imp superfamily members. In blue: trimeric complex 
Nop7, Erb1 and Ytm1. Information and figure adapted from (2, 7). 
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1.2 Parallel pathways during pre-60S maturation and 
specialized ribosomes 
In the field, most of the RiBi proteins involved in ribosome biogenesis are now 
characterised. Although the presence of multiple parallel pathways during yeast ribosome 
biogenesis has been highly debated, it is now an accepted concept and several groups are now 
working to uncover them (2). The presence of parallel/alternative pathways ensuring ribosome 
biogenesis is further supported by the presence of different pools of mature ribosomes within 
the cell under normal conditions and the emergence of specialized ribosomes under specific 
cellular stress (26-29).  In any case, substantial work still need to be performed in order to 
define the players involved in these parallel pathways, which is aided by the significant 
advances in proteomics.  
1.2.1 Hierarchies of processing factors 
1.2.1.1 Loss of essential RiBi factors does not result in cell death 
Although most RiBi factors are said to be essential, their depletion results in impaired 
or slowed cell growth, rather than cell death, while mature ribosomes are still produced. This 
emphasizes the presence of alternative maturation within the cell as an adaptive response to 
maintain the essential translation machinery and thus secure cell survival. Some work has 
been performed to elucidate some of these pathways during pre-90S maturation in which it 
has been shown that ribosome biogenesis first requires the t-UTP complex (Utp4, Utp5, Utp8, 
Utp9, Utp10, Utp15 and Nan1) and can then continue via at least three alternative pathways 
involving i) the RiBi protein Rrp5 and then the UTP-C complex (Utp22, Rrp7 and Cka1); ii) 
the U3-snoRNP complex; iii) the UTP-B complex (Pwp2, Dlp2, Utp21, Utp13, Utp18 and 
Utp6)  (25, 30, 31). The association of either the U3-snoRNP or the UTP-B complexes allows the 
incorporation of Bms1, a GTPase required for U3 snoRNA pairing with the pre-90S that is 
found associated to a lesser extent with Rcl1 (25, 30). Since U3 sno-RNAcan be involved in A0, 
A1 and A2 processing, this data suggests that in one pathway, Bms1 stabilizes the U3-snoRNP 
complex which is responsible for A0, A1 and A2 processing (9). In the pathway in which 
UTP-B enters the pre-90S particle, Bms1 possibly enters as a heterodimer with Rcl1, which 
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performs the A2 cleavage while other endonucleases perform A0 and A1 cleavages. Following 
Bms1 binding, two alternative pathways ensure ribosome biogenesis. In one case, Kre33 
enters the particle and in the other, Utp20 binding will allow the association of either the 
Mpp10 complex (Mpp10 and Imp4) or the protein Enp2 (25).  
However, several components of the pre-90S have still not been associated with this 
pathway, and imply that other alternative pathways exist but remain to be elucidated.  
Moreover, it has been shown that some proteins can enter as preformed modules (e.g. 
Rcl1/Bms1) or alone (e.g. Bms1), depending on the cellular context, which further adds to the 
complexity of elucidating these pathways. There is also some evidence of parallel pathways 
during pre-60S maturation, where the  Nop7 and Nug1 associated particles share nearly 
identical pre-rRNA content, indicating that they are involved in the same pre-rRNA 
processing events, and yet they have only a 25% overlap in RiBi protein content (32). 
 
1.2.1.2 RiBi protein paralogs 
In the past, protein paralogs were believed to have redundant functions. This, however, 
is not the case for at least some of the ribosomal proteins (Section 1.2.2.2). Some RiBi factors 
were also shown to have paralogs, as in the case of the Ssf1/Ssf2 and Fpr3/Fpr4 paralogs. 
Their potential role in the context of alternative pathways has never been investigated.  
Structural studies of the pre-rRNP particles are now elucidating part of the structural 
rearrangements required for its remodelling and those mainly involve stearic hindrance 
constraints. This could explain why a protein can enter the pre-rRNP particle alone (e.g. 
Bms1) or in a subcomplex (e.g. Bms1/Rcl1), depending on the previous RiBi proteins that 
associated with the pre-90S particle around its binding site (25, 30). As paralogs have subtle 
amino acid changes and are compacted in the pre-rRNPs, in close contact with other RiBi 
proteins, it is valid to ask whether these changes are sufficient to trigger alternative pathways. 
Unlike what was previously assumed, an extensive comparison of the Ssf1 and Ssf2 
interactors suggest that these paralogs have in fact non-redundant functions within the cell, a 
feature that has never been explored in the context of ribosome biogenesis (Section 1.3.2).  
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1.2.2 Specialized ribosomes 
1.2.2.1 Two types of ribosomes containing 5.8SS or 5.8SL rRNA 
Most evidently, there exist two types of ribosomes, containing either 5.8SS (80%) or 
5.8SL (20%) rRNA. Their divergence during ribosome maturation is clear because they 
generate two types of precursors from 27SA3 exonucleolytic or endonucleolytic processing, 
resulting in either 27SBL or 27SBS. However, the trans-acting factors involved in generating 
the minor pathway (27SBL) have not yet been reported and its cellular significance is still 
poorly understood. To this date, no clear assays have been performed to verify if these 
ribosomes have different affinities with different subsets of mRNAs or if they react differently 
when submitted to ribosomal stress as it has been shown for hypo-pseudourydilated 
ribosomes, which are more susceptible to frame shift errors and show decreased IRES-
dependent translation rate upon specific cellular stress (4, 26, 29, 33).  
 
1.2.2.2 Ribosomal proteins: paralogs with different functions 
Of the 78 ribosomal proteins, 59 have a paralog (A or B) (4). Two ribosomal pools, 
each containing one of the two paralogs, can be spatially separated within the cytoplasm 
suggesting that the ribosomes containing ribosomal protein paralogs could have distinct 
functions within the cell (28). Furthermore, to this day, it is unclear how assembly of these 
ribosomal protein paralogs onto the maturing ribosome occurs and whether it is achieved 
through parallel RiBi pathways.  
One specific function was demonstrated for three ribosomal proteins of the large 
subunit (Rpl7A, Rpl12B, and Rpl22A) and one of the small subunit (Rps18B). These 
ribosomal proteins were shown to have a role in the correct localisation and translation of 
ASH1 mRNA, while their paralogs do not (28). Interestingly, upon depletion of the LSU RiBi 
factors Loc1 or Puf6, the ribosomes carrying these particular ribosomal proteins are still 
generated yet mislocalized within the cytoplasm altering ASH1 mRNA transport and 
translation (28).  
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1.2.2.3 Ribosomal proteins and ribosome types 
More and more evidence pointing towards specialized ribosomes, that are also 
different in composition, are emerging. It has been reported recently that a retroviral and 
oncogenic protein, V-erbA, can alter ribosome biogenesis such that a second pool of 
ribosomes, which does not contain the ribosomal protein Rpl11, is generated (27). It has been 
suggested that these Rpl11-depleted ribosomes can have a higher translational affinity with 
certain types of mRNA (27). Given the fact that Rpl11 plays an important role in the activation 
of both tumor suppressors c-myc and p53, this mechanism by V-erbA appears to be an 
appropriate adaptive response to inhibit the cellular response upon infection. Another such 
examples is found in E. coli, where in order to survive the presence of the antibiotic 
kasugamycin, the bacteria generates functional ribosomes lacking at least six ribosomal 
proteins, two of which are essential (34). Because this antibiotic mimics mRNA structure 
between the P and E sites of the ribosome, loss of these ribosomal proteins most likely 
changes the ribosomal structure at this region such that the antibiotic is no longer able to 
block the ribosome during translation. 
 
1.3 Specific RiBi proteins 
1.3.1 Nucleolar protein 7 (Nop7)  
Pes1 was originally discovered as pescadillo in zebrafish, where it was shown to be 
important for eye development (35). Moreover, its mouse homolog Pes1 was shown to interact 
with the p53 suppressor Mdm2 in mouse astrocytes (35). In yeast, the NOP7 (Nucleolar 
Protein 7) gene is located in chromosome VII and its cellular protein abundance is ~ 4530 
molecules per cell according to SGD (30). Nop7 (also called Yeast pescadillo homolog 1) links 
ribosome biogenesis to cell cycle progression and DNA repair (1, 36). The protein has two coil-
coil regions one of which is in its C-terminal and contains a nuclear localisation signal (NLS, 
Fig. 1.3).  
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Figure 1.3: Nop7 protein and its domains 
Nop7 is composed of four main domains: pescadillo, a conserved region required for ribosome 
biogenesis; BRCT, a domain required for cell cycle and DNA damage responses; CC1 and CC2, two 
coil-coil regions, CC2 containing a nuclear localisation signal (NLS) which can be cleaved. For further 
details refer to main text. Image constructed according to information from (1). 
 
 
The C-terminal region needs to be truncated for some cellular functions since a shorter 
form of Nop7 was detected using an antibody against the N-terminus of the protein (1). This 
C-terminus-truncated form of Nop7 is cytoplasmic and co-sediments with polysomes (1). 
However, details on how this modification is triggered and why it is needed remain elusive to 
this date and do not seem to be linked to its function during ribosome biogenesis (1).  
In the following sections, only functions of full-length Nop7 will be discussed, as the 
affinity purifications isolated the interactors of C-terminally tagged Nop7 cells in log (Nop7-
PrA, Fig. 1.4A) and lag phase (Nop7-TAP, Fig. 1.4B) (37, 38). The lag phase interactors were 
identified in a high-throughput study and are therefore more likely to contain false positives. 
However, Nop7 particles during log phase also contain proteins involved in similar processes, 
and at least its interaction with ORC complexes has been confirmed in complementary 
immunoprecipitations assays (IPs, e.g. ORC2) (1). It is therefore possible that Nop7 has other 
functions in processes other than ribosome biogenesis, ensuring fine-tuning between these 
processes.  
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Figure 1.4: Nop7 interactors during log and lag phase 
(A) During log phase, Nop7-PrA is mostly associated with pre-60S RiBi proteins but is also 
associated with five proteins involved in other cellular processes. According to information from (37). 
(B) During lag phase, when ribosome biogenesis is shut down, Nop7-TAP is mostly associated with 
proteins which are involved in other cellular functions but is still associated with one RiBi protein. 
According to information from (38). 
1.3.1.1 Nop7 and ribosome biogenesis 
Through its evolutionary conserved pescadillo domain, nucleolar Nop7 enters early 
during ribosome biogenesis and is found in pre-90S and early pre-60S particles. During this 
stage it is most likely a scaffold protein as it is present in at least three distinct RNP particles 
during pre-60S maturation (Fig. 1.5) (36). It binds the C-terminal tail of Erb1 and forms a 
highly stable trimeric complex with Ytm1 (39). This trimeric complex is required for correct 
processing of 27SA3 pre-rRNA to 27SB through exonucleolytic trimming (step * of figure 
1.5) (1, 39).  Nop7 can also bind directly to pre-rRNA, possibly through its BRCT domain (12). 
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Its interaction with RNA was determined using a crosslinking technique and was pinpointed 
to helix H54 within the 5’coding region of 25S rRNA (12). Nop7 appears to travel with the pre-
60S subunit from the nucleolus to nuclear rim, and has been proposed to have different 
functions, processing, assembly and lastly quality control of export-competent subunits, 
depending on its subnuclear localisation (36).  
 
 
Figure 1.5: Ssf1 and Nop7 are involved in the LSU pathway 
Ssf1 and Nop7 have been found in three distinct particles of the LSU maturation pathway containing 
either 27SA2, 27SA3 and 27SBS pre-rRNA. Nop7 is known to form a trimeric complex necessary for 
exonucleolytic trimming of 27SA3. Adapted from (2, 7, 39). 
 
1.3.1.2 Nop7 depletion phenotype 
Upon depletion of Nop7, cell growth is severely delayed and is at least in part caused 
by delayed ribosome biogenesis, as the Dt roughly doubles and Nop7-depleted cells arrest 
longer in G2 (1, 36). However, even if cell growth was affected, depletion of Nop7 did not lead 
to cell death, which suggests that alternative mechanisms are still present to ensure ribosomal 
production. The proteins involved in these pathways however have never been investigated. 
What is known, is that whole cell extracts of Nop7-depleted showed a general decrease in 
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Ytm1 and Erb1 protein levels, which was not the case for other RiBi proteins that were not 
directly interacting with Nop7 (39). This suggests that formation of the trimeric complex is 
necessary for these proteins to be involved in ribosome biogenesis and that depletion of one of 
these proteins likely leads to a cellular down-regulation of the other two proteins by yet to be 
determined mechanisms. Interestingly, Nop7 also seems to have a synergistic interaction with 
Rpl25, however, in what capacity is still unclear. This assumption is due to the synthetic 
lethal phenotype observed upon Nop7 depletion in an Rpl25 temperature-sensitive strain in 
restrictive conditions (glucose-containing medium at 37°C) (36). 
Upon Nop7 depletion, pre-rRNA processing is also affected, as previously 
demonstrated by Northern blot, primer extension and pulse-chase analysis (36). Nop7 depletion 
profoundly affects LSU maturation: absence of Nop7 causes processing of 27SA3 pre-rRNA 
into 27SBL through endonucleolytic cleavage and a switch to the minor pathway producing 
5.8SL-containing ribosomes (36). Moreover, after 24 hours of depletion, slight accumulation of 
primary transcript 35S was observed with a reduction in 27SB, 7S and 6S precursors (36). Only 
mature 25S and 5.8SS rRNA decreased and an aberrant precursor was observed (23S), which 
indicated a delay in A0, A1 and A2 processing (36). Interestingly, Nop7-containing particles 
contain Drs1 both during log and lag phase although they do not directly interact with each 
other according to a yeast-two hybrid assay and although Drs1-depleted cells are also 
deficient in 25S and 5.8S pre-rRNA maturation (38, 40). This suggests that Nop7 and Drs1 are 
involved in similar pathways during ribosome biogenesis and are also associated with at least 
another common protein not involved in ribosome biogenesis during lag phase. Finally, an 
accumulation of aberrant pre-rRNA generated by premature C2 cleavage was also observed in 
Nop7-depleted cells by primer extension analysis from a probe annealing within ITS2 (36, 40). 
1.3.1.3 Nop7, cell cycle, DNA replication and DNA repair  
Nop7 is a member of the BRCT domain-containing family of proteins, which play an 
important function in human cells in the development of breast and colorectal cancer (41-44). 
This may explain some functions of PES1, the human Nop7 homolog, and its interactions 
with Mdm2 (36). The BRCT domain is located in between the two coil-coil regions and is also 
common to proteins involved during cell cycle progression and DNA repair, such as BRCA1, 
RAD9, DPB11 and ECT2 (Fig. 1.3) (45).  
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During log phase, Nop7 particles affinity purify (AP) with Msa1, a protein required to 
initiate transcription of G1-specific genes (30). A mechanism by which Nop7 is involved in 
regulating Msa1 activity is possible, as it has previously been shown that Nop7-depleted cells 
arrest longer in G1(1).  
During log phase, Nop7 has a role in DNA replication through associations with ORC 
complexes and Psf1, a protein involved in DNA replication machinery assembly (1). 
Consistent with Nop7 having a role in regulating DNA replication, very few Nop7-depleted 
cells arrest in S phase (1, 36).  It is possible that Nop7 remains associated with proteins involved 
in inhibiting DNA replication during lag phase as it is likely associated with an 
uncharacterized protein (Ykr018c) whose cellular levels are increased upon DNA replication 
stress (1, 30).  
In addition, the tubulin content of Nop7 depleted cells decreases in S phase cells (1). 
Consistent with Nop7 having a possible role in tubulin maintenance and remodelling, Nop7-
associated complexes were found to contain proteins involved in microtubule maintenance 
during both log (e.g. Kar3) and lag phase (e.g. Okp1). Kar3 is a microtubule motor required 
for spindle pole body formation during mitosis and meiosis, and Okp1 is a protein of 
unknown function required during kinetochore-microtubule assembly (30). Moreover, during 
log phase, it is known that Nop7 directly binds to Ytm1, a RiBi protein known to directly 
interact with tubulin and required to G1/S transition (46).  
 
1.3.1.4 Nop7 and protein paralogs 
Another interesting feature of Nop7, that is still unexplained, is that it interacts with 
proteins that have paralogs, both during log and lag phase. During log phase, Nop7-associated 
complexes contain Ssf1, Fpr4 (LSU RiBi factors, paralogs: Ssf2 and Fpr3 respectively) and 
Msa1 (cell cycle initiation, paralog: Msa2), during lag phase, Ykr018c (mitochondrial protein 
increased upon DNA replication stress, paralog: Iml2) and Uth1 (required for mitochondria 
biogenesis, paralogs: Nca3). Since Nop7 seems to be involved in several cellular processes 
together along ribosome biogenesis and the cell cycle (G1, S and G2), it is possible that it 
triggers slightly different cascades through interactions with both or just one of these 
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paralogs. Further investigation will be necessary to determine if Nop7-associated particles 
during lag phase really include Ykr018c and Uth1 or are false positives. 
 
1.3.1.5 Nop7 orthologs in higher eukaryotes 
As mentioned above, several Nop7 orthologs exist in higher eukaryotes, such as 
zebrafish, Xenopus laevis, mouse and humans. During embryogenesis, Pes mRNA has been 
found in several developing organs of different embryos. In mouse, the protein is found 
throughout developing brain structures; in Xenopus laevis, it is found in early eye structures, 
the neural crest, and pronephros development, while in zebrafish it is found in the eye, brain, 
and skeletal muscle structures (36, 47). Pes1 was also found to be upregulated in p53-/- cells as 
well as in some breast cancer tumors (36, 47). In higher eukaryotes, pescadillo protein can be 
sumoylated at two regions of its BRCT domain (1). Similar to yeast, it forms a trimeric 
complex with WD12 and Bop1, the human homologs of yeast Ytm1 and Erb1, that is required 
for progression into S phase and LSU biogenesis (48). Pes1 also has functions independent of 
ribosome biogenesis during Xenopus laevis pronephros development (47). 
 
1.3.2 Suppressor of Ste4 paralogs 1 and 2 (Ssf1/2) 
In the presence of pheromones, the two proteins Ssf1 and Ssf2 were found to suppress 
Ste4, allowing bud formation during the mating response (49, 50). This is how the Ssf proteins 
were discovered and named although the mechanisms for this regulation are still elusive to 
this date. This finding however shows that the Ssf proteins can function in other cellular 
processes. 
 
1.3.2.1 Ssf paralogs can bind RNA 
The Ssf proteins belong to the Brix/Imp superfamilly of proteins, which is further 
composed of LSU RiBi proteins Brx1, Rpf1, Rpf2, and pre-90S RiBi protein Imp4 (51, 52). The 
shared Brix domain contains a ơ70-like motif and confers to this superfamily the capacity to 
bind RNA. This has been demonstrated for Imp4, Rpf1 and Rpf2, which can all bind single-
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stranded (ss) RNA, but with different affinities (53). Wehner et al not only demonstrated the 
capacity of ơ70-like motif to bind RNA but also studied the depletion phenotypes for each of 
these proteins using pulse-chase and analyzed the rRNA precursors co-isolated during affinity 
purification of each of the proteins. From these analyses, the RNA binding site of the Ssf 
paralogs was suggested to be located within the ITS1, between cleavage site A3 and the 5’ 
coding region of mature 18S rRNA (52-54). Another study of the Imp/Brix superfamilly 
proposed that the family members closely interact with one other functionally (51). 
 
1.3.2.2 Differences between the Ssf proteins 
 The Ssf1 and Ssf2 proteins are believed to have arisen from genome duplication. Their 
genes are located in different chromosomes and are not expressed at the same levels under 
normal growth conditions (30). SSF1 is located on chromosome VIII and its protein abundance 
is ~8150 molecules per cell, while SSF2 is located on chromosome IV and its protein 
abundance is ~1350 molecules per cell (30).  
The two proteins share a 94% sequence homology, and, with a few exceptions, most of 
the non-homologous sequence regions contain amino acids with equivalent charge 
(exceptions in red, Fig. 1.6) (30, 52, 54). They share the Brix/ơ70-like motif and a predicted 
homo/heterobinding domain (HBD). 
 
 
Figure 1.6: Ssf1/2 proteins and their domains 
The Ssf paralogs share an RNA binding domain. In red are indicated the amino acids that do not 
have the same charge. According to information taken from (30, 52, 54) and Blastp alignment. 
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1.3.2.3 Ssf-protein depletion phenotype 
 Depletion of either of the paralogs has not been reported to affect ribosome biogenesis, 
yet depletion of both proteins simultaneously for 12 hours did affect pre-rRNA processing (54). 
The primary transcript, 35S pre-rRNA, accumulated along with aberrant precursors 23S, 
5’ETS-D and A2-C2 (54). The presence of these aberrant precursors indicated that A0, A1 and 
A2 processing was delayed and that C2 cleavage occurred prematurely. Concomitantly, 
precursors normally found in wild-type cells were no longer detected: 27SA2, 27SB, 20S, 7S 
and 6S pre-RNAs (54). Fatica et al also reported an overall reduction in mature rRNAs, 
including 5S rRNA (54). 5S rRNA is transcribed by RNA polymerase III in the nucleolus. It is 
processed and assembled with Rpl5 and then enters into the pre-60S particle after C2 cleavage 
in the nucleus, also associated with other RiBi proteins (Rpf2, Rrs1 and Rpl11) (17). Part of the 
drop in 5S rRNA could alternatively be explained by changes in the chromatin state caused by 
a drop in Ssf1 and Ssf2, as both proteins have been found to interact with histones modifiers. 
However, the paralogs are unexpectedly associated with proteins of opposite function 
(Fig. 1.7 A and B). Ssf2 has been found associated with histone deacetylases Rpd3 and Hda1, 
while Ssf1 has been found to be associated with a histone 3 methylase (Sdc1); a component of 
a complex that exchanges H2AZ to H2A (Swr1); and an acetylase of the N terminal tails of 
H4 and H2A (Eaf7) (38, 55, 56). Although these associations come from high-throughput data, 
which is background prone, those interactions could at least partially be accounted for the 
drop in overall transcription observed. During lag phase, Ssf1 was also found associated with 
histones 3 (Hht1 and Hht2) and 4 (Hhf1 and Hhf2) (55, 56).   
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(A) During log phase, most of the RiBi proteins associated with Ssf1 are not associated with Ssf2. 
Both Ssf proteins have also been linked to proteins not involved in ribosome biogenesis during log 
and (B) lag phase, suggesting that they are involved in non-overlapping cellular functions. According 
to information taken from (38, 54-56).
 
1.3.2.4 The Ssf paralogs can form complexes with different proteins  
To verify if the Ssf proteins can form similar complexes, reported affinity purification 
results were compared during lag and log phase.  
Cells in lag phase have not been extensively studied, but it is known that cells are no 
longer dividing, ribosome biogenesis is shut-off and cells survive with the existing pool of 
ribosome (57, 58). However, as many RiBi proteins have been found to be involved in other 
cellular processes during log phase (e.g. Nop7 and Ytm1). If RiBi proteins are present during 
lag phase, then they likely function as sensors for energetic changes within the cell. Data 
retrieved from (high throughput) lag phase affinity purifications suggest that both Ssf proteins 
are part of distinct complexes. Ssf1 AP during lag phase has not been performed but it was 
found as part of the Rnt1 particle (38).  Rnt1, an endonuclease, is an early RiBi factor required 
for rDNA transcription which has a role in closing rDNA repeats and increasing rDNA 
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transcription by physically interacting with RNA polymerase (pol) I (30, 59). If Ssf1 and Rnt1 
belong to common particle during lag phase, then Ssf1 could inhibit Rnt1 activity and thereby 
be indirectly involved in repressing rDNA transcription. Ssf2, on the other hand, was found to 
associate with proteins involved in amino acid synthesis (Ypl113c and Avt4), cell polarity 
(Dnf2) and the DNA damage response (Cdc1). If these interactions are real, then Ssf2 likely 
serves as a sensor of energy changes and DNA integrity. In addition to these proteins, Ssf2 
was also linked to a RanGTP of unknown function (Ygl164c) and Avt4, a protein belonging 
to the family of transporters required in the brain and CNS for release of neurotransmitters 
GABA-glycine. If these associations are real then Ssf2 and its higher eukaryote orthologs 
share an evolutionary conserved interaction that seems to be useful for HIV viral infection in 
higher eukaryotes (Fig. 1.7 and Section 1.3.2.5).  
During log phase, the Ssf1 particle contains several RiBi proteins, including Nop7 but 
excluding Ssf2, that have been associated to A3 and B1S+L processing (Dbp9, Nop7, Nop15, 
Npa1/Urb1, Nsa1 and Rlp7; Fig. 1.7A). The Ssf2 particle has never been analyzed in log 
phase cells. A search for its interactors revealed that it has been reported in very few RiBi 
particles. In accordance with its role in these steps, it is present in particles required for A3 
processing and B1S+L processing (Nop15, Nsa1, Rlp7) (55). Unexpectedly, Ssf2 interacts with 
Rrp15 and Nop53 using a coiled-coil motif (yeast two hybrid), whilst these proteins are absent 
from the Ssf1 particle (55, 60). Interestingly, Rrp15 is also absent from the Nop7 particle which 
suggests that both Ssf2 and Rrp15 are required in a processing pre-rRNP particle that is 
independent of the main pre-60S maturation pathway.  Together, these data are consistent 
with the Ssf1 and Ssf2 proteins performing a non-redundant function during ribosome 
biogenesis.  
1.3.2.5 Ssf1/2 orthologs in higher eukaryotes 
Interestingly, the need of a paralog for Ssf1 seems to be conserved in Xenopus laevis 
(Peter pan-b, Ppan-b) and even in humans, where Ppan2 is generated by alternative splicing 
events. In higher eukaryotes, Ppan is constitutively expressed in human cells of adults but, at 
least in Xenopus laevis, its expression is more regulated during embryogenesis (47, 61). Ppan 
mRNA is expressed in nuclei and mitochondria of cells during eye development, neural crest, 
craniofacial cartilage and pronephros development, and appears to be always associated with 
22 
regions rich in microtubule structures (47, 62). Tecza and collaborators depleted Ppan mRNA 
using a morpholino (MO) targeting both paralogs (verified by nBlast) and demonstrated that, 
during pronephros development, the essential Ppan pair is needed for embryogenesis, a 
function independent of ribosome biogenesis (47). Another study from the same group 
involved the use of the same MO and also of MO2, which targeted mRNA of Ppan-b only 
(verified by Blastn), with the same results, indicating that Ppan-b depletion is sufficient to 
affect early eye and cranial cartilage formation (62).  
In humans, the Ssf1 homolog Ppan, is always co-transcribed with the P2Y11 gene, an 
ATP receptor required during granulocytic differentiation, and up-regulation of both PPAN 
and P2Y11 genes has been linked to a specific type of leukemia (63). In HeLa extracts, up-
regulation of Ppan and Ppan-P2Y11 proteins has been observed as a response to the presence 
of HIV-1 Rev protein and Ran-GTP (64). The viral mRNA contains RRE sequences that are 
recognised by the Rev protein and complexes with Ran-GTP to transport the viral mRNA to 
the cytoplasm, where it is translated by ribosomes (65). Upregulation of PPAN is therefore a 
mechanism for forcing an increase in ribosome biogenesis.   
 
1.4 Ssf1, Ssf2 and Nop7  
1.4.1 Ssf1 and Nop7  
Isolated Ssf1-TAP complexes were previously reported to show tremendous overlap 
with Nop7-PrA ones (Fig. 1.8). This is not surprising, as both proteins assemble onto pre-60S 
particles during the same time, and both play a role during 27SA2, 27SA3 and 27SB 
processing.  However, some RiBi proteins have been found distinctly only in the Ssf1-TAP 
complexes: Puf6, a repressor of ASH1 mRNA translation; Dbp9, a RNA helicase involved in 
27S pre-rRNA processing (S and L) and Yef3, γ-subunit of elongation factor3 (30, 66). This 
suggests that Ssf1 might also belong to particles that do not contain Nop7. The Nop7 particle 
entails several very early and late factors, as it enters the pre-90S particle and is released at 
the nuclear rim. However, the Nop7 complex also contains proteins required for ETS1, ITS1 
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and ITS2 processing that are not part of the Ssf1 particle (Loc1, Nop15, Sda1, Mak10, Dhr2 
and Nop53), which suggests that it can form particles lacking Ssf1.  
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According to already published data, (A) most of the RiBi proteins associated with Ssf1 are also 
Nop7-associated during log phase while Ssf2 has been found with proteins mostly Nop7-associated. 
Ssf1, Ssf2 and Nop7 have also been linked to other proteins, suggesting that they are involved in 
other cellular functions both during (B) log and (C) lag phase. An asterix (*) indicates whenever a 
tagged version of Ssf1, Nop7 or Ssf2 was used as bait. Built according to information from M. 
Oeffinger, unpublished data, (38, 54-56, 60, 67-71).
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1.4.2 Ssf2 is most likely involved in a parallel pathway 
Ssf1 and Ssf2 paralogs have been predicted to heterodimerize and yet Ssf2 is absent in 
the Ssf1 particle (Fig. 1.8). Data analysis of high-throughput studies, have revealed that it 
belongs to the Cic1/Nsa3, Nsa1 and Rlp7 particles, like Ssf1. However, it also co-precipitates 
with RiBi proteins belonging to the Nop7 particle but not with Nop7. Moreover, it also 
directly associates with Rrp15 and Nop53, which are not part of the Ssf1 particle. As Ssf2 
compensates for the loss of Ssf1, it is likely that the compensation phenotype observed during 
ribosome biogenesis in ensured through an as yet uncharacterized alternative pathway. Thus 
studying the functions of Ssf1 and Ssf2 during ribosome biogenesis is relevant to the overall 
picture of ribosome assembly and maturation. 
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1.5 Research project  
The potential distinct and overlapping functions of the Ssf1 and Ssf2 paralogs have not 
yet been determined. Although the two proteins share 94% of their amino acids, they are able 
form complexes with histone modifiers of opposite function and with different protein sets 
during lag phase; this also seems to be the case during ribosome biogenesis in log phase (Fig. 
1.8) (38, 55, 56, 60). Both proteins have been predicted to bind to ITS1 pre-rRNA and play a role 
in preventing premature cleavage at site C2, which is located within ITS2 (Table I and Fig. 
1.9) (53, 54).   
 
Table I: Summary of what is known about Ssf1/2 and Nop7 
 Nop7 Ssf1 Ssf2 (94%identical to Ssf1) 
Cellular 
distribution Nucleolar, punctuated at nuclear rim 
(36) Nucleolar (50, 54) 
abundance 
(molec/cell) 4530 
(30) 8150 (30) 1350 (30) 
Known 
subcomplexes 
formed 
Ytm1/Erb1/Nop7 (39) N/D 
C term tail of Erb1 (39) N/D 
- Rrp15(60) 
- Nop53 (60) Direct 
interactions  
Nop7/Ssf1 in Xenopus laevis (47) N/D 
Binds pre-
rRNA? 
5’ of 25S (12) Predicted to bind ITS1 near the 5’ of 5.8S (53) 
Function 
during pre-
rRNA 
maturation 
Scaffold protein (36) N/D 
Depletion 
phenotype 
- Accumulation of 35S (36)  
- Aberrant 23S, premature C2 cleavage  (36) 
- Pre-rRNA reduction of 27SB, 7S, 6S (36) 
- Mature rRNA reduction: 25S, 5.8SS (36, 40) 
- Switch to 5.8SL- ribosome production (36) 
- Accumulation of 35S (54) 
- Reduction of 27SA2, 27SB, 20S, 7S, 6S(54) 
- Reduction of all mature rRNAs, including 5S (54) 
- Accumulation of aberrant 23S, 5’ETS-D, A2-C2(54)  
- Premature C2 cleavage (54) 
- Reduction of all mature rRNAs (54) 
Known - required for exit from G0  DNA replication 
- necessary for yeast budding (49, 50) 
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Nop7 is a protein predicted to have several functions, as it is found in at least three 
distinct sub-nuclear compartments and associated with changing pre-ribosomal complexes (36). 
The protein interacts with the 5’ coding region of 25S rRNA and its depletion causes a mild 
pre-mature C2 cleavage phenotype (Fig. 1.9) (12, 36). The trimeric Nop7-Erb1-Ytm1 complex 
has been extensively studied; the complex is only found in one of the pre-ribosomal 
complexes Nop7 can be found in during ribosome biogenesis, which is at the stage of 27SA3 
processing to 27SBS (39). Nop7 is a major player in the main LSU maturation route that 
generates 5.8SS-containing ribosomes.  
Recent evidence reported a direct interaction between Ssf1 and Nop7 in Xenopus 
laevis during pronephros development, an interaction independent of the proteins function in 
ribosome biogenesis (47). Similar information has already been used to identify a set of 
proteins that enter the pre-rRNP particle as a subcomplex during ribosome biogenesis, like the 
Rpf2 module required for 5S rRNA incorporation into the pre-60S particle following C2 
cleavage (17). A comparison of Ssf1 and Nop7 particles has revealed that both have many RiBi 
 
Figure 1.9: Similar to Ssf1/Ssf2 depletion, Nop7 depletion results in premature C2 
cleavage. 
Primer extension performed from probe 007 and resolved on 6% polyacrylamide gel showed that (A) 
Nop7 depleted cells  accumulate 26S pre-rRNA (as demonstrated by a stop at site C2), which is also 
observed upon (B) Ssf1 and Ssf2 depletion. Adapted from (36) and (54). 
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proteins in common yet also contain distinct RiBi proteins specifically involved in A3 and B1 
processing, which suggests that Ssf1 and Nop7 are involved in common as well as 
overlapping pre-60S maturation pathways (Fig. 1.8). On the other hand, Ssf2-associated 
particles have never been characterized, and this protein is not found in either Ssf1and Nop7 
particles but with RiBi proteins involved in 27S processing, suggesting that it has a non-
redundant function to Ssf1 during ribosome biogenesis. 
 
 
Further investigation of Ssf1 and Nop7 interactions during ribosome biogenesis and 
the better understanding of the role of Ssf2 during ribosome biogenesis and other cellular 
processes therefore become relevant.    
The aim of this project is to uncover the presence of parallel pathways during 
ribosome biogenesis that may involve different paralogs of known ribosome biogenesis 
factors, namely Ssf1 and Ssf2. 
 
My main hypotheses are: 
1. Ssf1 and Ssf2 associate with distinct pre-rRNP particles and subcomplexes. 
2. Nop7 and Ssf1 are genetically linked and function along the main LSU  
 maturation pathway. 
3. Nop7 and Ssf2 are not genetically linked.  
4. Ssf2 functions along an alternative parallel LSU maturation pathway,  
 independent of Ssf1 and Nop7.  
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To validate my hypotheses, I will:  
1. Use a PCR-based (polymerase chain reaction) strategy to generate  
 yeast strains to study Nop7/Ssf1/Ssf2 interactions.  
2. Use ssAP (single step affinity purification) to compare Ssf1 and Ssf2  
 complexes and identify potential subcomplexes. 
3. Use the generated strains to modulate one or two of the target proteins (SSf1, 
Ssf2 and/or Nop7) in order to uncover the presence of parallel pathways by 
monitoring changes in  
i. cell growth  
ii. total protein levels for the target factors  
iii. pre-rRNA processing  
iv. mRNA levels of the target proteins  
 
As both Ssf1 and Ssf2 can form homo or heterodimers, bind pre-rRNA and, 
potentially, also bind Nop7, I will also generate the necessary tools to validate these 
interactions in vitro. 
Hence I will: 
4. Use recombinant Ssf1, Ssf2 and Nop7 for in vitro interaction studies.  
  
 
 
 
 
 
 
 
2 Material and methods 
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2.1 General recipes and protocols 
2.1.1 Media composition 
Here is the media composition list used when manipulating bacterial and yeast strains. 
For agar plate preparation, the media was supplemented with 2% agar before autoclaving. 
 
2.1.1.1 For bacterial manipulation 
LB-Luria Broth: 1%(W/V) Bacto-tryptone, 0.5%(W/V) yeast extract, 1%(W/V) NaCl. 
Autoclaved. 
For agar plate preparation, the media was supplemented with 2% agar before autoclaving. 
 
SOC-Super optimal broth with catabolic repression: 2%(W/V) vegetal peptone, 0.5%(W/V) 
yeast extract, 10mM NaCl, 2.5mM KCl, 10mM MgCl2, 10mM MgSO4, 20mM glucose. 
Autoclaved. 
 
Table II : List of the antibiotics used when manipulating bacteria  
 
2.1.1.2 For yeast manipulation 
YPD: 1%(w/v) yeast extract, 2%(w/v) peptone, 2%(w/v) glucose. Autoclaved. 
YPGRS: 1%(w/v) yeast extract, 2%(w/v) peptone, 2%(w/v) galactose, 2%(w/v) raffinose, 
2%(w/v) sucrose. Autoclaved. 
 
Drop-out media: 1.5%(w/v) yeast nitrogen base (amino acid and ammonium sulfate free), 
5%(w/v) ammonium sulfate, 1X amino acids except methionine and/or histidine, 2% of each 
sugar needed. Filter sterilized. The media was prepared with freshly autoclaved water. 
Antibiotic Abbreviation Solubilised in 1000X stock (mg/mL) 
Ampicillin Amp 50%EtOH 50 
Kanamycin Kan Water 50 
Chloramphenicol CAM 100%EtOH 35 
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Drop-out media with antibiotics, ammonium sulfate was replaced with 0.1%(w/v) of  
monosodium glutamate. 
2.1.2 Whole cell lysis - protein extraction (72) 
The protocol used for whole cell lysis was taken from (72). Approximately 2.5 OD600 
(optical density) of cells were incubated for 5min (minutes) at RT (room temperature) with 
200μL of 0.1M NaOH. The pellet was then resuspended in 50μL of modified Laemmli SDS 
sample buffer  (detailed below) and stored at -20°C. Prior to loading, the samples were boiled 
for 3min at 95°C and spun. A 20μL volume of supernatant (1OD600 of cells) was loaded on a 
pre-cast 4-12% Bis-Tris gel.  
The modified Laemmli SDS sample buffer is a mixture of 0.06M Tris-HCl pH6.8, 5% 
glycerol, 2%SDS 4% β-mercaptoethanol and 0.0025% bromophenol blue, as described 
in (72). 
2.1.3 Western blot (WB) 
Bis-Tris gels (4-12%) were run at 185V for approximately 45min in a Tris-Tricine 
buffer. Protein transfer to nitrocellulose (NC) membrane or activated polyvinylidene 
difluoride (PVDF) membrane was performed for 2 hours (60V, 4°C) or overnight (30V, 4°C) 
in Towbin buffer. For WB analysis of yeast strains, antibodies PAP (α-PrA-HRP), α-HA 
(mouse), α-Nop7 (rabbit) and α-β-actin (mouse) were used (Table VIII). For recombinant 
protein purification, α-GST-HRP and α-HIS (mouse) antibodies were used (Table III).  
The membranes were blocked in 1XTBST and 5% non-fat milk or BSA rocking for 20 
min to 1hour at RT. The probing with antibody was usually performed rocking for 1hr at RT. 
If a secondary antibody was needed (α-mouse or α-rabbit), the membrane was washed twice 
in 1XTBST (5min, rocking) before probing the secondary antibody (30min, RT). Three 
washes in 1XTBST (5min, rocking) were performed prior to detection.  
To minimize background when probing secondary antibodies on PVDF membranes, 
the solution was supplemented with SDS and Tween 20 to a final concentration of 0.01% and 
0.1% respectively.  
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Table III : List of antibodies used  
Antibody Animal Provider 
Method of 
detection 
Concentration 
used 
Diluted in 
PAP (α-PrA-HRP) Rabbit Sigma ECL 1:7500 TBST/milk 
α-HA Mouse Genscript α-mouse 1:5000 TBST/milk 
α-GST-HRP Rabbit Genscript ECL 1:3000 TBST/milk 
α-HIS Mouse Sigma α-mouse 1:7500 TBST/milk 
α-Nop7 Rabbit (39) α-rabbit 1:7500 TBST/milk 
α-β-actin Mouse Abcam α-mouse 1:7500 TBST 
α-mouse Cy600 or Cy800 Llama LI-COR Odyssey* 1:20000 TBST/milk 
α-rabbit Cy600 or Cy800 Llama LI-COR Odyssey* 1:10000 TBST/milk 
*Odyssey: Infrared imaging system (LI-COR Biosciences) 
10X TBST, 1L: 24.2g Tris, 80g NaCl, 21mL Tween20 brought to pH 7.6 with HCl 
Tris glycine buffer, 1L: 3.03g Tris, 14.4g Glycine, 1g SDS 
Tris-trycine buffer, 1L: 3.63g Tris, 3.59g Trycine, 0.5g SDS 
Towbin buffer, 1L: 100mL MeOH, 3.03g Tris, 14.4g Glycine 
For PVDF membrane activation, the membrane was washed with MeOH and equilibrated in 
towbin buffer. 
2.1.4 Casting homemade gels – BioRad’s Mini protean 
To make home-made tris-glycine gels BioRad’s Mini protean’s system was used. The 
percentage of the gel varied depending on the size of the protein being analysed.  
 
Table IV : Volume (mL) of components needed to make resolving and stacking gels  
Resolving gel (10mL) Stacking gel (5mL) 
Components 
6% 8% 10% 5% 
Water 5.3 4.6 4.0 3.4 
30% acrylamide mix 2.0 2.7 3.3 0.83 
Tris solution* 2.5 2.5 2.5 0.63 
10% SDS 0.1 0.1 0.1 0.05 
10% ammonium 
persulfate (APS) 
0.1 0.1 0.1 0.05 
TEMED 0.008 0.006 0.004 0.005 
Protein size (kDa) 180-200 150 50-100 - 
*: For resolving gels, the Tris solution is 1.5M Tris-Cl pH 8.8. For stacking gels, it is 1M Tris-Cl pH6.8. 
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2.1.5 chDNA purification and DNA purification 
2.1.5.1 chDNA purification 
About 2.5ODs of cells were recovered from an o/n culture or from a plate and 
resuspended in 100μL of ultrapure water. The cells were treated with 100μL of breaking 
buffer (200mM NaOH, 2.5% SDS, 500mM NaCl, 2mM EDTA) for 5min at RT. 
Neutralisation was performed with 300μL of 0.5M Tris-HCl pH 6.8 and briefly vortex mixed 
to then add 500μL of a Phenol/Chloroform/Isoamyl alcohol (Ph/Cl/IAA corresponding ratio 
of 25:24:1). After thoroughly vortexing the sample at VMAX for 1min, the sample was spun at 
VMAX for 10minutes. The supernatant was then mixed to 2volumes of cold 100% EtOH and 
spun at VMAX for 10minutes at 4°C. The resulting pellet was then washed with 500μL of 70% 
cold EtOH, spun at VMAX for 3minutes at 4°C and air dried. The pellet was then resuspended 
in 50μL of ultrapure water, nanodrop quantified and the chDNA (chromosomal 
desoxyribonucleic acid) was adjusted to a final concentration of 250ng/μL for diagnostic 
PCRs (polymerase chain reaction) and of 100ng/μL cassette amplifications from chDNA. All 
DNA samples were stored at -20°C. 
 
2.1.5.2 DNA purification  
Gel extraction and column purification were performed during molecular cloning. 
E.Z.N.A Gel Extraction Kit from Omega bio-tech was used as described by the supplier. 
 
2.1.5.3 Gel extraction 
For DNA extraction of digested vector or insert from an agarose gel, the DNA was 
first migrated on a 0.5 or 1% agarose gel. The DNA band corresponding to the right 
molecular size was excised from the gel, weighted and melted at 55°C with a 1μL/μg volume 
ratio of binding buffer (XP2) supplied in the kit. The mix was passed through a HiBind DNA 
Mini Column by centrifuging for 1min at 10 000xg. The column was then washed once with 
300μL of XP2 buffer and twice with 700μL SPW Wash Buffer, each time centrifuging for 
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1min at 13 000xg. A final centrifugation of the column alone (2min, 13 000xg) was 
performed to completely remove the EtOH (from the wash buffer) prior to elution. The insert 
was then eluted in 30μL of a 50mM Tris-Cl pH8.5 solution provided in the kit.  
2.1.5.4 Column purification 
Column purification of DNA was performed to remove buffers and enzymes no longer 
needed. The protocol was the same as for gel extraction except that an equal volume of XP2 
binding buffer was added in the first step and no heating was necessary. Also, an additional 
washing with 700μL SPW Wash Buffer was performed. 
2.1.6 RNA extraction (73) and purification 
RNA extraction form yeast samples were performed using Trizol (Invitrogen) as 
described in (73). A total of 17-26 OD600 of cells (2.5-5.0x108cells) were pelleted and washed 
three times with water. The pelleted cells were resuspended in 500μL Trizol and 200μL of 
DEPC treated glass beads (0.4-0.5mm diameter). Cell walls were disrupted by vortexing (at 
least 6min, 4°C). The mixture was then incubated at 70°C (5 min) and at RT (3min). To 
separate the aqueous phase, 200μL of chloroform, mixed (vortexing for 15 sec), let stand at 
RT (3min) and centrifuged (VMAX, 15min, 4°C). Most of the aqueous phase (350μL) was 
transferred into a new tube containing 500μL of isopropanol. RNA precipitated at RT for 
10min and was pelleted by centrifugation (VMAX, 15min, 4°C). The pellet was washed once 
with 70% EtOH (1mL), centrifuged (VMAX, 5min, 4°C), air dried and resuspended in RNAse-
free water or formamide. The RNA was quantified (nanodrop) and stored at -80°C.  
For primer extension and qRT-PCR analysis, the RNA in water was DNAse treated 
using RNeasyMini-Kit (QIAGEN) as described by the manufacturer and quantified. 
2.1.7 Northern blot  
For northern blot analysis of high molecular weight pre-rRNA, 10μg of total RNA was 
resolved in a 1% agarose/1.25% formaldehyde gel (11X14cm) in 30mM tricine, 30mM 
triethanolamine, as described in (74). Passive transfer of the RNA onto HyBond-N+ nylon 
membrane was performed overnight in 10X SSC. To resolve low molecular weight species, 
10μg of total RNA was run in an 8% polyacrylamide/ 7M urea gel in 1X TBE as described in 
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(36). RNA transfer onto HyBond-N+ nylon membrane was performed overnight in 0.5X TBE 
buffer (12V). Following transfer, RNA was cross-linked to the nylon membrane (stratalinker, 
1200J/m2, 254nm) and probed at 37°C essentially as described in (36) but using fluorescently 
labelled probes (labelling protocol is detailed below). Briefly, the membrane was pre-
hybridized with pre-hybridization buffer (6XSSPE, 5X Denhardt’s, 2% Fish Sperm DNA, 
0.2% SDS) pre-heated to 65°C and let cool to 37°C for 15minutes. The membrane was 
incubated with the fluorescent probe (20pmol) for at least 1 hour and washed once with 6X 
SSPE (15min, 37°C) and scanned using Odyssey infrared imaging system (LI-COR 
Biosciences). The approximate locations of the probes used in this study are schematised in 
the following figure:  
 
A  
001: 5’-CCAGTTACGAAAATTCTTG; 002: 5’-GCTCTTTGCTCTTGCC;  
003: 5’-TGTTACCTCTGGGCCC; 005: 5’- ATGAAAACTCCACAGTG 
006: 5’-AGATTAGCCGCAGTTGG; 007: 5’-CTCCGCTTATTGATATGC;  
008: 5’-CATGGCTTAATCTTTGAGAC; 017: 5’-GCGTTGTTCATCGATGC;  
020: 5’-TGAGAAGGAAATGACGCT; 041: 5’- CTACTCGGTCAGGCTC.
B 
 
Figure 2.1: Probe sequences and approximate target location in the pre-rRNA 
(A) The probes sequences and (B) the approximate location they target in the pre-rRNA  were 
constructed according to data from (36, 54). 
 
10X TBE, 500mL: 54g Tris, 27.5g Boric acid, 20mL 0.5M EDTA pH8. 
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2.1.7.1 Probe labelling 
For northern blot (NB) detection of pre-rRNA species, probes were ordered from IDT with a 
5’ and 3’ amine. For fluorescent primer extension, the primer order had only one amine (5’). 
The following protocol was used for probe labelling. 20μg of probe was resuspended in 20μL 
of 100mM NaCO3 pH 9 buffer and incubated (no light, overnight RT) with 50μg of Dylight 
NHS ester 800 (Thermo Scientific). The following day, a nucleotide removal kit (Quiagen) 
was used as described by the supplier. The eluted labelled probe was quantified (nanodrop) 
and 20pmol of probe was used for NB detection and 10pmol of probe was used for each 
primer extension reaction.  
2.1.8 Reverse transcription and primer extension 
For both reverse transcription and primer extension, SuperScript II reverse 
transcriptase (RT from Invitrogen) was used. 
The reverse transcription reaction was performed as described by the supplier using 
random hexamers (Operon). Briefly, 1μg or RNA was mixed to 100ng of random primers and 
1μL of dNTP mix (each 10mM) in a final volume of 13μL. This mix was incubated at 70°C 
for 5 minutes and then let on ice for 1 minute. 4μL of 5X first strand buffer  and 2μL of 0.1M 
DTT (both supplied in the kit) were added and the new mix was incubated at room 
temperature (RT) for 2 minutes, after which 1μL of the enzyme was added for total volume of 
20μL. This mix was incubated at RT for 10 minutes and then at 42°C for 50 minutes. To 
inactivate the enzyme, the reaction mix was incubated at 70°C for 15 minutes. The cDNAs 
obtained were used for quantitative real-time PCR (qRT-PCR). As negative controls for the 
qRT-PCR reaction (RT-), an additional μg of total RNA per sample was prepared in parallel 
but water was added instead of the enzyme.  
Primer extension analysis was performed using 1μg of total RNA per sample 
essentially as described in (75). Briefly, a 13μL mix of total RNA, 10pmol of fluorescently 
5’-labelled probe 007 and 1μL of 10mM dNTP mix was incubated at 95°C for 1 minute and 
slowly let cool to 42°C for 3minutes. Then, 4μL of 5X standard buffer and 2μL of 0.1M DTT 
was added and incubated at 42°C for 2min. 1μL of enzyme was added and the reaction was 
performed at 42°C for 50 min, after which 2μL of 3M NaOAc pH 5.2 and 40μL of 100% 
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EtOH were used to stop the reaction. After centrifugation, the pellet was resuspended in 10μL 
of loading dye (7M urea, 1X TBE, bromophenol blue). 1.5μL of this mix was separated on an 
8% polyacrylamide gel and detected using Odyssey infrared imaging system.  
2.1.9 Plasmid purification 
For plasmid purifications, Wizard Plus SV Minipreps DNA purification system from 
Promega was used. At each step during cell lysis, mixing by ups and downs or inversion was 
preferred to vortexing. All centrifugation steps involving the column were performed at VMAX 
(13.2 Krpm) and RT.  
Essentially, cells from 5mL of o/n grown cultures were pelleted and resuspended in 
250μL of Cell resuspension buffer, lysed by adding 250μL of Cell Lysis Solution and 10μL of 
alkaline protease solution and incubating for 5min at RT. To neutralize the solution, 350μL of 
neutralization solution was added and then the lysed cells were centrifuged at top speed for 
10min at RT. The supernatant was passed through the supplied spin column by centrifugation 
for 1min. The column was then washed with 750μL and then with 250μL of wash solution by 
centrifugation for 1min. Remaining EtOH was removed from the column with an additional 
centrifugation step (2min) and then the plasmid was eluted in 50μL of nuclease free water. 
The plasmid was quantified (Nanodrop), brought to a final concentration of 100ng/μL and 
visualised on a 0.5% agarose gel. Plasmids were stored at -20°C. 
 
2.1.10 Bacterial transformation 
For plasmids transformed in NEB turbo cells (Table X), NEB’s protocol was used. In 
summary, the competent cells were thawed on ice and 50μL of cells were gently mixed and 
then incubated on ice for 30minutes with 100ng of plasmid. The cells were then heat shocked 
for 30sec at 42°C then let stand on ice for 5min. After adding 950uL of SOC media to each 
tube, the cells were incubated for 1hr at 37°C at 500rpm. The cells were then pelleted and 
resuspended in 100μL of SOC media for spreading onto an LB+Res plate (antibiotic depends 
on the plasmid that was transformed) and incubated for 16hrs at 30°C. 
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For transformations in pLYS and RipL cells (Table V), the protocol varied slightly: 
LB media was used instead of SOC and the 5min incubation on ice following the heat shock 
was not performed. These cells were incubated at 37°C o/n. 
 
Table V: List of bacterial cells used for plasmid preparation and expression of 
recombinant protein  
Purpose ID Strain Genotype Antibiotic resistance 
Plasmid 
preparation NEB Turbo 
NEB Turbo competent E. 
coli (High Efficiency) 
F´ proA+B+ lacIq Δ lacZ M15/ fhuA2 Δ(lac-
proAB) glnV gal R(zgb-
210::Tn10)TetS endA1 thi-1 Δ(hsdS-mcrB)5 
- 
RIPL BL21-CodonPlus (DE3)-RIPL competent cells 
E. coli B F- ompT hsdS(rB-mB-) dcm+Tetr 
galλ(DE3) endA Hte [argU proL Camr] 
[argU ileY leuW Strep/Specr] 
Tet r Camr 
Strep/Sper Expression 
vector 
pLys BL21-Gold(DE3)pLysS competent cells 
E. coli B F- ompT hsdS(rB-mB-) dcm+Tetr 
galλ(DE3) endA Hte [pLYS Camr] Tet 
r Camr 
 
2.2 Molecular cloning 
To ensure the proper directionality of the insert, primers were designed so that BamHI 
and Xho1 restriction enzyme sites flanked the gene’s ORF at its N and C terminal respectively 
during molecular cloning. For N-terminal GST-TEV tagging, the pGEX4T1 vector was used. 
For N-terminal His6-TEV tagging, the pET28 MHL GS vector was used. This vector is the 
pET28-MHL vector in which a BamH1 site (GS) was added in house between the TEV 
cleavage site and Nde1 restriction enzyme site. 
 
Table VI: Plasmids used for molecular cloning  
RES position in 
plasmid (bp) Plasmid 
Plasmid 
size (bp) 
Resistance 
Type of 
N-term 
tagging BamH1 Xho1 
Expected length of 
vector after RE 
treatment (bp) 
Reference 
pGEX4T1 4969 Amp GST-TEV 930 954 4786 GE Healthcare 
pET28- 
MHL GS 
7331 Kan His6-TEV 5125 7166 5287 Oeffinger lab 
 
The plasmids above were cut using BamH1 and Xho1. Of the digestion products, the 
one with the expected length (Table VI) was gel purified and the ends were treated with 
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Antarctic Phosphatase to change the phosphate group into an OH and prevent re-ligation of 
the vector.  
 
The following table shows the primers used to create the inserts for molecular cloning 
(Table VII). All primers were designed to have 6 random nucleotides at their 5’, followed by 
a restriction enzyme site (RES), a start (for forward primer) or stop codon (for reverse primer) 
and 27nts complementary to the beginning of the gene (after the start) or its end (before the 
stop codon). For the 3’ primers used with the pET28-MHLGS vector, 2 additional stop 
codons were added, as recommended in the pET28-MHL parental vector specifications sheet.  
 
Table VII: Primers used for molecular cloning  
 
2.2.1 Insert preparation 
The expected size of the insert depended on the length of the target gene listed in table 
VIII + 30 to 36nt. The target gene ORF was amplified by PCR from purified W303a chDNA 
using the primers listed in table VII. The annealing temperature corresponded to the lowest 
salt-adjusted Tm value minus 3°C (Table IX). The PCR recipe and program were used are the 
following:  
PCR mix final concentrations:  iProof buffer 1X, 5’and 3’ primers 0.5pmol/ul, 200μM of each 
dNTP, 2% DMSO, 1ng/uL chDNA, 0.25U/uL Taq. 
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Table VIII: Size of genes selected for molecular cloning  
Gene SSF1 SSF2 NOP7 
gene length (nt) 1362 1362 1818 
 
Table IX: PCR program used to amplify the insert from chDNA  
Temperature (°C) Time (min:sec) Number of cycles 
98 0:30 1X 
98 0:05 
SSF1/2: 66  NOP7:63 0:10 
72 0:30 
30X 
72 5:00 1X 
4 Forever  
 
The insert was then purified form a 1% agarose gel using the gel extraction protocol 
detailed in section 2.1.5.3 and then digested in parallel with the parental vector. 
 
2.2.2 Restriction enzyme digestion  
Because both BamH1-HF and Xho1 restriction enzymes (RE, from BioLabs) are 
compatible with the same buffer, the digestion of both the insert and vector using these 
enzymes could be performed simultaneously. The inserts and the vectors were each treated 
with both restriction enzymes for 1hr to o/n at 37°C in a total volume of 50μL. The reaction 
mix contained final concentrations of 1X Buffer4, 0.5μg/μL BSA, 3μg of vector or 30μL of 
purified insert and 1.5(U/μL) active units of each enzyme. The insert was then cleaned 
following the enzymatic clean-up protocol (Section 2.1.5.4) and then Nanodrop quantified 
and visualised for purity in a 1% agarose gel. 
To make sure it did not re-ligate itself, the vector was treated with Antarctic 
Phosphatase. To do so, the RE-treated vector was run on a 1% agarose gel and the band 
corresponding to the expected size of the digested vector (Table VI) was extracted from the 
gel (Section 2.1.5.3). The eluted vector was treated with Antarctic Phosphatase for 15-30min 
at 37°C in a total reaction volume of 50μL containing 30μL purified vector, Antarctic 
Phosphatase 1X buffer, Antarctic Phosphatase 0.1U/μL. The reaction mix was incubated at 
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65°C for 5min to fully inactivate the enzyme and then let for 5min on ice. The vector was 
quantified using the Nanodrop and visualised for purity in a 1% agarose gel prior to ligation.  
 
2.2.3 Verification of relative abundance of V and I and plasmid 
ligation  
To efficiently ligate the vector with the insert, the ratio of insert to plasmid had to be 
of 3:1. At the end of the procedure, 100ng of plasmid was needed to transform into the rapid-
growing bacterial NEB turbo cells. To ensure proper ratio, the following calculation was 
performed. This calculation allowed us to take into account the size of the linearized vector 
and of the insert to ensure that the ratio was of 3.  
 
 
Prior to ligation, a final verification on agarose gel was performed with 50ng of insert 
and digested/antarctic phosphatase-treated plasmid. The amount of insert calculated was 
incubated with 100ng of vector 1hr at 16°C, using the smallest volume possible (eg. 10μL). 
The reaction-mix contained 1X T4 DNA ligase buffer, 100ng of plasmid, calculated amount 
of insert, 1μL T4 DNA ligase. 
The plasmids were transformed into NEB turbo cells and grown for 8 hours at 37°C 
and then 15-20 single colonies were selected from the transformation plate. These 
transformants were grown in 500μL LB+Res at 37°C for 2-3hours while shaking at 500rpm. 
Then, 500μL of Ph/Ch/IAA was added and thoroughly vortexed, then spun at VMAX, 56μL of 
10X buffer was added and 5μL of the top layer was loaded on a 0.5% agarose gel to compare 
the clone’s plasmid to the parental vector. Because the plasmid is now different in size, it will 
migrate differently in its supercoiled and circular forms (Fig. 2.2). 
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 Parental 
Vector 
 New plasmid 
  
  
Nicked 
Linear 
Supercoiled  
  
Figure 2.2: Expected bands when screening for positive plasmid transformants 
As the new plasmid is expected to be of higher molecular weight that the parental plasmid, 
the nicked, linear and supercoiled forms of the new plasmid are expected to migrate 
differently on gel. 
 
 
From this preliminary analysis, 5-6 potentially positive clones per plasmid were grown 
in liquid LB+resistance (3-5mL) o/n at 30°C, plasmids were purified and quantified using 
Nanodrop. To test for positive plasmids, a restriction enzyme digestion was performed using 
500ng of plasmid in a total volume of 10 to 20μL of RE digestion reaction using restriction 
enzymes BamHI and XhoI (detailed above). The bands were resolved on 1% agarose gel. 
Three positive clones per plasmid were sent for sequencing using T7 promoter, T7 terminator 
and the primer internal for the ORF of the gene. The internal primer was chosen about 500np 
after the start of the gene (Table X). 
  
Table X: Primers used to sequence-validate the plasmids    
# Primer name 
pG
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1 
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Sequence Sa
lt 
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T m
 (°
C
) 
1 5’_500bpSeqSSF1 √ √ Fwd 5` TCT ATG TTT CAG AAT ATT TTC 50 
2 5’_500bpSeqSSF2 √ √ Fwd 5` TCC ATG TTC CAG AAT ATT TTC 54 
3 5’_500bpSeqNop7 √  Fwd 5` TTA GCC TAT GTT GCC AAG GAA 57 
4 T7 Promoter √ √ Fwd 5` TAA TAC GAC TCA CTA TAG GG 48 
5 T7 terminator √ √ Rev 5` GCT AGT TAT TGC TCA GCG G 54 
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2.3 Recombinant protein  
2.3.1 Recombinant protein expression 
Once the clones were confirmed by sequencing, the plasmids were transformed in 
pLYS and RipL cells because they were available in the lab (Table X). Recombinant protein 
expression was assayed for each transformant using varying amounts of IPTG (0.5 or 1mM) 
and different temperatures (16°C, 25°C and 37°C).  A 300μL aliquot was taken at time-points 
0, 2, 4 and o/n. Then the best induction conditions were selected for large-scale inductions 
(Table XI). 
 
Table XI: List of plasmids generated and optimized conditions for optimal protein 
expression 
 
Plasmid name 
Plasmid 
size (bp) 
Background Resistance N-term tag 
Optimized induction 
conditions 
Reference 
GST-TEV-NOP7 6763 pGEX4T1 Amp GST-TEV pLYS, 1mM IPTG, 16°C o/n This study 
GST-TEV-SSF1 6307 pGEX4T1 Amp GST-TEV RipL, 0.5mM IPTG, 16°C, o/n This study 
GST-TEV-SSF2 6307 pGEX4T1 Amp GST-TEV pLYS, 1mM IPTG, 16°C o/n This study 
HIS6-TEV-SSF1 6649 pET28 MHL GS Kan His6-TEV pLYS, 1mM IPTG, 16°C o/n This study 
HIS6-TEV-SSF2 6649 pET28 MHL GS Kan His6-TEV RipL, 1mM IPTG, 16°C o/n This study 
 
2.3.1.1 Small-scale optimisation 
Each plasmid was transformed in pLYS cells. A single colony was streaked and then 
grown o/n in 5mL of LB+CAM+Res at 37°C (Tables VII, X and XVI). The following day, 
300μL of the o/n culture was grown for 2hrs in 6ml of fresh LB+CAM+Res (37°C), resulting 
in an OD600 between 0.6-0.8. The cells were then divided in two 3mL aliquots and induced 
with 0.5 or 1mM IPTG. The 3mL aliquots were then divided into three aliquots of 1mL and 
shifted to 16°C, 25°C or 37°C. At each time-point (0, 2, 4hrs and o/n), a 300μL aliquot of 
culture was sampled for whole cell lysis treatment followed by WB analysis. The gels were 
run on a 10% Tris-glycine SDS-PAGE (Table IX) and blotted in activated PVDF membranes 
for immunodetection. To visualize the relative abundance of the protein, the membranes were 
stained for 1min with coomassie and destained with several washes in a destaining solution 
containing 25% ethanol.  
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The same procedure was performed for each plasmid when transformed in RipL cells. 
Once the best protein induction conditions were determined, large scale inductions were 
performed from each plasmid.   
 
2.3.1.2 Recombinant protein expression  
Each plasmid was transformed into the expression vector chosen from the optimization 
trials. The cells were streaked from glycerol stock onto LB +CAM +Res plates at 37°C, 
150rpm, o/n. The following day, the clones were each grown over-day up to an OD600~0.6 at 
37°C, 150rpm (pre-culture). For each liter of induced culture, 50mL of pre-culture was 
prepared. The cells were let at 4°C o/n. The following day, the pelleted pre-culture cells were 
resuspended into 1L of LB media+CAM+Res and grown up to a final OD600 of 0.6. Then, the 
media was spiked with IPTG and shifted to the induction temperature determined during the 
optimisation step. The following day, the cells were pelleted at 4°C, 4000rpm for 20min. The 
pellet was weighed, flash-frozen with liquid nitrogen, and kept at -80°C for recombinant 
protein purification. 
 
2.3.2 Recombinant protein purification 
2.3.2.1 His6-tagged proteins 
For each gram of pellet, 7mL of binding buffer (100mM HEPES pH7.4/500mM 
NaCl/20mM imidazole/10 µg/mL antipain/2 µg/mL leupeptin/1 µg/mL pepstatine/2 µg/mL 
aprotinine/1 mM PMSF/70KU lysozyme) was used. The thawed sample was vortex 
resuspended, homogenized on ice (polytron, 1min) and incubated for 30min at 4°C on a 
rotating wheel, to let the lysozyme break down the cell walls. After 30min of incubation, the 
cells were sonicated using 5 cycles of 1min sonication, 1min on ice. DNA was broken by 
passing the mix several times through a syringe. The SN obtained after centrifugation 
(16 000g, 20min, 4°C) was filtered (0.22μm), de-gazed and passed into a HP His-Trap 1mL 
column HP from GE healthcare (FPLC). The column was washed with a volume of wash 
buffer (100mM HEPES pH7.4/500mM NaCl/50mM imidazole) equivalent to the injected 
sample and the proteins bound to the column were eluted in 4mL fractions of elution buffer 
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with increasing imidazole concentrations (100mM HEPES pH7.4/500mM NaCl with 75, 100, 
300 or 500mM imidazole). 
For analysis, 60μL of every fraction was recovered, mixed with 12μL of 6Xloading 
dye, and boiled (95°C, 5min). To validate the fractions to pool for the following steps, 1/500th 
of each fraction were resolved on two 10% Tris-glycine SDS-PAGE gels. One of them was 
Coomassie stained (Fig. 2.3 A) and the other was transferred on a NC membrane and blotted 
with α-HIS antibody (Fig. 2.3 B). The fractions containing the protein were dialyzed against a 
100mM Hepes pH8.0/ 10mM KCl/ 10mM MgCl2/ 150mM NaCl/ 20% glycerol buffer and 
concentrated on a PALL concentrator with a MWCO of 30kDa as specified by the supplier. 
To verify the amount of recombinant protein obtained and potentially lost, a 37th of input, 
retention and filtrate samples were resolved on a 4-12% Bis-Tris gel together with BSA 
samples of varying concentrations, later used as a standard curve. The resolved samples were 
transferred to a PVDF membrane and detected using α-his (mouse) as the primary antibody 
and α-mouse Cy800 as secondary antibody for detection of the tag (Odyssey). The PVDF 
membrane was then Coomassie-stained to approximate the amounts of purified protein from 
the BSA standard curve. 
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Figure 2.3: FPLC purification 
His6-Ssf1 recombinant protein was purified by FPLC. A 500th of each purification step was resolved 
on a 10% SDS-PAGE gel and either (A) Coomassie stained  or (B) transferred to a NC membrane 
and blotted with α-His. For further information, refer to text. 
 
 
2.3.2.2 GST-tagged proteins 
The frozen pellet was vortex resuspended in 10mL of binding buffer (1XPBS, 70KU 
lysozyme), homogenized on ice (polytron, 1min) and incubated for 30min at 4°C on a rotating 
wheel for lysozyme treatment. The cells were then sonicated 5 for cycles of 1min sonication, 
1min on ice. DNA was further broken by passing the mix several times through a syringe. The 
SN obtained after centrifugation (16 000g, 20min, 4°C) was incubated for 1hr, 4°C, gentle 
agitation with a 750uL aliquot of homogenous ‘Glutathione Sepharose 4 fast flow’ resin from 
GE Healthcare pre-washed with binding buffer. The beads were then recovered by 
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centrifugation (1200rpm, 2min, 4°C) and washed three to four times with wash buffer 
(1XPBS). The recombinant protein was then eluted three times in 375uL of elution buffer 
(50mM Tris-Cl/10mM reduced glutathione pH8.0, 10min, RT). To validate the fractions to 
pool for the following steps 1/50th of the eluates were run on a 10% Tris-glycine SDS-PAGE, 
transferred on PVDF membrane. Eluates in which recombinant protein was detected using 
anti-GST-HRP antibody (home-made ECL detection) were pooled, the eluates were 
concentrated and switched to 100mM Hepes pH8.0/ 150mM NaCl/ 0.5mM EDTA/ 10% 
glycerol/ 0.1% triton/1mM DTT buffer by passing them on a PALL concentrator with a 
MWCO of 30kDa as specified by the supplier (Fig. 2.4). To verify the amount of recombinant 
protein loss and the efficacy of cleaning, a 37th of input, retention and filtrate samples were 
taken each time the MWCO column was used. These samples were resolved on a 10% 
tris-glycine SDS-PAGE gel next to BSA samples of varying concentrations, latter used as a 
standard curve. The resolved samples were transferred to a PVDF membrane and blotted 
using α-GST-HRP antibody for detection of the tag. The PVDF membrane was then 
Coomassie-stained to approximate the amounts of purified protein from the BSA standard 
curve. 
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Figure 2.4: Molecular weight cut-off  
The buffer was exchanged and the recombinant protein was separated from free tag using a 
molecular weight cut-off column of 30kDa. Free-tag and tagged protein were detected with 
α-GST-HRP antibody and the final concentration of purified protein was approximated using 
a BSA standard curve (μg/μL) and Coomassie staining. Here, a 37th of each purification step 
for GST-Ssf1 was resolved on a 10% SDS-PAGE gel and transferred on a PVDF membrane. 
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2.4 Construction of yeast strains 
Two different haploid baker’s yeast strains (Saccharomyces cerevisiae) were tested as 
parental: CML476a and W303a. Due to a growth defect detected in the CML476a strain, 
W303a was chosen as suitable background strain for all experiments in this project.  
 
2.4.1 Endogenous modifications in yeast 
The modifications performed were essentially I) insertion of a regulatable promoter in 
front of the gene of interest, II) deletion of the gene of interest, and III) C-terminal tagging of 
the gene of interest. In all cases, the procedure was based on the same principle: (Fig. 2.5) 
primers (Table XII) with a 5’ region (45-66nts) targeting the gene of interest and followed by 
18-20nts annealing with a plasmid containing the modification were designed. They were 
used to amplify a 1840-2236nt long cassette from a plasmid containing the modification 
(Table XIII) by PCR (Table XIV). The purified cassette was then transformed into the haploid 
background strain where it integrated into the genome by recombinant homology. A selection 
marker within the cassette allowed the survival of positive transformants in the presence of an 
antibiotic (Gal1 promoter: G418; Met25 promoter: ClonNAT, gene deletion: hygromycin B - 
hph), or the absence of an essential amino acid (C-terminal PrA tags: histidine plated directly 
onto media lacking histidine). In the case of drug-resistance cassettes, all cells were first 
grown in permissive media (YPD or SD-methionine) to form colonies. Then, positive 
transformants were selected by replica plating the colonies onto fresh, permissive media 
supplemented with the corresponding antibiotic (drug concentrations: Table XV). In the case 
of G418 resistant cassettes, a first selection was performed in 200μg active units of G418 per 
mL of replica plate and then a second replica plate was performed with a higher concentration 
of G418 (600μg of active units/mL). All transformants were tested by diagnostic PCR. The 
control primers are listed in Table XVI. The primer pairs used and their expected PCR 
product sizes indicating positive or negative transformants are listed in Table XVII. The 
standardized diagnostic PCR program is described in Table XVIII.   
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Figure 2.5: Types of modifications performed to yeast cells. 
(A) Using primers that can anneal with a plasmid and recognise a specific region in the genome, the 
cassette was amplified by PCR and cleaned. (B) The cassettes were then transformed into haploid 
cells where (C) the cassettes integrated into the genome by recombinant homology. Positive 
transformants were validated by diagnostic PCR using control primers whose approximate locations 
are schematized here.  
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Table XII: List of primers used for yeast transformations  
Pu
rp
os
e 
Name Direction Sequence* 
Used 
with 
plasmid 
5'pGal1::NOP7 Fwd 5' AAA AAT TTT GGA AGG TTA ATT AGA GAT GTG TAG TAA ATC CTG CTG GTG GAA TAC ATT TTA GAA TTC GAG CTC GTT TAA AC 1 
pG
al
 
in
se
rt
io
n 
3'pGal1::NOP7 Rev 5' AGC TTG AGA TCT GGT AAT AAA GTT TCT TGC GTT ACC TCT GGT GTT TTT CTT CTT GAT TCT GCA CTG AGC AGC GTA ATC TG 1 
5'pMet25::SSF1 Fwd 5' AAA AGA GTA TAA TCC AGA TAT AGC AGA CAA TAA AAT TTC AAG ATG CGT ACG CTG CAG GTC GAC 2 
pM
et
25
 
in
se
rt
io
n 
3'pMet25::SSF1 Rev 5' AGG TGT AAG CTG TGC ATG TGT TCT TTT CTT TTG TCT TCT CTT GGC CAT CGA TGA ATT CTC TGT CG 2 
5'HphDelSsf2 Fwd 5' TAA TAT TCG ACT AAA TTG CAG CTG CTA GGT CAC CAT CCC GCA CAT ACC TTA GAT ATT TTG GAA CTA ATG CGT ACG CTG CAG GTC GAC 3 
G
en
e 
de
le
tio
n 
3'HphDelSsf2 Rev 
5' ATC GGA GTC ATG GCT ACT ATA TGG ATA GTG ATG TTA CGT ACG 
GAG GAT ATA TAT ACA TAT CGT GCA TAA ATC GAT GAA TTC GAG CTC 
G 
3 
5'Cic1PrACterm Fwd 5' GAA AAA GAA TCT AGC GAG TCA GAA GCT GTC AAG AAG GCT AAA AGT GGT GAA GCT CAA AAA CTT AAT 4 
3'Cic1PrACterm Rev 5' GCA CCG CAC TCT ATG AAA TTC AAA TTT TTT TCT TCA CAA GAA AAA  GTC GAC GGT ATC GAT AAG CTT 4 
5'Ssf1PrACterm Fwd 5' AGT GAC AGC GAA CAT TAT GGT AGC GTA CCA GAG GAT CTA GAT AGT GAC TTA TTT AGT GAG GTC GAAGGT GAA GCT CAA AAA CTT AAT 4 
3'Ssf1PrACterm Rev 5' TAT ATG TAT CAA GTA TGC AAT TTA TCT AAA GTG AAG AAG TAT ACG TGC GTT GGT GGA TAG CCA GGC GTC GAC GGT ATC GAT AAG CTT 4 
5'Ssf2PrACterm Fwd 5' GAT GTA CCA GAG GAT TTG GAT AGT GAC TTA TTC AGT GAA GTA GAA GGT GAA GCT CAA AAA CTT AAT 4 
C
te
rm
 P
rA
 
3'Ssf2PrACterm Rev 5'  TAT GAA TAA ACA GAC ACT TCC TGG TTC TTT AAG TCC ATC GGA GTC GTC GAC GGT ATC GAT AAG CTT 4 
*: sequence underligned corresponds to start or stop, sequence in bold sequence annealing with plasmid 
 
 
Table XIII: List of plasmids used to make the cassettes used for yeast transformations  
Modification type 
# Plasmid 
Plasmid 
size 
(bp) 
Bacterial 
resistance Term Nature of tag 
Yeast 
selection 
marker 
Expected 
length of 
insert* 
(bp) 
Reference 
1 
pFA6a-Pgal-3HA-
KanMX6 
4821 Amp N pGAL1::3xHA- 
-
KanMX6 
2236 (76) 
2 pYM-N36 4347 Amp N pMet25::3XHA- clonNAT 1892 (77) 
3 pFa6a-hphNT1 4167 Amp Gene deletion Hph 1840 (77) 
4 pBXA-PrA-SpHis5 2595 Amp C -PrA -HIS5 1950-1980 (78) 
*: variation depends on the length of sequence in the primer annealing with the target gene 
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Table XIV: PCR programs used to generate cassettes from plasmids  
Plasmids 1, 4  Plasmids 2, 3 (modified from Janke 2004) 
Temperature (°C) Time (min:sec) # Cycles  Temperature (°C) Time (min:sec) # Cycles 
98 0:30 1X  98 0:30 1X 
98 0:05  98 b 1:00 
SSF1/2: 66 0:10  54 0:30 
72 0:30 
30X 
 72 1:20 
10X 
72 5:00 1X  98 1:00 
4 Forever 1X  54 0:30 
    72 1:20+0:10/cycle 
20X 
    4 Forever 1X 
a: The elongation time depended on the expected length of product specified in table XVIII: iProof taq elongates 1KB/30sec. 
 
Table XV: List of antibiotics used when manipulating yeast  
 
 
 
 
 
 
Table XVI: List of control primers used to validate yeast transformants  
 
 
 
 
Antibiotic Abbreviation 
1X concentration 
(μg/mL) 
Geneticin G418 200 and then 600 
Noursethricine ClonNAT 300 
Hygromycin B Hph 300 
Name direction Sequence Salt adjusted Tm (°C) 
5'UTR NOP7 Fwd 5' ACC ATA CAG GTC TTG ATA AAT 53.5 
5'UTR SSF1 Fwd 5' AAA AAG TAG ACG AAG AAG CTC 56.7 
5'UTR SSF2 Fwd 5' CTT CCT TTT TGG TCT TTA GTC 56.7 
3’N-ORF of KanMX6 Rev 5' ATC GCG AGC CCA TTT ATA CCC 48 
3’N-ORF of hph Rev 5' CAT CAC AGT TTG CCA GTG ATA 58.7 
3’N-ORF SSF1*/2 Rev 5' GAA GTC CTT TAC TAA TTG GTT 54.8 
5’C-ORF CIC1 Fwd 5’ TCC GAA TTG GGT TCA ATT TTC 55.5 
5’C-ORF SSF1*/2 Fwd 5' GAA GGT CAA GGA AAA GAT GAT 56.7 
5’C-ORF SSF1/2* Fwd 5' TTG GAA AGA AGA AAA GCT AGA 54.8 
3'UTR CIC1 Rev 5' CCG AGA AAC CAA TAT TCA AAT 53.5 
3'UTR SSF1 Rev 5' TCT GAG ATC TAC GTT TCC TTT 56.7 
3'UTR SSF2 Rev 5' ATA TTT ACT TTG AGG TGT TCC 54.8 
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Table XVII: Expected PCR product sizes in genomically modified and control strains 
*: Because of the high homology at the nucleotide level, most 21nt primers could anneal to a certain extent both SSF genes. 
However, their 5’ and 3’ UTR sequences are different from each other according to a blast2seq alignment. 
 
 
Table XVIII : Standardized diagnostic PCR program 
Temperature (°C) Time(min:sec) Number of cycles 
95 5:00 1X 
95 0:30 
52 0:30 
68 2:30 
39X 
68 5:00 1X 
4 Forever  
 
2.4.1.1 Regulatable promoter 
Following recombinant homology, the sequence upstream of the gene start site was 
replaced by a selection marker followed by regulatable promoter and a 3xHA tag replacing 
the endogenous promoter. The selection markers were KanMX6 for the Gal1 promoter and 
clonNAT for the Met25 promoter. Positive transformants were detected using diagnostic 
PCR. A 21nt-long primer annealing with the 5’UTR (fwd) of the gene was used. In the case of 
the MET25 promoter insertion, a 21nt-long primer annealing with the SSF1 ORF was used 
and positive transformants were expected to yield a 2152nt-long PCR product, compared to a 
260nt-long PCR product for negative transformants. For the Gal1 promoter insertion, the 
reverse primer was 21nt-long and annealed with the resistance marker used. Only positive 
transformants generated a PCR product (1387nt-long).  
Diagnostic PCR Control primer location* 
Expected PCR 
product size (bp) 
Term 
primer 
set 
tests for FWD REV If WT 
if 
modified 
Nature of modification 
1 SSF1 5’UTR modification 5'UTR SSF1 3’N-ORF SSF1*/2 260 2152 pMet25 insertion 
2 SSF2 presence 5'UTR SSF2 3’N-ORF SSF1*/2 629 - - 
3 SSF2 ORF replacement 5'UTR SSF2 3’N-ORF of hph - 935 gene replaced by hph gene 
N 
4 NOP7 5’UTR modification 5'UTR NOP7 3’N-ORF of KanMX6 - 1387 pGal1 insertion 
5 SSF2 modification 5’C-ORF SSF1/2* 3'UTR SSF2 282 2163 PrA tag 
6 SSF1 modification 5’C-ORF SSF1*/2 3'UTR SSF1 263 2177 PrA tag C 
7 CIC1 modification 5’C-ORF CIC1 3'UTR CIC1 264 2178 PrA tag 
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2.4.1.2 Gene deletion 
Following recombinant homology, the complete gene, including its start and stop 
codons, was replaced by hygromycine B resistance. To screen for positive clones, diagnostic 
PCR using a primer annealing in the 5’UTR of the deleted gene and another annealing within 
the ORF of the selection marker was performed. Only positive transformants generated a PCR 
product (935nt-long). 
 
2.4.1.3 C terminal fusion 
Following recombinant homology, the stop codon of the targeted gene and about 45 
nucleotides after the stop codon were replaced by the PrA tag, a stop codon, and the histidine 
selection marker, with its start and stop codons. The remaining 3’ UTR of the gene was 
therefore shifted downstream. To screen for positive clones, a 21nt-long primer was designed 
in the forward strand of the gene ORF. It was used in pair with a 21nt-long primer that 
annealed a region about 200nts after the endogenous stop codon of the gene. Negative 
transformants gave a 263-282nt-long PCR product and positive transformants gave a 2163-
2178nt-long PCR product. 
2.4.2 Cassette amplification and purification  
The cassettes used to carry out the genomic yeast modifications were amplified from 
the plasmids listed in Table XIII using primers listed in Table XII. Usually, 200-500μL of 
PCR mix was used with the following final concentrations: 1XiProof buffer, 0.5pmol/μL of 5’ 
and 3’ primers, 200μM of each dNTP, 2% DMSO, 1ng/μL plasmid, 0.25U/μL Taq. The PCR 
programs used depended on the plasmid and are summarized in Table XIV.  
 
The PCR product was cleaned prior to transformation into the yeast cells. The 
phenol/Chloroform/IAA clean-up procedure used is the following: the PCR reactions were 
topped to 450μL with water and vortexed for 30sec with 450μL of phenol/Chloroform/IAA 
and then spun at VMAX for 2min to separate phases. To precipitate the DNA, 400μL of the 
aqueous phase was mixed with 40μL of a 3M NaOAc pH5.2 solution, 2μL of glycogen stock 
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solution (10mg/μL) and 1000μL of 100% EtOH. This mixture was then stored at -20°C from 
30min to o/n and then centrifuged for 10min at 4°C, VMAX. The pellet was then washed with 
500μL of 70% EtOH and air-dried at RT. The pellet was then resuspended in 11μL of water 
of which 1μL was used for visualisation on gel and 10μL for transformation.  
2.4.3 Yeast transformation 
For yeast transformations, yeast cells were first made competent as follows: 50mL of 
yeast cells in log phase were grown to an OD600 of 0.6-0.8, washed with 50mL and then with 
1mL of water. The cleaned cells were recovered by centrifugation at 30sec at 4000rpm and 
made competent by treating them with 1XTELiAc (1mM Tris-Cl, 0.1mM EDTA, 100mM 
LiAc pH8.0) three times (1x1mL and 2x0.5mL). The cells were finally resuspended in 500μL 
of 1XTELiAc and 50μL of cells were used for yeast transformation. 
For the transformation, 50μL of competent cells were incubated with 10μL of cleaned 
PCR product, 5μL of carrier DNA and 300μL of PEG4000 (0.4g/mL PEG 4000, 1X TELiAc) 
for 30min at 30°C, 400rpm. The cells were then heat shocked for 15min at 42°C, pelleted, 
resuspended in 100μL of 1X TE and plated on appropriate plates. Single clones were streaked 
and validated by PCR and WB.  
All working stock solutions were prepared fresh and filter sterilized using a 0.45μm 
filter.  
 
2.4.4 Screening for yeast transformants 
2.4.4.1 Diagnostic PCR 
To screen for positive transformants, diagnostic PCRs were performed on purified 
chDNA (Section 2.1.5.1). Biobasic’s taq DNA polymerase was used to amplify the genome 
according to the specifications of the product provided by the supplier. A typical 25uL PCR 
mix contained the following final concentration of reagents:  1X PCR buffer, 0.5pmol/μL of 
5’ and 3’ primers, 200μM of each dNTP, 20% DMSO, 100ng/μL chDNA, 0.25U/μL Taq. The 
standardized diagnostic PCR program used is detailed in Table XVIII. To standardize the 
PCR program, the annealing temperature (Tm) was set to 52°C. Since Biobasic’s taq DNA 
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polymerase transcribes 1kb/min at 68°C and the longest expected PCR product was of 
2178bp, elongation time was set to 2min30sec. At the end of the run, 3μL of 10X loading dye 
was added to the mix and 3-5μL was loaded on a 1% agarose gel and run in 1X TBE for 
visualisation (Fig. 2.6). 
 
 
 
Figure 2.6: Diagnostic PCR 
To validate transformants, diagnostic PCRs were performed on their purified chDNA (250ng) with 
sets of primers listed in Table XVI and using a standardized diagnostic PCR program (Table XVIII) 
Lane 1 shows where the primers migrate, W303a was used as negative control (lanes 2-5). Lanes 7-
10 show that the PrA tag of either Ssf1 or Ssf2 is specific (expected sizes of amplicons are listed in 
Table XVII). 
 
2.5 Growth curve  
The strains were grown in 250mL of permissive media to an OD600 ranging between 
0.2-0.6. At T0, the cells were pelleted, washed twice with sterile water and shifted in 
repressive media. At each time-point, the cells were diluted with repressive media to an OD600 
ranging between 0.2-0.6 to keep them logarithmic phase throughout the experiment. Two 
samples were collected at each time-point (20OD600 and 10OD600), washed twice with 
ultrapure water and stored at -80°C for subsequent RNA (NB, primer extension, qRT-PCR) 
and protein analysis (WB). The OD600 was measured before and after dilution at each 
timepoint to calculate the dilution factor of the time-point (DFtp=DObefore/DOafter) and the 
cumulative dilution factor (DFcum= DFtp* DFcum previous). The growth curve was performed at 
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least in duplicate for each strain. To construct the graphs of the relative OD600 against time, 
the mean and standard deviation of the replicates’ relative OD600 was calculated for each 
time-point and outliers were discarded when the standard deviation was half of the mean. 
 
2.5.1 Serial dilution 
As a rapid way to confirm that only the depletion of both SSF proteins generated a 
growth defect similar to other essential RiBi proteins, a serial dilution test was performed. 
Cells were taken from plate or from liquid culture and brought to an OD600 of 1 (DIL0). For 
the serial dilution 100μL of the previous cell dilution was mixed with 900μL of sterile water. 
This procedure was performed to obtain DIL-1 (1/10), -2(1/100) and -3(1/1000). To test the 
inducible promoter, spots of 10μL of each culture were dried on permissive and restrictive 
plates and grown at 30°C.   
 
2.6 Cell harvest and cryo-lysis (78) 
Cell harvest and cryo-lysis was performed as described in (78).  
2.6.1 Cell harvest 
Depending on the amount of material needed, 0.2-6L of cells were grown up to an 
OD600 of 0.8 and spun at 4000xg for 5min. The cells were then washed twice with 50mL of 
water. The pellet was resuspended on ice with an equal volume of resuspension buffer (1.2% 
PVP-40, 20mM HEPES pH 7.4, 1:100 protease inhibitor cocktail, 1:100 solution P and 
1:1000 DTT) and spun twice at 2600xg for 15min at 4°C to completely remove the 
supernatant. The pellet was then passed through a syringe onto a 50mL falcon tube filled with 
liquid nitrogen, broken down into smaller pieces with a spatula and stored at -80°C. 
 
58
2.6.2 Cryo-lysis 
The noodles were placed into a metal jar filled with metal beads and pre-chilled with 
liquid nitrogen.  The cells were cryo-lysed using a Retsch PM-100 ball mill (eight cycles of 
400rpm, 1min rotation clockwise, 1min rotation counter-clockwise, 1min rotation clockwise). 
The jar was chilled in liquid nitrogen in between cycles. The final cell powder was stored at 
-80°C. 
 
 
Figure 2.7: Cryolysis and storage
The cells were harvested during log phase, treated with PVP buffer, cryo-lysed and stored at -80°C. 
Taken from (78). 
 
 
2.7 Conjugating of Dynabeads with rabbit IgG (78) 
This protocol was carried out as described in (78) to obtain 160μg of rabbit IgG 
per mg of Dynabeads, with a final concentration of 0.15μg of beads per μL of solution. Total 
volumes and amounts are listed here but, to facilitate magnetic bead recovery, the mixtures 
were divided into four equal volumes in 15mL Falcon tubes.  
To reconstitute the magnetic beads, 300mg of Dynabeads were resuspended in 16mL 
of a 0.1M NaPO4, pH7.4 buffer by vortexing for 30sec. The solution was incubated at RT, 
rocking for 10min and the beads were recovered using a magnetic holder and washed with 
16mL of the same buffer by vortexing (15sec).  
To prepare the antibodies, 3.525mL of a 14mg/mL rabbit IgG stock was mixed with 
9.850mL of 0.1M NaPO4, pH7.4 and then 6.650mL of 3M NH4SO4 was slowly added while 
shaking. The solution was then filtered using a 0.22μm filter.   
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Once the antibody solution was ready, the beads were magnetically recovered and 
incubated for 18-24hrs at 30°C, rocking. The beads were then submitted to a series of washes:   
 1X 12mL of 100mM Glycine pH 2.5;  
 1X: 12mL of 10mM Tris pH8.8;  
 1X: 12mL of 100mM Triethylamine;  
 5X: 12mL of PBS 1X, rocking for 5minutes; 
 1X: 12mL of PBS 1X, 0.5% Triton X-100, rocking for 5minutes; 
 1X: 12mL of PBS 1X, 0.5% Triton X-100, rocking for 15minutes. 
All the beads were then resuspended in 2mL of 1X PBS, 0.02% NaN3 and can be stored at 
4°C for up to several months. 
PBS 1X, 1L: 0.26g NaH2PO4*H2O, 1.44g Na2HPO4*2H2O, 8.78g NaCl, final pH 7.4 
2.8 Single-Step affinity purification (ssAP) (78) 
Intact pre-rRNP complexes recovery was performed as described in (78). In the 
96-well single step affinity purification (ssAP), a variant of the protocol was used to fit in 
2mL wells in which everything was scaled down to 0.2-0.4g of cell powder. 
2.8.1 ssAP and the extraction buffer 
To determine the relative stability of the complexes made by Ssf1 and Ssf2 proteins, 
strains in which they were PrA-tagged were used to perform their single step affinity 
purification in a 96-well AP design detailed below, using 26 different extraction buffers with 
various types of salt of varying stringency and concentrations (Fig. 2.8). Some of these 
buffers are detailed in the results section in Figure 3.1.  
Because of the relative abundance of these proteins in the cell, 0.2g of cell grindate 
was used for Ssf1-PrA (8150 molecules/cell) and Nop7-PrA (4530 molecules/cell) baits and 
0.4g of grindate was used for Ssf2-PrA (1350 molecules/cell). The background strain 
(W303a) and the PrA tag expressed alone (pZPR::PrA) were used as negative controls. First, 
the cells were harvested and cryo-lysed using the protocol detailed in Section 2.6. For 0.2g of 
frozen cell grindate, 10μL of rabbit IgG conjugated Dynabeads (0.15μg/μL, Section 2.7) were 
pre-washed three times in 200μL of extraction buffer and resuspended in 10-15μL of 
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extraction buffer. The cell grindate was then thawed on ice and resuspended by pipetting in 
1.8mL (for a 1:9 ratio) or 0.8mL (for a 1:4 ratio) of cold extraction buffer. The mixture was 
spun at 4°C, 3500rpm for 10min and the supernatant was incubated with the beads at 4°C for 
30min with slow rotation. The beads were then magnetically recovered and washed three 
times with 250μL of extraction buffer and then incubated at RT with 250μL of last wash 
buffer (100mM NH4OAc/0.1mM MgCl2/0.02% Tween20) for 5min and with slow rotation. 
The PrA tagged protein along with its RNP complex was then eluted by incubating it twice 
with 250μL of elution buffer solution (500mM NH4OAc/0.5mM EDTA) with slow rotation 
for 20min at RT. The eluates were pooled, dried using a speedvac compatible with organic 
solvents, and stored at -80°C. 
 
 
   
 
Figure 2.8:Affinity purification of intact pre-rRNP complexes.  
Intact pre-rRNP complexes are recovered from cryo-lyzed log-phase cultures using a 
rapid single step affinity purification (ssAP) and buffers optimized for each bait protein. 
Adapted from (78, 79). 
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2.8.2 Pre-rRNP complex visualisation 
  The proteins were resuspended in 16μL of 1X loading dye, heated at 70°C for 10min. 
8μL of the mixture was resolved using a pre-cast 4-12% Bis-Tris gel and proteins were 
visualized as described in (78) using a silver staining kit from invitrogen. To discriminate by 
eye more easily proteins belonging to the rRNPs from the background proteins, the W303a 
AP performed in the same buffer, which always gave a higher background than the PrA tag 
expressed alone, was superposed to the bait proteins AP using Photoshop.  
2.9 Protease accessibility laddering (80)  
For this experiment, a variant of the affinity purification protocol detailed in 
Section 2.8.2 was used as described in (80). For Ssf1-PrA and Nop7-PrA, 1.25g of thawed 
cell grindate was resuspended in TBT buffer (20mM Hepes pH 7.4, 100mM NaCl, 110mM 
KOAc, 0.1% Tween20, 2mM MgCl2, 1:500 PIC, 1mM DTT, 1:5000 antifoam) supplemented 
with 1% Triton-X100 (1:9 ratio, vortex, 30sec), homogenized (polytron, 30sec) and 
centrifuged (15min, 2000g, 4°C). The supernatant was incubated with IgG-coupled magnetic 
beads for 1hr at 4°C. The beads were then submitted to five washes (1mL TBT+200mM 
MgCl2). The beads were then resuspended in 250μL of 1X endoproteinase reaction buffer 
previously supplemented with 80ng of endoproteinase and 50μL aliquots were collected at 
timepoints 0.5, 3, 15, 75min. The reaction was stopped by adding Last Wash Buffer and 
incubating for 5minutes. Elution was then performed with 2x500μL of elution buffer (rock 
20min at RT). Eluate was dried using a speed-vac, o/n at RT. For all previous steps, 
everything was doubled for SSF2-PRA cell grindate. The pellet was resuspended in 30μL of 
loading dye and 3μL was resolved on gel and immunoblotted on a PVDF membrane for PAP 
detection. For preliminary analysis, the amino acid sequence for each protein was compared 
to the proteolysis pattern obtained by the three endoproteinases. This allowed detecting the 
regions that were more susceptible for proteolysis (Fig. 2.9). 
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Figure 2.9 : Protease accessibility laddering (PAL) to detect exposed domains. 
Using stringent buffer conditions, the PrA-tagged protein is recovered from cryolyzed cell grindate 
using magnetic beads and submitted to protease degradation. The PrA-recovered C-terminal end 
was analyzed by western blot. Figure taken from (80). 
 
Roche endoproteinases Asp-N (catalog ID : 1 420 488 or 1 054 589, 2ug/vial), Lys-C 
(catalog ID : 1 420 429, 5ug/vial) and Trypsin (catalog ID : 1 521 187, 25ug/vial) were 
reconstituted on ice in 50uL of ultrapure water, as recommended by the supplier. Single used 
aliquots of 2.5uL were flash-frozen in liquid nitrogen and stored at -80°C.   
To prepare the endoproteinase working stock for the PAL experiment, an aliquot of 
each endoproteinase was diluted with their respective 1X endoproteinase reaction buffer Asp-
N (50mM Na2PO4 pH8.0, 0.1%SDS; 3.75μL), Lys-C (25mM Tris-Cl pH8.5, 0.1% SDS, 1mM 
EDTA; 11μL), Trypsin (100mM Tris-Cl pH8.5, 0.1%SDS; 64μL) to give a mix of about 
16ng/μL.  
2.10 qRT-PCR 
To screen for any changes in mRNA levels of our proteins of interest in response to 
the depletion of one of them, quantitative reverse transcriptase polymerase chain reaction 
(qRT-PCR) was performed on cDNAs obtained using random primers (Section 2.1.8). 
The primers (Table XIX) were designed to have a salt adjusted Tm close to 60°C and 
to generate a PCR product of 96-173bps. An additional care was taken when designing the 
primers to be able to discriminate between the mRNA of each of the Ssf paralogs. The 
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sequence tag present in some strains (HA-SSF1, SSF1-PRA, SSF2-PRA) was used to 
discriminate between both Ssf paralog, as one primer was designed fully or partially in this 
sequence. Endogenous primers for each protein were also designed and validated using 
PrimerBlast (endSSF1, endSSF2, endNOP7). 
 
Table XIX: Primers designed for qRT-PCR 
Primer ID Sequence Salt adjusted Tm (°C) 
5RTPCR-SSF2PRA Fwd 5’-AGG TCA AGG GAA AGA TGG TG 59 
3RTPCR-SSF2PRA Rev 5’- TTT GAG CTT CAC CTT CTA CTT CA 58 
5RTPCR-SSF1PRA Fwd 5’- CGA TGA GCG ATG ATG AGT CT 59 
3RTPCR-SSF1PRA Rev 5’- GCT TCA CCT TCG ACC TCA CTA 59 
5RTPCR-HASSF1 Fwd 5’ AAT TCA TCG GCC AAG AGA AG 59 
3RTPCR-HASSF1 Rev 5’-CAC TCT GAT TAC CAT TGA CTT AGG TAT 58 
5RTPCR-endSSF1 Fwd 5’- ACA GTG CCG AAT TTG CAT CG 60 
3RTPCR-endSSF1 Rev 5’-ACC GGT GTT CTT TGG GAC TT 59.5 
5RTPCR-endSSF2 Fwd 5’-TCT CAA ACT TCG CTG TCG CA 60 
3RTPCR-endSSF2 Rev 5’- ACG TGG AGT TGG TTG CGA AT 60.5 
5RTPCR-endNOP7 Fwd 5’- CAA GGG CTC TAC TGC ACC AA 60 
3RT-PCRendNOP7 Rev 5’-CCC TAC CCA AAG CCC TTG TT 60 
Controls 
ACT1fwd (81) Fwd 5’-ATT ATA TGT TTA GAG GTT GCT GCT TTG G 58 
ACT1rev (81) Fwd 5’-CAA TTC GTT GTA GAA GGT ATG ATG CC 60 
UBC6fwd (81) Fwd 5’-GAT ACT TGG AAT CCT GGC TGG TCT GTC TC 69 
UBC6rev (81) Rev 5’- AAA GGG TCT TCT GTT TCA TCA CCT GTA TTT GC 66 
 
 
Before attempting the experiment, the efficiency of each primer sets were tested as 
follows: 5μL of four different samples were mixed together (dilution 1/4) and further diluted 
with 60μL of water (Vtot=80 μL) and the same procedure was done with their corresponding 
negative controls (RT-). These dilutions (1/16) were considered to be dilution 1 in the 
qRT-PCR tests. The RT+ was further diluted in series to give dilutions 1/10, 1/100, 1/1000 
and1/10 000 (10μL of previous dilution in 90μL water). For each primer set, the PCR reaction 
was performed in duplicate for each cDNA dilutions (1 to 1/10 000) and for RT- (Dil 1). Each 
reaction contained 3μL of cDNA (of varying dilutions), 5μL of SYBR Select Master Mix (2X, 
from Applied Biosystems) and 0.5μL of each primer set (10μM stocks). The PCR was 
performed in a 96-well format using ViiA7 and with the following PCR program: 50°C, 
2min; 95°C, 2min and 40X (95°C, 15sec; 60°C, 1min), followed by a melting curve analysis. 
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The preliminary analysis showed that the primers recognized only one template, as a 
single peak, with the same Tm, was observed in the melting curve plot for all cDNA dilutions. 
Here, a representative melting curve obtained for one primer set which targets UBC6 mRNA 
is presented and shows a single peak (Fig 2.10A). The threshold cycle (Ct) value can be 
linearly correlated to the levels of target cDNA present in the sample, as demonstrated by the 
standard curve (Fig 2.10B). For all primer sets, R2 of this standard curve ranged between 
0.98-1. From these analyses, it was determined that the best dilution of cDNA to use for every 
sample was DIL1, as it gave a Ct value of about 20 cycles for all genes tested under normal 
conditions. For normalisation purposes, mRNA levels of actin and UBC6 were also tested for 
every sample. All samples were normalized against actin or UBC6 (81). To detect mRNA level 
changes for a given gene, its mRNA levels at time 0 were assigned the value of 1.  
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A 
 
B 
 
Figure 2.10: UBC6 qRT-PCR melting and standard curves 
Prior to their use, each primer set was tested to validate their template specificity (melting curve) and 
linear correlation (R2 = 0.98-1) between CT values and levels of target cDNA (standard curve). Here: 
the UBC6 primers (A) generate a single narrow peak for all cDNA dilutions, which indicate that the 
primers are specific. (B) Additionally, the UBC6 primers generate CT values which can be linearly 
correlated (R2=1) with the levels of target cDNA present in a given sample. 
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The specificity of the endogenous primers targeting SSF1 (endSSF1) and SSF2 
mRNA (endSSF2) was verified (Fig. 2.11) by testing them using the cDNA of 
MET::HA-SSF1/SSF2-PRA strain before and after shutting off the repressible promoter 
(depleted HA-SSF1 mRNA). Their results were compared to the primer sets overlapping with 
the tags (SSF2-PRA and HA-SSF1). The endSSF2 primers detected no significant change in 
mRNA levels after HA-SSF1 depletion (1.052), similar to what was obtained using the 
SSF2-PRA primers (1.016). The endSSF1 primer set detected a decrease in mRNA upon 
HA-SSF1 depletion (0.157), similar to what was observed with the HA-SSF1 primer 
set (0.051). The endogenous primers are therefore specific, as they give similar results when 
compared to the primer sets overlapping with the tags (SSF2-PRA and HA-SSF1). 
 
 
Figure 2.11: Endogenous primers designed for qRT-PCR can discriminate between SSF 
paralogs.  
As SSF1 and SSF2 mRNAs are highly similar, the specificity of the primer pairs targeting their 
endogenous sequence needed to be verified. (A) The endogenous primers were tested against the 
cDNA of MET::HA-SSF1/SSF2-PRA strain, before (lanes 1 and 3) and after (lanes 2 and 4) )shutting 
off the repressible promoter (HA-SSF1 depletion). (B)These gave similar results as primers overlaping 
with the tags (HA-SSF1 and SSF2-PRA), which confirmed their specificity. 
  
 
 
 
 
 
 
 
3 Results 
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3.1 Generation of Yeast strains  
The Ssf proteins share 94% of their sequence and are believed to be redundant in the 
cell. However, analysis of their BioGRID interactors has revealed that this is not the case. The 
first aim of this project is to determine if there are notable differences between the particles 
that the Ssf proteins form, as the Ssf2-particle has never been reported during log phase. For 
this purpose, SSF1-PRA and SSF2-PRA strains were generated to compare their particles and 
potentially detect subcomplexes they form by ssAP (Section 3.2). In these assays, the controls 
were W303a and the PRA-tag expressed alone.  
Another aim is to potentially uncover the presence of parallel pathways during ribosome 
biogenesis involving one of the Ssf paralogs and Nop7. To alter the levels of these proteins, 
several strains were generated by genomically modifying haploid W303a (regulatable 
promoter insertion, gene deletion and C-termini tag insertion, Table XX). For this purpose, 
primers were designed to anneal with a genomic sequence of W303a in their 5’ (45-66nts) 
followed by a sequence annealing (18-21nts) with a plasmid containing the modification and a 
resistance cassette. The generated cassette was transformed into the background strain and 
transformants were validated by WB and diagnostic PCR.  
 
Combination strains were constructed to potentially uncover the presence of parallel 
pathways involving Nop7/Ssf1 and Ssf2 (Sections 3.3). All strains have a C-termini PRA-
tagged gene that is under its own promoter. The PRA-tag is relatively small (27kDa), and has 
been selected for its capacity of strongly bind to IgG antibodies, a feature useful for pre-rRNP 
complex isolation by ssAP (Section 3.2). The PRA-tag can also be readily detected using an 
HRP-coupled rabbit antibody (PAP), which was useful to monitor the behavior of the tagged 
RiBi proteins upon depletion of Ssf1 and/or Nop7 (Section 3.3). SSF1 and NOP7 genes were 
put under the influence of a regulatable promoter (Met25 and Gal1 respectively) and their 
levels can be monitored by WB through an N-termini HA epitope (3kDa) that has been 
integrated into the cassette. These promoters slightly over-express the target proteins in 
permissive media (-methionine and GRS respectively) but this does not happen to negatively 
affect cell growth or progression of ribosome biogenesis. By switching media (+met and 
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dextrose respectively), the expression of the protein that is under the control of the regulatable 
promoter can be modulated. As the Ssf proteins might have a different function during 
ribosome biogenesis, the SSF2 gene was deleted in some strains.  
 
Table XX: Yeast strains used in this study 
Name/phenotype Background Genotype Reference 
W303a - MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15}  (78) 
ZPR::PRA W303 
MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YGR211W::PRA } 
(78) 
SSF1-PRA 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YHR066W-PRA-SpHIS5} 
This study 
SSF2-PRA 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YDR312W-PRA-SpHIS5} 
This study 
NOP7-PRA 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15  
YGR103W-PRA-SpHIS5 } 
(78) 
SSF2-PRA/ MET25::SSF1 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YDR312W-PRA-SpHIS5 ClonNAT-MET25::3HA-YHR066W} 
This study 
CIC1-PRA/ 
MET25::SSF1/ ΔSSF2 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YHR052W::PRA-SpHIS5 ClonNAT-MET25::3HA-YHR066W 
YDR312WΔ::hph} 
This study 
NOP7-PRA/ 
MET25::SSF1/  ΔSSF2 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15  
YGR103W-PRA-SpHIS5 ClonNAT-MET25::3HA-YHR066W 
YDR312WΔ::hph} 
This  study 
SSF1-PRA/ GAL1::NOP7 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YHR066W-PRA-SpHIS5 KanMX6-GAL1::3HA-YGR103W} 
This study 
SSF2-PRA/ GAL1::NOP7 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YDR312W-PRA-SpHIS5 KanMX6-GAL1::3HA-YGR103W} 
This study 
SSF1-PRA/ GAL1::NOP7/ 
ΔSSF2 
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YHR066W-PRA-SpHIS5 KanMX6-GAL1::3HA-YGR103W 
YDR312WΔ::hph} 
This study 
SSF2-PRA/ GAL1::NOP7/ 
MET25::SSF1  
W303 MATa {leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
YDR312W-PRA-SpHIS5 KanMX6-GAL1::3HA-YGR103W 
ClonNAT-MET25::3HA-YHR066W} 
This study 
 
All combination strains were analyzed in repressive media that is upon depletion of 
HA-SSF1 and/or HA-NOP7 in the presence or absence of SSF2. Each strain was tested during 
three independent experiments, except the SSF1-PRA/GAL1::NOP7/ΔSSF2 strain, which was 
tested in duplicate only. For all strains, cell growth was monitored in repressive media for at 
least 20 hours as described in Section 2.5. In addition to changes in cell growth, total protein 
levels of the selected proteins were monitored by WB. Changes in pre-rRNA processing were 
monitored by NB using fluorescently labelled probes and the mature rRNAs were also 
detected by methylene blue staining. As premature C2 cleavage was reported upon Nop7 
depletion and also upon depletion of the SSF proteins, primer extension analysis of the C2 and 
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C1/C1’ sites were also performed for all strains. Changes in SSF1, SSF2 and NOP7 mRNA 
levels were monitored by qRT-PCR (Section 3.6). 
Finally, as both Ssf1 and Ssf2 potentially form homo or heterodimers, bind pre-rRNA 
and also bind Nop7, plasmids were constructed and the optimised conditions were determined 
for recombinant Ssf1, Ssf2 and Nop7 protein purification (Section 2.3). The recombinant 
protein will be useful for future in vitro interaction studies. In order to look for potential 
folding differences between Ssf1 and Ssf2, Ssf1-PrA and Ssf2-PrA proteins were submitted to 
protease accessibility laddering while they were in complex with other proteins (Section 3.7). 
 
3.2 Ssf1 and Ssf2 form similar complexes 
In order to compare Ssf1-PrA and Ssf2-PrA particles and potentially detect 
subcomplexes that these proteins form, ssAP (single-step affinity purification) was performed 
using a 96-well format. SSF1-PRA and SSF2-PRA cells were harvested and cryo-lysed. 
During the ssAP, the particle is recovered either intact or partially disrupted, depending on the 
stability of the particle and on the stringency of the buffer used during the ssAP. Since the 
relative stability of the complexes made by Ssf1 and Ssf2 proteins were not known, various 
salts were selected according to their stabilisation properties: KOAc > NH4OAc > NaCl > 
NaCitrate (79, 82, 83). In order to obtain buffers of varying stringency, these salts were used in 
different concentrations ranging from 100-300mM and once, MgCl2 and DTT were used in 
low concentrations (2mM and 1mM respectively in buffer 1, TBT). The detailed composition 
of the buffers is detailed in Fig. 3.1C. The cell grindate was solubilised in the selected buffer 
and incubated with IgG-coupled magnetic metal beads (78). The PrA tagged protein along with 
its intact or partially disrupted pre-rRNP complex was then eluted from the beads using 
NH4OH. Proteins were separated by size (4-12% Bis-Tris) and visualized by silver staining 
(78). The controls used are the background strain (W303a) and the PrA tag expressed alone 
under the control of the ZPR1 promoter (ZPR::PRA).  
In general, W303a cells generated more background than ZPR::PRA; hence bands 
found in these two control strains were considered contaminants (Fig. 3.1B). The buffer giving 
the most background contained 100mM KOAc salt (Fig. 3.1A, buffer4). Neither addition of 
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DTT nor MgCl2 had an effect on the band patterns observed (Fig. 3.1A, buffer1), which 
suggest that the particle stability is not affected by disruption of proteins with disulfide bonds 
nor by stabilizing RNA-protein interactions (78, 84). To verify if a change in the powder to 
buffer ratio had an effect on the the background observed in the control strains, ssAP was 
performed using two powder to buffer rations (1:9 and 1:4) but this did not generate a 
significant change in the background for buffers #1, 2, 3 and 6. 
Ssf1-PrA and Ssf2-PrA ssAPs revealed identical band patterns, which indicate that 
these proteins are most likely associated with similar sets of proteins. In particular, six proteins 
that have not yet been identified by MS repeatedly appeared in complex with each of the Ssf 
proteins (Fig. 3.1A). If these proteins are tightly bound to Ssf1-containing particles, then they 
are likely present in the proteins previously identified Ssf1 and likely enter the particle at the 
same time as Ssf1 (Fig. 1.7) (54, 67). A protein of ~90kDa and two proteins appearing as a 
doublet at ~70kDas were continuously present, even under high-stringency conditions (buffer 
#6, NaCitrate 200mM) and could correspond to Dbp9, Drs1 and Nog1 (85).  The data suggest 
that the Ssf proteins form a stable sub-complex with these proteins. One protein of ~90kDas 
and two ~130kDas were repeatedly observed except when using NaCitrate-containing buffers, 
which are highly-stringent (buffers #3, #6 and #11). This probably indicates that these proteins 
are required for the sub-complex containing one of the Ssf proteins to assemble into the pre-
rRNP complex and likely correspond to Dbp10, Noc1and Noc2. All of the patterns mentioned 
above are more strongly detected with SSF2-PRA than SSF1-PRA, indicating that the sub-
complex is more stable with Ssf2. Both Ssf1 and Ssf2 associated complexes are completely 
disrupted in the presence of NaCitrate 300mM (buffer #11), which indicate that their 
interactions are less stable than other sub-complexes found during ribosome biogenesis, such 
as Noc1-Noc2 and Noc2-Noc3 heterodimers, which were still recovered in the low molecular 
weight fractions of a sucrose gradient using a buffer containing 800mM KCl (86). The presence 
of a sub-complex containing Ssf1 protein is further supported by a sucrose gradient analysis 
which detected Ssf1-PrA in fractions of lower molecular weight than the 40S (54).  MS analysis 
of the Ssf particles is necessary to unambiguously identify the most abundant RiBi proteins in 
these particles and will be the next step. 
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Figure 3.1: Stability of key pre-rRNP complex components 
Grindate (0.25-0.5g) of cells were used. In these strains, (A) Ssf1 or Ssf2 was C-termini tagged (PrA) 
and used as bait (*) for ssAP. Recurring band patterns observed are indicated (-). (B) W303a and a 
strain expressing the PrA (*) tag alone were used as background strains. (C) Buffers of varying 
stringency were used for ssAP for each strain. For buffers #1, #2, #3 and #6, cell grindate to buffer 
ratio of 1:4 was also tested to verify if this change had a significant effect on background. 
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3.3 Ssf2 does not fully compensate for the loss of Ssf1 
Initially, tetrad analysis of a diploid yeast strain lacking one copy of the SSF1 and 
SSF2 genes generated an inviable haploid spore, which corresponded to the one lacking both 
genes (49). The other spores did not generate an obvious phenotype. In this study, a 
HA-SSF1-depleted strain was tested by serial dilution and the strain generated as many 
colonies as the wild-type strains but which were smaller, suggesting a mild growth defect 
(Fig. 3.2). The same phenotype was also observed in a strain slightly over-expressing 
HA-SSF1 in which SSF2 was deleted (data not shown). Consistent with the finding that the 
Ssf proteins are essential, HA-SSF1-depleted/SSF2 cells showed a growth defect similar to 
that observed upon depletion of an essential RiBi protein, like Nop7.  
 
 
Figure 3.2: SSF1-depletion mildly affects cell growth 
In permissive media, the three strains grow at a similar rate. In restrictive media, Ssf1-
depleted cells show a mild growth defect while Ssf1-depleted/SSF2-cells show a severe 
growth defect. 
 
To further characterize this mild growth defect observed upon depletion of one of the 
SSF proteins, a growth curve was performed, which allows to quantify cell growth. The 
doubling time (Dt) of wild-type cells (WT, W303a) was of 90min (Fig. 3.3-3.5A). The 
precursors detected by NB in W303a were: 27SA (both 27SA2 and 27SA3) and 27SB, 23S, 
20S, A3-C2, 7S, 6S; to a lesser extent, 27SA2 and non-detectable levels of A2-C2 (Fig. 3.3-
3.5D, lanes 1-2). Primer extension using a probe annealing to the 5’ coding region of the 25S 
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allowed the amplification of part of the ITS2. For W303a, this analysis showed no primer 
extension stop at the C2 site and a normal C1’ and C1 stops, which indicates normal 5’ 
processing of 25S (Fig. 3.3-3.5F lanes 1-2). The levels of mature rRNAs did not change (25S, 
18S 5.8S and 5S). These were detected by using probes targeting their 5’ (Fig. 3.3-3.5D lanes 
1-2) and also by staining the membrane with methylene blue (Fig. 3.3-3.5E lanes 1-2). 
Staining also detected tRNAs, which could serve as a loading control, since 5S rRNA has been 
shown to decrease upon depletion of the Ssf paralogs. 
HA-Ssf1 protein, was no longer detected after 6 hours of growing in repressive media 
(YPD+met) for the three strains tested, which indirectly confirmed repression of the HA-SSF1 
gene. The Dt of HA-SSF1-depleted cells in which Ssf2 was present was of 120min 
(MET::SSF1/SSF2-PRA, Fig. 3.3A). Analysis of total protein showed that total Ssf2-PrA 
levels increased in these strains, which may indicated the existence of a compensatory 
mechanism (Fig. 3.3B lanes 3-6). However, this increase in Ssf2 was not sufficient to maintain 
ribosome biogenesis, which, at least partially, may explain the mild decrease in cell growth. 
Accumulation of 35S precursor and 23S and A3-C2 pre-rRNA indicate that ribosome 
biogenesis was mildly affected in this strain (Fig. 3.3D lanes 3-4). The levels of other 
intermediates and mature rRNAs did not seem to change and primer extension showed no stop 
at the C2 site as well as normal C1’ and C1 stops (Fig. 3.3D-F lanes 3-4). 
Two ΔSSF2 populations were also tested (MET::SSF1/ΔSSF2/CIC1-PRA and 
MET::SSF1/ΔSSF2/NOP7-PRA). In permissive media (t0), pre-rRNA analysis of these strains 
showed an accumulation of 35S (Fig. 3.3D lanes 5 and 7), indicating that slightly over-
expressed levels of Ssf1 cannot fully compensate for the loss of Ssf2. In repressive media, the 
Dt of each population was of 168 and 180min respectively, a significant decrease in cell 
growth characteristic of the depletion of an essential RiBi gene, like Nop7 (Fig. 3.4A). As the 
depletion phenotype observed upon depletion of both of the Ssf proteins has been reported by 
Fatica et al, NB analysis and primer extension of the pre-rRNAs for these strains would 
corroborate their depletion phenotype. Therefore, an accumulation of 35S pre-rRNA and a 
reduction in 27SA2, 27SB, 20S, 7S, 6S precursors is expected, as well as a premature C2 
cleavage (primer extension), a reduction of all mature rRNAs, including 5S, and accumulation 
of aberrant pre-rRNAs (23S, 5’ETS-D, A2-C2) (54). However, the background strains used in 
the previous study is W3031a, a strain sensitive to oxidative stress because of mutations in the 
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YBP1 gene. Therefore, it would be normal to observe slight differences in pre-rRNA 
processing, but the background strain used in this study (W303a) is expected to be more fit. 
Upon HA-SSF1 depletion, MET::SSF1/ΔSSF2/CIC1-PRA showed a slight 
accumulation of 35S, concomitant with a decrease in 27SA2, 27SAs and 27SBs, 20S, 7S, 6S 
precursors, as previously reported (Fig. 3.3D lane 6). A premature C2 cleavage was detected 
using primer extension as well as a mild decrease in C1’ and C1 stops, which indicate that the 
ITS2 processing from the C2 cleavage site to the mature end of the 5’-25SrRNA is delayed 
(Fig. 3.3F lane 6). The 23S (5’ETS-A3) pre-rRNA was still visible but decreased and this was 
concomitant with the appearance of a 22S (A0-A3) precursor, which indicate that A0 site-
processing is delayed but still occurring in the absence of the Ssf proteins (Fig. 3.3D lane 6). 
The probe required for 5’ETS-D pre-rRNA detection was not available at the time the probing 
was performed. Aberrant A2-C2 pre-rRNA could not be detected before or after depletion, 
which highlights a difference in pre-rRNA processing between W3031a and W303a. Instead, 
A3-C2 pre-rRNA accumulated, which indicate a premature C2 cleavage is occurring, since it 
would be normally cleaved after complete ITS1 processing (Fig. 3.3D lane6). A decrease in all 
mature rRNAs, including the 5S, was detected by NB and methylene blue staining, confirming 
that depletion of the Ssf proteins induces a decrease in all mature rRNAs (Fig 3.3 D-E lanes 
5-6). The same phenotype was observed for MET::SSF1/ΔSSF2/NOP7-PRA. 
 
3.3.1 Nop7 levels are affected by Ssf protein levels 
Using an antibody against endogenous Nop7, it was possible to detect constant levels 
of Nop7 in wild-type cells. However, endogenous levels of Nop7 could not be detected in the 
MET::SSF1/SSF2-PRA strain or in the CIC1-PRA/MET::SSF1/ΔSSF2 strain, which suggest 
that Nop7 levels are decreased in these strains. Alternatively, this could also be explained in 
limitations of the WB analysis. However, analysis of the levels of Nop7-PrA in the third strain 
showed that the Nop7 protein levels decreased in the absence on the Ssf proteins, whereas 
Cic1-PrA protein levels, another RiBi protein, did not change (Fig. 3.3B lanes 7-11). Taken 
together, this data therefore contradicts the hypothesis that Nop7 and Ssf2 are not genetically 
linked and suggests that the levels of Nop7 are correlated to the cellular levels both Ssf 
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proteins. Additional analysis of other strains will help determine if the contrary is also valid 
(Section 3.5). 
 
 
 
Figure 3.3 : Ssf2 does not fully compensate for the loss of Ssf1 
Depletion of HA-SSF1 was performed by switching cells in repressive media (YPD+5mM met). (A) 
Cell growth was monitored for these cells in the presence (light blue) or absence of Ssf2 (orange). (B) 
Levels of Ssf2 were assayed for several timepoints. Ssf1 depletion was confirmed by WB and actin 
was used as loading control.  Total protein levels of Ssf2, the antibodies used for WB analysis are 
indicated at the right. (C) Using fluorescent probes, (D) total RNAs were analyzed by NB. (E) The 
most abundant RNAs were also detected using methylene blue staining. (F) Using 1μg of RNA, primer 
extension was performed to detect changes C2 and C1/C1’ site-processing. 
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3.4 Nop7 and Ssf1 belong to a similar maturation route  
As demonstrated in the previous section, Ssf2 is upregulated in the absence of Ssf1, 
and depletion of both Ssf proteins downregulate the levels of Nop7. A strain was constructed 
in which HA-Nop7 and HA-Ssf1 levels could be independently regulated by changing media 
to dextrose or adding methionine respectively.  
Prior to repressing HA-NOP7 and/or HA-SSF1 genes, GAL::NOP7/MET::SSF1/SSF2-
PRA cells showed normal pre-rRNA processing phenotype, except for a mild increase in 35S, 
which show that the slight overexpression of HA-Ssf1 mildly affects the levels of its paralog, 
Ssf2, which performs a function that cannot be fully compensated for by Ssf1 (Fig. 3.4D-F 
lanes 1-3).  
This strain allowed testing if HA-Nop7 depletion affects the levels of Ssf2-PrA, when 
Ssf1 levels are stably regulated by means of a regulatable promoter. Under these conditions, 
cellular Dt increased to 180min (Fig. 3.4A), which corroborates the growth phenotype defect 
previously reported in Nop7-depleted cells (36). Upon HA-Nop7 depletion, HA-Ssf1 levels did 
not notably change, which was partially expected since the transcription of the gene was 
controlled by the Met25 promoter. Ssf2-PrA levels decreased, confirming that Ssf2 and Nop7 
are genetically linked (Fig. 3.4B lanes 1-2). The strain used in the previously reported study 
used a variant of S288C, which differs from W303a in that it cannot form pseudohyphae and 
has a mutated HAP1 gene, which alters normal processes occurring in the mitochondria. 
Therefore, slight changes in pre-rRNA processing are expected between the previously 
reported results and the ones obtained in this study. Furthermore, pre-rRNA processing should 
also be modified because the levels of the Ssf proteins are altered under these conditions and 
these were found associated with histone modifiers of opposite function. Ssf1 was found 
associated with Eaf7 a histone acetylase and acetyltransferases open DNA while Ssf2 has been 
associated with deacetylases Rpd3 and Hda1 and these should close chromatin (55).  
HA-NOP7-depleted cells showed a strong accumulation of 35S, premature C2-site 
processing and a reduction in 27SA/27SB, 7S and 6S pre-rRNA (Fig. 3.4D and F lanes 3-4), 
which is consistent with previous results (36). However, instead of observing an accumulation 
of aberrant 23S (5’ETS-A3) pre-rRNA, this precursor decreased and a lower molecular weight 
precursor, probably 22S (A0-A3), was observed (Fig. 3.4D lanes 3-4), which suggest that under 
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these conditions A0 processing can still occur.  A reduction in 25S, 18S, 5S and 5.8S rRNA 
was detected by NB and methylene blue staining but problems with the gel resolution did not 
allow discriminating between short and long forms of 5.8S rRNA (Fig. 3.4D-E). These results 
suggest that, in addition to the effect of Nop7 depletion, this phenotype is also resulting from 
the altered levels of the Ssf proteins. For instance, as Ssf2 can be found in affinity 
purifications of histone deacetylases, while Ssf1 can be found associated with histone 
acetylases, the resulting levels of these proteins for this strain under these conditions could 
have a role in closing rDNA repeats and reducing transcription. 
If Nop7 and Ssf1 belong to a same maturation route, as hypothesised, their 
simultaneous depletion should result in an increase of cellular Dt from 90 to 180min, as 
observed upon Nop7 depletion. Indeed, cellular Dt increased to 180min and WB analysis 
revealed increased Ssf2-PrA levels (Fig. 3.4A). During NB analysis, no 35S, 27SA/27SB, 
27SA2 precursors were detected (Fig. 3.4D lane 6). Levels of 23S were not detected but there 
was a slight accumulation of 22S and 20S (A1-A2) pre-rRNA, which suggest that A0, A1 and 
A3 processing can occur under these conditions. No change in A2-C2 and A3-C2 levels were 
detected, which suggest that these pre-rRNAs are still normally processed (Fig. 3.4D lane 6). 
However, premature C2-site processing was detected by primer extension and was 
concomitant with undetectable levels of 7S and 6S pre-rRNA, suggesting that these precursors 
are rapidly processed or even degraded under these conditions, as the levels or 5.8S rRNA 
were nearly non detectable by NB and non detectable by methylene blue staining (Fig. 3.4D-F 
lane 6). Lower levels of mature rRNAs were detected, including 5S rRNA by NB and 
methylene blue staining (Fig. 3.4D-E lane 6), which suggest that overall transcription was also 
affected upon depletion of Nop7 and Ssf1. Together, these data suggest that Nop7 and Ssf1 are 
genetically linked and function in a similar maturation route, as hypothesised. 
3.4.1 Ssf2-PrA levels are inversely correlated to Nop7 and Ssf1 
If Nop7 and Ssf2 are not genetically linked, no change in Ssf2-PrA levels is expected 
upon HA-Nop7 depletion. After 16 hours of repressing HA-NOP7 gene transcription (Gal1 
promoter shut-off in SD-met), HA-Nop7 protein levels were no longer detected, indirectly 
confirming the repression of the gene transcription, and HA-Ssf1 protein levels detected did 
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not change, as its gene was under the expression of a regulatable promoter that was kept on 
(Fig. 3.4B lanes 1-2). Unexpectedly, Ssf2-PrA levels decreased under these conditions, which 
imply that its protein levels can be correlated to Nop7 proteins levels. In the same strain, 
depletion of HA-Ssf1 increased Ssf2-PrA levels (Fig. 3.4B lanes 1 and 3), which corroborates 
that was previously observed in the MET::SSF1/SSF2-PRA strain (Fig. 3.3A and B lanes 4-6). 
If Ssf2 is inversely regulated by Nop7 and Ssf1 depletions, then simultaneous repression of 
both HA-SSF1 and HA-NOP7 genes would show intermediate levels of Ssf2. WB analysis 
revealed that this is the case and therefore show that Nop7 and Ssf1 protein levels inversely 
correlate to the levels of Ssf2. This contradicts the hypothesis that Nop7 and Ssf2 are not 
genetically linked.  
 
3.4.2 HA-Nop7 levels unexpectedly increase upon depletion of HA-
Ssf1 in the presence of Ssf2 
After 24 hours of repressing HA-SSF1 gene transcription (Met25 promoter shut-off in 
GRS+met), HA-Ssf1 levels were no longer detected, Ssf2-PrA levels increased cellular Dt was 
of 120min (Fig. 3.4A and B lanes 1 and 3). This phenotype is identical to the one observed 
upon HA-Ssf1 depletion in the MET::SSF1/SSF2-PRA strain and further corroborates that 
Ssf2 cannot fully compensate for the loss of HA-Ssf1 (Fig. 3.3 lanes 3-6). As the HA-NOP7 
gene is under the Gal promoter, the HA-Nop7 levels are slightly higher than in wild-type cells, 
which is expected. As these conditions were tested in the same WB and actin levels are 
similar, the HA-Nop7 levels should be the same before and after depletion of HA-Ssf1 (Fig. 
3.4B lanes 1 and 3). Unexpectedly, HA-Nop7 levels increased, which contradicts the 
observation in the MET::SSF1/SSF2-PRA strain, where Nop7 levels were undetectable, and 
was concomitant with a mild accumulation of 35S and 23S pre-rRNA (Fig. 3.3B lanes 3-6). 
HA-Ssf1 depletion delays pre-rRNA processing and is most likely responsible for the 35S pre-
rRNA accumulation observed (Fig. 3.4D lane 5). As Nop7 has been associated with 27SAB 
processing, its increase should result in faster processing of 27SAB precursors (36).  This 
phenotype is indeed observed in these cells and is concomitant with premature C2 site 
cleavage, as observed by primer extension (Fig. 3.4D and F), which suggest that the C2 site is 
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partially unprotected when HA-Ssf1 is absent but HA-Nop7 and Ssf2-PrA are increased. The 
levels of the other precursors and mature rRNAs did not notably change (Fig. 3.4D and E). 
This data therefore suggests that the increase in HA-Nop7 levels observed by WB is real and 
qRT-PCR analysis of its mRNA levels should determine if the cell achieves this by stabilising 
its mRNA or rather by increasing its translation rate or stabilising the protein. These results are 
presented and discussed in Section 3.6. 
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Figure 3.4: Ssf1 and Nop7 belong to a similar maturation route 
Depletion of HA-SSF1 and/or HA-NOP7 was performed by switching cells in repressive media (SD-
met, GRS+5mM met or YPD+5mM met). (A) Cell growth was monitored upon depletion of HA-Nop7 
(orange), HA-Ssf1 (light blue), and simultaneous depletion of both proteins (orange). (B) Levels of HA-
Ssf1, HA-Nop7 and Ssf2-PrA were assayed for each condition by WB and actin was used as loading 
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control.  The antibodies used for WB analysis are indicated at the right. (C) Using fluorescent probes, 
(D) total RNAs were analyzed by NB. (E) The most abundant RNAs were also detected using 
methylene blue staining. (F) Using 1μg of RNA, primer extension was performed to detect changes C2 
and C1/C1’ site-processing. 
 
3.5 Nop7 depletion in the absence of Ssf2 may generate 
aberrant ribosomes and severely impair cell growth 
First, in order to further support the finding that Nop7 levels affect both Ssf1 and Ssf2 
protein levels, Nop7 was depleted in two strains in which both Ssf proteins were present and 
regulated by their endogenous promoters. Depletion of Nop7 was validated by WB and the Dt 
was of 180min in both strains (Fig. 3.5A and B lanes 1-8). In the first strain, Ssf1-PrA levels 
decreased over time and the same was observed for Ssf2-PrA in the second strain. These 
results therefore further validate that Nop7 levels are correlated to the levels of both Ssf 
proteins.  
As previously demonstrated, Nop7 and Ssf1 most likely function in a same maturation 
route. Unexpectedly, the levels of Ssf proteins are correlated to Nop7 levels and the contrary is 
also valid, which links Ssf2 with Nop7. However, it is still possible that Ssf2 functions in a 
parallel LSU maturation pathway, independent of Ssf1 and Nop7. In order to test this 
hypothesis, HA-Nop7 was depleted in a strain in which Ssf1 was C-termini PrA-tagged and 
SSF2 was deleted from the genome. In restrictive media, the Dt of NOP7-depleted/SSF2-
cells was of 372min (Fig. 3.5A). At time 0, the levels of Ssf1-PrA were significantly lower in 
this strain compared to the other strain in which Ssf2 was still present (Fig. 3.5B lanes 1 and 
9). Previously, it was observed that Ssf2-PrA levels increased as a response to Ssf1 depletion 
(Figs. 3.3 lanes 3-6 and 3.4B lanes 1 and 3) but the the contrary does not seem to be the case. 
This therefore suggests that the levels of the Ssf proteins are regulated in the cell through 
independent mechanisms. Upon Nop7 depletion, the levels of Ssf1-PrA increase and then 
decrease only in SSF2-cells (Fig. 3.5B lanes 9-12).  
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Prior to HA-Nop7 depletion, GAL::NOP7/SSF1-PRA/ΔSSF2 cells show a pre-rRNA 
processing phenotype comparable to WT (Fig. 3.5D-F lanes 1-3) except for a mild 
accumulation of 35S pre-rRNA that was also observed in other strains in which Ssf2 was 
deleted (Fig. 3.3D lanes 5 and7). 
Upon depletion of  Nop7 and Ssf2, pre-rRNA processing defects would be expected to 
resemble features of both phenotypes (Table I). However, after HA-NOP7 depletion, 35S pre-
rRNA levels did not change, 18S and 5S levels dramatically decreased and no other pre-rRNA 
or mature rRNA could be detected by NB (Fig. 3.5D lane4). Primer extension using a probe 
that hybridized within the 5’ end of mature 25S rRNA (007) did unfortunately not reveal any 
accumulation of premature cleavage of the C2-site (Fig. 3.5F lane4). Methylene blue staining 
showed strong accumulation rRNAs that were slightly lower in molecular weight than 25S, 
18Sand 5S (Fig. 3.5E lane4). 
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Figure 3.5: Ssf2 belongs to a parallel LSU maturation pathway independent of Nop7 and 
Ssf1  
Depletion of HA-NOP7 was performed by growing cells in repressive media (YPD). (A) Cell growth was 
monitored upon depletion of HA-Nop7 (orange, red). (B) Levels of HA-Nop7, Ssf1-PrA and Ssf2-PrA 
were assayed by WB and actin was used as loading control.  The antibodies used for WB analysis are 
indicated at the right. (C) Using fluorescent probes, (D) total RNAs were analyzed by NB. (E) The most 
abundant RNAs were also detected using methylene blue staining. (F) Using 1μg of RNA, primer 
extension was performed to detect changes C2 and C1/C1’ site-processing. 
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3.6 The cell regulates differently the levels of Ssf2 and 
Nop7 
3.6.1 Upon depletion of Ssf1 or both Ssf proteins, Nop7 mRNA is 
stabilized and its translation rate is modulated  
As previously shown, Nop7 protein levels unexpectedly decreased upon depletion of 
Ssf1 or in the absence of the Ssf proteins (Fig. 3.3B lanes 1-11). It is therefore valid to ask 
whether regulation of Nop7 is performed transcriptionally, post-transcriptionally or both. 
Upon depletion of Ssf1, both in presence (Fig. 3.6A lanes 1-2) and absence of Ssf2 (Fig. 3.6B 
lanes 1-4), the mRNA levels of Nop7 significantly increased. Because the decrease in Nop7 
protein is not concomitant with a decrease in its mRNA, then post-transcriptional mechanisms 
exist that degrade Nop7 protein. Alternatively this could also be explained by a decreased 
affinity of its transcript with the translational machinery. The increase in NOP7 mRNA levels 
could be explained by increased transcriptional rate or is stabilised under these conditions. 
Using the Gal regulatable promoter, NOP7 gene transcription was kept constant upon HA-
Ssf1 depletion (Fig. 3.6A lane 5). Under these conditions, there was an increase in its mRNA, 
which suggests that the increase in NOP7 mRNA levels results from an increase in its 
stabilisation. Although NOP7 mRNA levels always increased, its protein levels either 
decreased (Fig. 3.3B lanes 1-11) or increased (Fig. 3.4B lanes 1 and 3). This data is therefore 
consistent with the supposition that altering the levels of at least one of the Ssf proteins 
generates NOP7 mRNA stabilisation with changes in its translational rate and/or protein 
stability. 
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3.6.2 Upon depletion of Ssf1 or Nop7+Ssf1 proteins, Ssf2 protein 
levels change, its mRNA levels remains stable and its 
translation rate is modulated  
As Ssf2 proteins levels are upregulated in the absence of Ssf1 and downregulated in the 
absence of Nop7, analysis of its mRNA levels could provide further insight on the 
mechanisms the cell used to regulated Ssf2 protein levels. Upon depletion of Ssf1, the mRNA 
levels of Ssf2 did not significantly change, suggesting that the protein levels of Ssf2 result 
from the stabilisation of the protein or from increased translation rate of its transcript 
(Fig. 3.6A lanes 1-2). Depletion of Nop7 or both Nop7 and Ssf1 protein levels also did not 
significantly change the mRNA levels of SSF2, which further support this idea. In this strain, 
Ssf1 depletion, resulted in an increase in both Ssf2 and Nop7 protein levels and the levels of 
SSF2 mRNA significantly decreased (0.588-fold, Fig. 3.6A lanes 3 and 5). 
 
Upon Nop7 depletion, the SSF1 gene was under the expression of Met25 promoter and 
both levels of mRNA and protein remained constant (Figs. 3.6A lane 4 and 3.4B lanes 1-2 
respectively). This implies that if the levels of mRNA change, it is most probably caused by a 
change in transcriptional rate of the gene. In another strain, Nop7-depleted/ Ssf2 cells 
increased the levels of SSF1 mRNA (1.521-fold increase, Fig. 3.6B lane 5-6). This increase 
was however concomitant with significantly lower levels of Ssf1 proteins that fluctuated over 
time (Fig. 3.6B lanes 9-12). In order to better understand if the fluctuation of Ssf1 protein 
observed is linked to a change in its mRNA, a timepoint analysis of SSF1 mRNA will be 
required for this strain.  
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Figure 3.6: qRT-PCR analysis of NOP7, SSF1 and SSF2 mRNA levels 
For each strain, cells in log phase were collected in the presence or absence of Ssf1 and or Nop7, 
regulated by means of distinct regulatable promoters. Using random primers and reverse 
transcriptase II, cDNAs were created from total RNA extracts. Primer sets specifically targeting unique 
endogenous sequences of key mRNAs were used for RT-PCR. Results were normalised against actin 
or UBC6, which are expected to remain constant. Assays in which Ssf2 is (A) present or (B) absent. 
 
3.7 Structural changes of Ssf1, Ssf2 and Nop7  
In an attempt to discern potential protein folding differences between Ssf1 and Ssf2, a 
protease accessibility laddering (PAL) assay was performed as per (80). Depending if the 
protein is alone or in complex, protein folding changes are expected and can be associated 
with changes in the accessibility of specific amino acids in the protein sequence when 
degraded using limited protease activity (87-89). The PAL assay can also confirm fold 
recognitions and sequence structures (80). The PAL assay was also chosen because the cell 
grindate of log phase strains with either Ssf1, Ssf2 or Nop7 C-terminally tagged (PrA) were 
already available in the lab. The tagged protein is recovered in its natively folded state using 
single-step affinity purification (ssAP) and it can be recovered alone or in complex, depending 
on the buffers stringency and the stability of the complexes it forms with other proteins. 
Limited proteolysis is then used to target exposed surface loops and domain-linking segments. 
The resulting C terminal PrA tagged fragments of the protein can then be tracked by western 
blot (Fig. 2.9) (80). For each sample, three different endoproteinases targeting one or two amino 
acids were used: Asp-N (D, aspartic acid), Lys-C (K, lysine) and trypsin (K, lysine and R, 
arginine), which helped locate the reacting amino acids. By comparing changes in proteolytic 
cleavages when the protein is alone or in complex, structural changes can be inferred and the 
exact location of the amino acid sequence can be identified by Edman sequencing (80). 
As a preliminary step, NOP7-PRA, SSF1-PRA and SSF2-PRA strains were submitted to 
limited proteolysis using a low stringency buffer (20 mM K/HEPES pH 7.4, 110 mM KOAc, 2 
mM MgCl2, 0.1% Tween 20, 1 mM DTT, 1:500 protease inhibitor cocktail) (80). The exposed 
regions of the Nop7 protein, when it is in complex with other proteins, can be approximated to 
regions located between its known domains (Fig. 3.7A). When they are in complex, both Ssf 
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proteins fold similarly and the exposed regions were approximated to regions located between 
domains (Fig. 3.7B). The The Ssf proteins show a similar pattern, consistent with the finding 
that the Ssf proteins are most likely associated with similar sets of proteins (Section 3.2). 
Cleavage patterns of the Ssf and Nop7 proteins when they are in complex with other RiBi 
factors under normal cellular conditions have been identified in this study.  
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Figure 3.7: Exposed domains of key proteins when in complex. 
Using stringent buffer conditions, the PrA-tagged protein is recovered from cryolyzed cell grindate 
using magnetic beads and submitted to protease degradation (*: full length). The PrA-recovered 
C-terminal end was analyzed by western blot. Nop7 (A) and Ssf (B) proteins domains constructed 
according to information taken from (54), (52) and (1). 
  
 
 
 
 
 
 
 
4 Discussion and perspectives 
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4.1 Ssf1 and Ssf2 form similar pre-rRNP particles and 
subcomplexes 
In the cell, Ssf1 is six times more abundant than its paralog, Ssf2. The Ssf1 affinity 
purification complex has previously been reported during log phase and contains many LSU 
RiBi factors, consistent with its role during ribosome biogenesis. Both paralogs can potentially 
heterodimerize with each other, although Ssf1 particles do not seem to contain Ssf2 under 
normal conditions (54). Moreover, Ssf2 has been found in particles in which Ssf1 is absent, like 
the Arx1 particle (90). Therefore, taken together, this data suggests that both proteins associate 
with distinct particles during ribosome biogenesis. However, analysis of the Ssf1 and Ssf2 
associated complexes has revealed that both paralogs form similar pre-rRNP complexes under 
normal growing conditions (Fig. 3.2 A, all buffers except #3, #6 and #11).  
Above 60kDa, six proteins consistently observed in higher abundance are probably 
always found in particles containing Ssf1 or Ssf2 (Fig. 3.1). It is therefore very likely that 
those six proteins are Dbp9, Dbp10, Drs1, Noc1, Noc2 and Nog1, as they are present in the 
previously reported Ssf1-particle and match the corresponding molecular weights (54). Also, if 
the particles are nearly identical, then Ssf1-particles are very likely to also contain Rrp15 
(LSU RiBi factor) and Nop53 (pre-90S RiBi factor) proteins, as Ssf2 has been shown to 
directly interact with Ssf2 (54, 60). Unfortunately, both RiBi are expected to run below the 
60kDa region, which showed high background. MS analysis will therefore be necessary to 
determine whether these proteins are found in both complexes, or not.  
Significant disruption of the particles revealed that three of the components previously 
observed in high abundance were still associated with the bait proteins and are likely Dbp9, 
Drs1 and Nog1, as these RiBi  proteins are predicted to enter the LSU maturing particle nearly 
at the same time as Ssf1 and could represent a subcomplex (Fig. 3.2 A, buffer #6) (85).. 
Previously, this type of observation has proven to be effective in identifying proteins that enter 
the pre-rRNP particle as subcomplexes, as is the case of Rpf2, Rrs1, Rpl5 and Rpl11 (17). Ssf1 
was previously detected in fractions of lower molecular weight than the 40S subunit during a 
sucrose gradient analysis, which further supports that this protein belongs to a yet unidentified 
subcomplex (54).  A sucrose gradient separation coupled to ssAP of the fractions of lower 
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molecular weight than the 40S sub-unit followed by MS analysis would allow the 
identification of these proteins as this method proved effective in identifying the Nop7-Erb1-
Ytm1 subcomplex (1). Once unambiguously identified, in vitro studies could be performed in 
order to validate their interaction.  
It is tempting to speculate that the other highly abundant proteins, likely Dbp10, Noc1 
and Noc2, are required for the entry of the tetrameric subcomplex into the pre-60S particle 
(Fig. 1.2) (85). However, if the proteins are not Dbp10, Noc1 and Noc2, then it is possible that 
these proteins are enriched in the particle because they associate earlier with the pre-60S and 
leave later than the Ssf proteins. In this latter scenario, the disappearance of these proteins in 
buffers of higher stringency would reflect that they are not in close proximity with the Ssf 
proteins in the pre-60S particles. Identification of these proteins by MS together with the data 
already available for the RiBi proteins will provide further insight. 
Ssf1 and Ssf2 differ in charge at only nine amino acids and yet Ssf2 appeared to make 
stronger interactions with the above mentioned proteins (Figs. 1.4 and 3.1). It is therefore 
likely that the nature of amino acids 281, 282, 290, 299, 300, 316, 411, 413 and 427 in Ssf2 
stabilize protein-protein. In order to verify this hypothesis, PCR-induced mutations could be 
performed on one paralog to change these amino acids and verify if a change in the stability of 
the associated subcomplex can be observed. In the short-term, MS analysis will readily 
identify these components and also distinguish background from real interactors below 60kDa, 
since some patterns are also conserved between the Ssf1 and Ssf2 particles in this region; 
however, these bands are most likely r-proteins in both ssAPs. 
4.2 Nop7, Ssf1 and Ssf2 proteins are genetically linked 
Thorough analysis of data available prior to this study, lead to the hypothesis that Nop7 
and Ssf1 were genetically linked and function in the main LSU maturation pathway, whereas 
Nop7 and Ssf2 were not genetically linked. Moreover, it was hypothesized during this study 
that Ssf2 functioned in a parallel, unreported pathway. In order to uncover the presence of 
parallel maturation pathways during ribosome biogenesis using Nop7, Ssf1 and Ssf2, one or 
two of these proteins were modulated, and changes in cell growth, total protein and mRNA 
levels (for some key factors) and pre-rRNA processing were monitored. Results concur with 
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the likely presence of parallel pathways independently involving Ssf1 or Ssf2 (Section 3.5). 
Results also suggest that Nop7 is genetically linked with Ssf1 but, also with Ssf2, contrary to 
what was previously expected. This study also uncovered an unreported phenotype observed 
upon Ssf2 and Nop7 depletion, which raises several questions that will be addressed in this 
section and will require further investigation.  
A heat map that summarizes all phenotypes observed in this study is listed in 
Table XXI. Phenotypes were divided in three; (A) in the first section, Ssf1 depletion in the 
presence of Ssf2 was observed with endogenous or slightly overexpressed Nop7 protein. (B) 
In the second section, the growth phenotype previously reported in SSF1-depleted/SSF2 cells 
was corroborated in two strains (54). The growth phenotype previously reported in Nop7-
depleted cells was almost identical to the phenotype observed in cells Nop7-depleted but 
slightly overexpressed Ssf1-protein (36). (C) Finally, Nop7 depletion in Ssf1-depleted or Ssf2 
cells was assayed. In all cases, depletion of the targeted protein and its mRNA levels were 
validated by WB and qRT-PCR, respectively. 
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Table XXI : Summary of the phenotypes observed  
To summarize the phenotypes observed (cell growth, pre-rRNA, mRNA, protein levels), a heat map was constructed for all the strains 
tested. (A): depletion of Ssf1 only. (B) Absence of both Ssf proteins. (C) Depletion of Nop7 under different cellular contexts. 
96 
4.2.1 Comparison between reported and observed phenotypes is 
limited because of the choice of the background strain  
As background strain W303a was used in this study. The previously reported Nop7-
depletion phenotype was reported in S288C-derived cells, which differs from W303a in that it 
cannot form pseudohyphae and has a mutated HAP1 gene, which alters normal processes 
occurring in the mitochondria (36). The depletion phenotype observed upon depletion of the Ssf 
proteins was reported in W303-1a cells, which are W303a cells sensitive to oxidative stress 
due to further mutations in the YBP1 gene (54). Therefore, strain variability has to be 
considered and could account for some differences observed during pre-rRNA processing. 
However, because W303a is less genetically modified than S288C and W3031a, it is expected 
to be the most fit.  
Another improvement in the NB assays would be to independently probe for 5S and 
5.8S rRNA, instead of simultaneously. Because these rRNAs are very close in size 
(5S: 121bases, 5.8SL: 160bases, and 5.8Ss: 154bases), the 5S signal was very strong and it did 
not allow discrimination between the 5.8SS and 5.8SL forms of rRNAs. Ideally a separate gel 
of lower polyacrylamide content (6% instead of 8%) and for a longer period of time should be 
run to resolve 5.8SS and 5.8SL rRNAs. Primer extension analysis could also be performed. 
Upon depletion of the Ssf proteins, A0 and A1 cleavages are expected to be severely 
delayed and to occur after ITS1 processing is completed, leading to an accumulation of 
aberrant 5’ ETS-D pre-rRNA (54). However, with the probes used in this study, this aberrant 
form of pre-RNA could not be detected.  Additional analyses could be performed using a 
probe targeting the 5’ETS of pre-rRNA (033). This, however, would most likely detect the 
accumulation of this pre-rRNA only in the cases where both Ssf paralogs have been deleted, as 
reported previously (54). Therefore, using this probe is not expected to alter the conclusions of 
this study.  
4.2.2 Ssf1 depletion cannot be fully compensated for by Ssf2 
Previous tetrad dissection studies have reported that the presence of one Ssf paralogs is 
sufficient for cell viability (49). Since Ssf1 and Ssf2 are required during the mating response 
and cell budding, deletion of both proteins impairs cell division, particularly during meiosis, 
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and cells arrest in G1 while no obvious phenotype was observed in cells lacking Ssf1 (49, 54). 
The current study shows a mild growth defect in SSF1-depleted cells (Dt: 120min, Table 
XXIA) which is likely explained by a slower processing of 35S pre-rRNA, indicating 
slowerpre-90S particle formation despite increased levels of Ssf2. Also, aberrant precursors 
indicated a mild processing delay of A0, A1 and A2 sites (23S: 5’ETS-A3) concomitant with 
the mild increase in premature C2 cleavage (A3-C2). As deletion of one single endonuclease 
does not seem to greatly affect A0, A1 or A2 processing, it has been proposed that several 
endonucleases can ensure these pre-rRNA processing events to take place. Endonucleases 
required during ribosome biogenesis include Rnt1 (A0, A2), Rcl1 (A2), RNase MRP (A0, A1, 
A2, A3) (4-6, 8). In addition to endonucleases, U3 snoRNPs have also been reported to have the 
capacity to bind and cleave at A0, A1 and A2 sites (76, 91). The pre-rRNA precursors 
accumulating in the absence of Ssf1 point towards a mild delay in U3-dependent cleavages 
(A0-A2). It would therefore be of interest to verify if the Ssf2-particle contains the components 
of the U3-snoRNP complex, which include Sof1, Mpp10, Rrp9, Lcp5 and whether or not these 
change upon depletion of Ssf1 (76, 91). Alternatively, the delay could also be explained by lower 
activity of the Imp3 protein, which is necessary for the recruitment of U3-snoRNP complex on 
the pre-rRNA concomitant with a longer occupancy of the Imp/Brix-family member Imp4, 
which has been reported to bind to U3 RNA, and promote its release from pre-rRNA (76, 91).  
A delay in A0-A2 cleavages should result in a premature A3 cleavage, generating 23S 
and 27SA3 pre-rRNA, the latter of which was not shown in this assay. However, the presence 
of an A3-C2 precursor suggests that 27SA3 is further prematurely cleaved at C2, which should 
also generate 26S’ (C2-B0). Presence of this precursor was not assayed in this study but could 
be detected using a probe hybridizing within the 3’ETS2. Taken together, these results 
indicate that Ssf1 depletion, and hence function, of Ssf1 cannot be fully compensated for by 
Ssf2, despite a clearly increased level. 
4.2.2.1 The effect of Ssf1 depletion depends on the cellular level of 
other RiBi proteins  
Ssf1 depletion was also performed in another strain where Nop7 was slightly 
overexpressed (MET::SSF1/SSF2-PRA/GAL::NOP7, SSF1-depletion, Table XXIA).  
98 
The growth phenotype observed in this strain is nearly identical as with 
MET::SSF1/SSF2-PRA cells. However, no 23S aberrant pre-rRNA was detected in these cells, 
and therefore the phenotype cannot be explained by a delay in U3-dependent cleavages (10). 
Therefore, accumulation of the 35S pre-rRNA in these cells could fit a scenario in which 
mechanisms up regulating 35S pre-rRNA transcriptional rate and creating a mild accumulation 
of this precursor. As both Ssf proteins were found in the particles of histone modifiers, the 
second scenario is plausible but would require further investigation. For example, AP-MS 
could be performed to assay changes in the Sdc1, Swr1, Eaf7, Rpd3 and Hda1-containing 
particles caused by the modulation of the Ssf proteins (Fig. 1.7A) (55, 56).  
In this strain, GAL::NOP7 mRNA levels unexpectedly increased upon Ssf1 depletion.. 
Since Nop7 is an important scaffold protein required for 27S pre-rRNA processing, its 
increased levels likely accounts for decreased levels of 27SA/SB and 27SA2 pre-rRNA of 
these precursors observed in this strain. However, a decrease in these pre-rRNAs could also be 
caused by an accumulation of 27SA3 precursor. The levels of this pre-rRNA can be verified by 
probing between the A3 and B1 sites (probe 001) and, alternatively, by primer extension 
analysis. If no change or a decrease in 27SA3 precursor is confirmed, then the phenotype 
would fit this scenario. Higher levels of Nop7 may increase the processing rate of 27S 
precursors, which, along with Ssf1 depletion, could generate less stable pre-rRNP complexes 
and a few of these complexes do not completely protect their C2-site.  
According to results presented in this study, Ssf2 is part of both Nop7-dependent and 
independent pathways (Section 3.5). Therefore, the Nop7/Erb1/Ytm1 complex is likely 
required in both common and parallel pathways involving Ssf2 under these conditions. It 
would therefore be if interest to i) identify the proteins present and the ones disappearing from 
the Ssf2-particle upon Nop7-depletion these conditions and ii) PRA-tag a protein not 
associated to Ssf2-containing particles in a MET::SSF1/GAL::NOP7 background. 
Together, this data further reiterates that Ssf1 and Ssf2 proteins cannot fully 
compensate for the loss of one another. Furthermore, it suggests that accumulation of different 
precursors at steady-state levels depend on the available levels of specific RiBi proteins.  
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4.2.3 Nop7 is genetically linked with both Ssf proteins  
Pre-rRNA processing defects associated with NOP7-depleted and SSF1-
depleted/SSF2 cells were previously reported and have been successfully reproduced in this 
study (Tables I and XXIB) (36, 54). As the absence of Ssf proteins affects early events that occur 
co-transcriptionally and can potentially associate with histone modifiers (Fig. 1.7A), it would 
be interesting to verify if rDNA transcription rates are altered in SSF1-depleted/SSF2 cells 
by performing either a Miller spread or psoralen assay.  
What seems clear from whole cell protein analyses is that absence of both Ssf proteins 
correlated with a decrease in Nop7, but not Cic1. The Cic1 protein is a RiBi protein binding 
within ITS2, close to the Nop7 binding site (12). It has been shown to interact with Nop7 
(protein-fragment complementation assay) in at least one particle, and finally, it is part of both 
the Ssf1 and Nop7 associated complexes while is not likely to physically interact with the Ssf 
proteins (12, 54). Furthermore, Ssf1 and Ssf2 protein levels decrease upon Nop7 depletion. This 
data therefore adds weight to Nop7 being genetically linked with Ssf1 and, unexpectedly, also 
with Ssf2.  
Previously, it has been observed that depletion of one component of the 
Nop7-Erb1-Ytm1 trimeric complex affects the total protein levels of the two other components 
without altering other RiBi proteins present in the same pre-60S particle (39). However, under 
normal conditions, the Nop7 associated particle was found to contain only Ssf1, suggesting 
that Nop7 has higher affinity for Ssf1, which may change when Ssf1 is absent, and Ssf2 is 
present in higher levels. This will be validated in future characterization of these interactions 
in vitro and ex vivo.  
 
4.2.4 Nop7/Ssf1 and Ssf2 can be part of parallel pathways 
Because of an observed correlation between the levels of Nop7, Ssf1 and Ssf2, NOP7 
depletion was assayed i) when SSF1 was slightly overexpressed (MET::SSF1, promoter on) 
or; ii) depleted (MET::SSF1, promoter off); and, iii) when SSF2 was deleted. The doubling 
time (Dt) of NOP7-depleted cells was not affected (180min) upon alteration of Ssf1 proteins 
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levels (by either overexpression or depletion) while the Dt of NOP7-depleted/SSF2Δ cells 
nearly doubled (372min). 
4.2.4.1 Altering the levels of the Ssf proteins can reduce the number of 
open rDNA 
In this study, a reduction of 5S rRNA was observed in SSF1-depleted/SSF2-cells, as 
previously reported (54). In addition, an unambiguous reduction in 5S rRNA was observed in 
GAL::NOP7/MET::SSF1/SSF2-PRA cells but only upon the simultaneous depletion of Nop7 
and Ssf1 (Fig. 3.4D-E lane6). Unlike an Ssf1-depletion, Nop7 depletion was shown to 
correlate with a drop in Ssf2 (Figs 3.3B lanes 3-6 and 3.5B lanes 5-8). Consequently, the 
simultaneous depletion of Nop7 and Ssf1 resulted in a moderate increase in Ssf2 (Fig. 3.4B). 
As the main maturation pathway was blocked under these conditions (Nop7 depletion), it is 
logical to imagine LSU ribosome biogenesis being driven by a larger proportion of Ssf2-
containing particles lacking Nop7 and Ssf1. As 5S rRNA is not transcribed by RNA pol I but 
is located between rDNA repeats, its reduction is likely caused by a reduction in the number of 
open rDNA repeats, which is dependent on the activity of chromatin remodelling factors. Ssf1 
and Ssf2 potentially associate with chromatin modifiers; it is therefore very likely that Ssf2 is 
not abundant enough in these cells to perform every one of its cellular functions. In is 
therefore highly probable that, Ssf2 fails to associate with Rpd3 and Hda1, or other chromatin 
modifiers, resulting in a decresase in the number of open rDNA repeats (Fig 1.7A). As 
transcription of the four rRNA genes is tightly correlated through TORC1, a decrease in 
transcription rate of RNA pol I, assayed by a Miller spread, could indirectly explain the 
reduction in 5S rRNA and will be performed.  
4.2.4.2 Nop7 and Ssf1 depletion  
It was previously reported that upon Nop7 depletion a switch to the minor pathway, 
that makes 5.8SL-containing ribosomes, occurs (36). It has also been reported that Nop7 binds 
to 5’-25S rRNA, and yet its depletion, or that of both Nop7 and Ssf1 simultaneously, does not 
result in ‘de-protection’ of this region, as (Table XXI C ) (12). This data supports the existence 
of an alternative pathway along which at least another RiBi factor that can bind pre-rRNA is 
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able to ensure the protection of this region and will be likely be found enriched in the Ssf2-
containign particles upon Ssf1+Nop7 depletion.  
4.2.4.3 Absence of Nop7 and Ssf2 generate a dominant negative mutant 
with severely impaired cell growth 
The effect of Nop7-depletion in the absence of Ssf2 was assayed in 
GAL::NOP7/SSF1-PRA/ΔSSF2 cells (Fig. 3.5B lanes 9-12). From what was observed in 
previous strains, at time 0, Ssf1 should compensate for the absence of Ssf2, and its levels 
should be increased or at least wild-type. Unexpectedly, Ssf1 protein levels were almost non-
detectable at time 0, which suggests that in the absence of Ssf2 and the minor overexpression 
of Nop7, Ssf1 becomes dispensable. This results therefore implies that there is at least one 
pathway in which ribosome maturation occurs independent on Ssf1 and Ssf2 and the presence 
of Nop7.  Upon Nop7 depletion, cellular doubling time was of 372min (roughly 6 hours) and 
Ssf1 levels slightly increased (6 and 16 hours), and could be caused by increased number of 
cells delayed during formation of the bud tip, where Ssf1 is likely needed (30). Information of 
such fluctuations has been overlooked in the literature. Changes in RiBi protein levels of as a 
response to depletion of another RiBi protein, if available, include only two time points (levels 
before and after depletion). Moreover, this information is often limited to proteins known to 
form stable complexes during ribosome biogenesis, as the Nop7/Ytm1/Erb1 complex, while 
RPs are used as controls (39).  
When grown in media repressing the NOP7 gene, cells showed a dominant negative 
phenotype for growth: its Dt increased to 372min. As Nop7 depletion can account for 
doubling the normal Dt, the additional 182min can be explained only by the absence of Ssf2. 
Therefore, taken together, this indicates that Ssf2 functions in an alternative pathway, 
independent of Nop7.  
 
4.2.4.3.1 Slow growing cells, fast pre-rRNA processing and aberrant ribosomes  
With the exception of modest levels of 35S, 22S, 18S and 5S, no other precursor or 
mature form of rRNA accumulated, pointing towards unusually fast pre-rRNA processing 
(Table XXI C). Methylene blue staining detected highly abundant, lower molecular weight 
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forms of 25S, 18S were undetected with probes targeting their 5’ coding regions 
(5’18S+115bases = probe 008; 5’25S+135 bases = probe 007). 
During ribosome biogenesis, Nop7 binds to the 5’ region of 25S rRNA(12)  The Ssf 
proteins likely bind to ITS1 and participate in the formation of ITS1-5’ 5.8S base pairing 
structure required to preventing hairpin structure formation (11, 12, 53). Results therefore suggests 
that Nop7 and the Ssf pair therefore likely protect 5’ ends of 25S and 5.8S rRNA during 
ribosome biogenesis from 5’→3’ degradation and imply that there exists at least one protein 
which can bind the 5’ regions of the 25S in particles devoid of Nop7. Presence of likely 
5’trimmed 18S rRNA in Nop7-depleted/SSF2 cells also suggest that the Ssf proteins might 
have a role in stabilising RNA-protein, protein-protein interactions or both in pre-90S particles 
which will protect the 5’ region of 18S rRNA. 
Results could reflect that there exists a small, nearly undetectable pool of normal 
ribosomes while there is a trong accunmulation of pre-rRNA degradation products In the past, 
pre-rRNA degradation products have been detected upon depletion of RiBi proteins, giving 
specific degradation patterns but this was not observed in this study (Fig. 3.5D) (92). 
Degradation of aberrant pre-rRNA usually occurs very fast and degradation products can be 
probed upon depletion of exosome components or exonucleases (e.g Rrp17 and Rat1) but 
neither Nop7, Ssf1 nor Ssf2 are knwon or predicted exonucleases (7, 93). A scenario in which 
NOP7-depleted/SSF cells produce aberrant ribosomes which are inefficient in mRNA 
translation could explain the highly impaired cell growth observed. In either scenario, 
polysome gradient analysis coupled with RNA analysis of the collected fractions would 
address these questions. 
 
4.2.5 Nop7/Ssf1, Ssf2 and parallel pathways during ribosome 
biogenesis 
Previously it had been shown that pre-90S processing events can occur via two 
alternative pathways (31). However, the study was focused on pre-90S and pre-40S particles, 
and no study so far has shown whether the LSU can also be processed by alternative 
pathways. What is known, however, are all the components required to incorporate the 5S 
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rRNA, which is mediated, as previously mentioned, by Rpf2 and timed to coincide with C2 
processing (17). 
Is it possible that early associations dictate the downstream pre-rRNA processing 
events that will generate 5.8SS or 5.8SL-containing ribosomes? This possibility will be 
explored in this subsection, taking into account the results obtained during this study, and 
should be further supported by performing additional NB probing, primer extension (ITS1) 
and MS analysis of the bait proteins for all the strains tested in this study (permissive and 
restrictive conditions). In some strains, especially in the case of 
GAL::NOP7/ΔSSF2/SSF1-PRA, pulse-chase analysis should be performed.  
 
4.2.5.1 There exists a LSU maturation pathway dependent on 
Ssf1/Ssf2 heterodimer  
As demonstrated in this study, the Ssf proteins associate within similar complexes under 
normal cellular conditions. This study has also shown that the Ssf proteins cannot fully 
compensate for the loss of each other, and that this is due to the fact that they do not function 
along the same but parallel pathways. It is tempting to speculate that the Ssf proteins can only 
homodimerize, however, Ssf1 is one result in a search for physical and genetic interactions of 
Ssf2 (30). Thus, this possibility cannot be ruled out with the available data but it could suggest 
that Ssf1/Ssf2 heterodimer is relatively rare under normal conditions, since the Ssf1 particle 
does not contain Ssf2 (54). In vitro studies (solution binding assay) will have to be performed to 
ultimately explore either possibility.  
 
4.2.5.2 The 5.8SS pathway is mostly Ssf1/Nop7 dependent 
Upon Nop7 depletion, cells switch to producing high levels of 5.8SL-containing 
ribosomes, which are normally the result of a less preferred RiBi pathway. Cells lacking both 
Ssf proteins generate less ribosomes overall, possibly due to a drop in transcription, yet the 
ratio of 5.8SS to 5.8SL does not change, suggesting that these proteins are involved in events 
upstream of both pathways leading to the different forms of 5.8SrRNAs.  
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Early pre-90S processing events can occur via two alternative pathways, one of which 
is Rrp5 (Noc1/Noc2)/UTP-C dependent (31). Both Nop7 and Ssf1 proteins most likely follow 
this pathway as both of their particles (Fig 1.8A) contain Noc1/Noc2 heterodimer and Nop7-
containing particles also include Rrp5. From what has been published, and the data obtained 
during this study, it can be speculated that Nop7 is likely genetically linked to both Ssf 
proteins but that it is most often found with Ssf1, as Nop7 normally only binds with Ssf1 in its 
homodimeric form. This scenario would explain why Ssf2 is not part of Nop7 associated 
complexes (37). However, even if Ssf2 is not part of the Rrp5-dependent pre-90S pathway, it 
can, albeit to a lesser extent, be associated with B1S processing through its direct interaction 
with Rrp15, a protein required for B1S processing, which is also not part of Nop7 associated 
complexes. Upon Nop7 depletion, both Ssf protein levels drop but are still detectable. It is 
therefore possible that B1S processing still occurs in these cells through Ssf2-Rrp15-containing 
particles as well as Ssf1-containing particles. What is certain is that, Nop7-depleted cells are 
able to successfully protect the 5’ends of rRNA, through a yet unidentified mechanism, as no 
overly exonucleolytically processed 5’ forms of 25S, 18S and 5S rRNAs could be detected.   
 
4.2.5.3 Ssf2 is probably linked to the U3 snoRNP/Bms1-dependent 
pre-90S pathway  
The Rpf2 particle  is the only one that has been reported to contain the Ssf2 protein (17). 
Why has Ssf2 not been reported in other particles? This could be due to previous detection 
limitations in MS analysis in addition to the low abundance of the protein. Another reason 
could be that Ssf2 is involved in the pre-90S pathway, which is U3 snoRNP/Bms1 dependent. 
Ssf1 and Nop7 particles contain all Noc1/Noc2 and members of the Imp/Brix superfamily 
(Brx1, Ssf1, Rpf1, and Rpf2) except Imp4 and Ssf2 (51, 52). As previously mentioned, pre-90S 
processing events can also occur through a pathway that is U3 snoRNP/Bms1 dependent and 
requires Imp3 and Imp4 RiBi factors (31). Imp3 has been reported to recruit U3 RNA on the 
pre-rRNA and Imp4 (Imp4/Brix family) has been reported to bind to U3 RNA, and promote its 
release from pre-rRNA (76). U3-RNA plays a role in correct processing of A0 to A2 sites. If 
Ssf2 is involved in this pathway, then MS analysis of its particle under at least some of the 
conditions tested during this study should identify U3 snoRNP components or Bms1 as well as 
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other components usually attributed to pre-90S or early pre-40S maturation. If Ssf2 does 
belong into this pathway, then it was most likely ruled out as background in pre-90S and pre-
40S studies due to its high similarity with Ssf1, which was associated with pre-60S 
maturation.  
 
4.2.5.4 Ribosome biogenesis devoid of A3-cluster factors 
In the field, some believe that pre-60S maturation is split from pre-40S maturation and 
others believe that it can be coupled. Results from this study suggest that Nop7/Ssf1 and Ssf2 
might play a role in stabilizing the RiBi factors required for 5’ protection of 18S, 5.8S and 25S 
rRNAs and therefore implies that particles exist in which the LSU and SSU RiBi factors are 
partially stabilizing each other in the pre-90S particle. In one scenario, in which Nop7 is 
depleted, this stabilizing role might be compensated by particles lacking A3-cluster ribosomes, 
as defined by Granneman et al (2011). These particles most probably contain Ssf2 and other 
factors that are able to bind pre-rRNA within the ITS1 and ITS2 regions. These proteins are 
also stabilizing a second structure later during LSU pre-rRNA processing that will ensure the  
protection of the 5S rRNA. Upon depletion of both Ssf2 and Nop7, the stabilization role 
required during both of these cases cannot be efficiently compensated by the presence of Ssf1 
alone, and the 5’ of the rRNAs become unprotected. 
 
4.2.6 Regulating protein levels 
Another aspect of the dynamics of the RiBi proteins is regulation of their protein 
levels. A qRT-PCR analysis of the mRNA coupled with whole-protein extract analysis could 
determine on how the cell specifically regulates its protein levels. Overall, this analysis 
indicates that the cell uses different mechanisms for regulating the levels or a RiBi protein, 
and those depend on the cellular context. 
 
106 
4.2.6.1 SSF2 is mostly post-transcriptionally regulated 
In the MET::SSF1/SSF2-PRA, the protein levels of Ssf2 increased but its mRNA levels 
remained constant (1.052-fold). In the MET::SSF1/SSF2-PRA/GAL::NOP7 strain, when Ssf1 
was depleted and Nop7 protein levels increased, Ssf2 protein levels increased, yet its mRNA 
levels decreased (0.588-fold). In all other cases studied in the same strain, which is upon Nop7 
depletion or Nop7+Ssf1 depletion, the mRNA levels did not significantly change (1.252-fold 
and 0.906-fold), whilst the protein levels respectively decreased and increased. However, 
these results were analyzed in triplicate and generated high variability and should therefore be 
repeated. From the data available, it can be concluded that SSF2 mRNA stability and/or 
transcription can be altered, depending on the cellular context; Ssf2 protein levels can also be 
modulated by stabilizing the protein, or changing its translation rate. 
 
4.2.6.2 NOP7 mRNA can be stabilized  
In the MET::SSF1/SSF2-PRA strain, Nop7 protein levels were not detectable but its 
mRNA levels were significantly increased (1.72-fold). Upon Ssf1 depletion in the 
MET::SSF1/SSF2-PRA/GAL::NOP7 strain, there was an increase in Nop7 mRNA levels 
(2.161X) and protein, which could also be attributed to its expression being driven from a Gal-
promoter. In the MET::SSF1/ΔSSF2/CIC1-PRA strain, endogenous Nop7 protein levels were 
not detectable although its mRNA levels significantly increased (1.386-fold). The 
MET::SSF1/ΔSSF2/NOP7-PRA strain further corroborated that Nop7 protein levels decreases 
even if its mRNA levels increased (4.294-fold). Because the NOP7 gene was under the control 
of a regulatable promoter and the mRNA levels increased, this data suggests that Nop7 mRNA 
transcription rate is not altered in response to a stress, but its mRNA becomes stabilized. This 
explains the increase of NOP7 mRNA in all cases. Because Nop7 protein usually decreased, 
either the protein is degraded faster or is less translated. Why its mRNA is not targeted for 
degradation, has to be determined. 
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4.2.6.3 Ssf1 regulation needs to be further studied 
Ssf1 mRNA levels were assayed in two strains. In the first strain, there was no change 
in Ssf1 mRNA (1.025-fold) and protein levels upon Nop7 depletion 
(MET::SSF1/SSF2-PRA/GAL::NOP7), when Ssf2 was present. In the second strain, Ssf2 
protein was completely absent, Nop7 was depleted and the Ssf1 gene was under its 
endogenous promoter (GAL::NOP7/SSF1-PRA/ΔSSF2). Under these conditions, Ssf1 protein 
levels fluctuated significantly (Table XXIC). At the last timepoint observed, Ssf1 protein 
levels were nearly non-detectable, whilst its mRNA levels were increased (1.5-fold). Because 
Ssf1 protein levels unexpectedly fluctuated in the absence of Ssf2, its mRNA levels should be 
assayed under the same conditions but in the presence of Ssf2 protein (GAL::NOP7/SSF1-
PRA) before drawing any conclusions.  
 
4.3 Dissecting structural changes in Ssf1, Ssf2 and Nop7  
Using the buffer for complex purification detailed in (80), cleavage patterns of the 
Ssf1, Ssf2 and Nop7 proteins when they are in complex with other RiBi factors have been 
identified in this study. The exposed regions corresponded to regions located between domains 
(Fig. 3.7A and B). The Ssf proteins show a similar pattern, consistent with the finding that 
they are most likely associated with similar sets of proteins (Section 3.2). 
Because of the nature of the proteins and the strength of the association it forms with 
other RiBi proteins, the stringency of the buffer required to recover a RiBi protein alone 
changes and needs to be individually validated. The ssAP buffer condition that is stringent 
enough to completely disrupt complexes formed by the Ssf proteins (20mM Hepes pH 7.4, 
300mM NaCitrate, 0.5% Triton, 0.1% Tween 20, 1:100 solution P) has been identified in this 
study and will allow to detect possible changes in Ssf1 and Ssf2 protein folding when they are 
alone. Nop7 forms a tight trimeric sub-complex with Erb1 and Ytm1. The buffers detailed in 
Section 3.2 were not stringent enough to recover Nop7-PrA as a single protein (data not 
shown). Further investigation is necessary to identify a ssAP buffer stringent enough to 
completely disrupt Nop7-PrA pre-rRNP complexes.  
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It is possible to recover endogenously-folded bait protein alone, without associated 
proteins, by coupling ssAP with a highly stringent buffer. Alternatively, association with 
endogenous Nop7 protein recovered in this fashion could be tested using recombinant Ssf1 or 
Ssf2 protein, and if an interaction is detected, limited protease accessibility assay on this 
complex could provide further information on changes in Nop7 protein folding upon binding 
with the Ssf proteins. The same could be performed using Ssf1 or Ssf2 as bait proteins and 
recombinant Nop7. 
 
4.4 Nop7 likely interacts directly with Ssf1 
Previously it has been reported that Ssf1 and Nop7 directly interact with each other 
during Xenopus laevis pronephros development, independently of ribosome biogenesis (Ssf2 
has not been tested) (47). The possibility of them physically interacting with each other during 
yeast ribosome biogenesis was supported by the accumulation of a common, aberrant pre-
rRNA (26S) upon their independent depletion, suggesting premature C2 cleavage in both cases 
(Fig. 1.7) (36, 54).  
Several aspects of the Ssf proteins need to be validated by in vitro studies, such as their 
capacity to bind rRNA through their family conserved ό70-like motif, and their capacity to 
homo- and/or heterodimerize with each other, through their predicted homo/hetero-binding 
domain (Fig. 1.4). Furthermore, the potential interaction of Ssf1 with Nop7 also needs to be 
validated in vitro. Given the high similarity to Ssf1, a potential interaction of Ssf2 with Nop7 
also needs to be addressed. During this study, the plasmids required to generate recombinant 
proteins were cloned and the conditions for the expression of recombinant Nop7, Ssf1 and 
Ssf2 were optimized (Table XI and Figs. 2.3-2.4) and will allow in vitro solution binding 
studies to test for these protein-protein interactions. The capacity of the Ssf proteins to bind 
RNA will also be tested since they are believed to protect, though binding, the 5’ coding 
region of 5.8S during 27SA3 5’→3’ trimming of ITS1, thus slowing the activity of the 
exonuclease (Rat1 or Rrp17) (7, 12, 53).  
 
  
 
 
 
 
 
 
 
5 Conclusion 
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The Ssf1 and Ssf2 proteins have been implied to fulfil redundant functions in the cell 
and during ribosome biogenesis. This work supports this observation to some extent, as it 
highlights that, under normal conditions, both paralogs can make identical pre-rRNP particles. 
However, analysis of the stability of these particles using buffers of different stringency during 
ssAP suggests that Ssf2-PrA containing complexes may be more stable. Disruption of the 
affinity purified particles using higher stringency buffers revealed that at least three proteins, 
likely Dbp9, Drs1 and Nog1 strongly affinity purify with the bait proteins and likely represent 
a subcomplex. 
Although cellular levels of Ssf2-PrA increased upon SSF1-depletion, this works 
provides evidence that the Ssf proteins cannot entirely compensate for the loss of each other, 
as pre-rRNA processing was mildly delayed in SSF1-depleted cells. The pre-rRNA processing 
defects previously reported for both Nop7-depleted and SSF1-depleted/SSF2Δ cells were 
corroborated (36, 54). This work also provides evidence that Ssf1 and Ssf2 levels are correlated 
to the levels of Nop7 and are genetically linked. The Ssf1 and Nop7 proteins might be 
required, under normal conditions, in the major pre-rRNA maturation pathway, which is 
further reinforced by the fact that they are found in particles associated with tagged Nop7 and 
Ssf1. Nop7 depletion, when Ssf1 was overexpressed, and generated a pre-rRNA depletion 
phenotype reminiscent of the depletion phenotype observed in the absence of both Ssf 
proteins. Simultaneous depletion of Nop7 and Ssf1 in the presence of Ssf2 also and generated 
less ribosomes, as shown by Northern blot analysis. The pre-rRNA depletion phenotype 
observed here was reminiscent of the one observed upon depletion of both Ssf proteins, in 
which transcription and early processing appears delayed.  
In clear contrast, simultaneous absence of Nop7 and Ssf2 in the presence of Ssf1 
showed a dominant negative growth phenotype with a strong accumulation of what appears to 
be overly exonucleolytically processed 5’ forms of 25S, 18S and 5S rRNAs and no 5.8S 
rRNA. To this date, such depletion phenotype has never been reported and implies that there 
exists an early particle that requires the presence of Nop7/Ssf1 or Ssf2 to correctly stabilize 
RiBi proteins required for 5’ protection of rRNA coding regions. In fact is was previously 
suggested that Ssf1 would fulfil such a role for 25S and 5.8S, however it appears that Ssf1 
alone is not sufficient for the protection of 5’ends of pre-rRNAs. These results also imply that 
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under these conditions, incorporation of 5S rRNA in the pre-60S particle is possible but that 
this rRNA becomes unprotected and at least partially degraded, a phenotype never previously 
observed. Further analysis of the Northern blots generated as well as additional assays will 
allow a more detailed analysis of this phenotype and its origins. Moreover, performing ssAP 
coupled with MS/MS will allow screening for any pre-rRNP particle changes in all the strains 
and conditions tested in this study.  
While cellular Ssf2 protein levels varied, its mRNA levels remained relatively stable in 
four of the five conditions it was tested, which suggests that it is mostly post-transcriptionally 
regulated. This clearly contrasts with the cellular regulation of Nop7 protein. In three of the 
four cases studied, Nop7 protein levels appeared decreased and in the fourth case, the gene 
was steadily transcribed under the Gal1 promoter and WB analysis showed a clear increase in 
Nop7 protein upon Ssf1 depletion. In the four cases, Nop7 mRNA increased, which suggest 
that NOP7 mRNA stabilisation. 
Taken together, these results strongly suggest that the Ssf paralogs function in fact along 
separate parallel maturation pathways during yeast ribosome biogenesis, and are not, as 
previously thought, interchangeable. These findings highlight the relevance to further 
characterise these proteins in vitro. RNA binding and solution binding assays can be 
performed in the future, as recombinant proteins have been generated in this study. As other 
paralogs, such as for example Fpr3 and Fpr4, are believed to play also a functionally 
redundant role during ribosome biogenesis, results presented in this study raise the question as 
to whether these proteins as well as others are truly functional homologues, or fulfil functional 
different tasks along different branches of the pathway or under certain circumstances. Better 
understanding the binding partners of such paralogs could provide a good starting point for 
new studies. In ribosome biogenesis of higher eukaryotes there are 74 RiBi proteins which 
have no homolog in yeast and which include several paralogs or proteins submitted to 
alternative splicing (94). The present study suggests that these paralogs can be used as tools to 
gain better understanding of the additional layers of complexity observed during ribosome 
biogenesis in these cells and may finally lead to an understanding of why so many proteins are 
involved in this intricate pathway. 
  
Bibliography 
1. Du YC, Stillman B. Yph1p, an ORC-interacting protein: potential links between cell 
proliferation control, DNA replication, and ribosome biogenesis. Cell. 2002;109(7):835-48. 
Epub 2002/07/12. 
2. Dez C, Tollervey D. Ribosome synthesis meets the cell cycle. Current opinion in 
microbiology. 2004;7(6):631-7. Epub 2004/11/24. 
3. Albert B, Leger-Silvestre I, Normand C, Ostermaier MK, Perez-Fernandez J, Panov 
KI, et al. RNA polymerase I-specific subunits promote polymerase clustering to enhance the 
rRNA gene transcription cycle. The Journal of cell biology. 2011;192(2):277-93. Epub 
2011/01/26. 
4. Venema J, Tollervey D. Ribosome synthesis in Saccharomyces cerevisiae. Annual 
review of genetics. 1999;33:261-311. Epub 2000/02/26. 
5. Elela SA, Igel H, Ares M, Jr. RNase III cleaves eukaryotic preribosomal RNA at a U3 
snoRNP-dependent site. Cell. 1996;85(1):115-24. Epub 1996/04/05. 
6. Lindahl L, Bommankanti A, Li X, Hayden L, Jones A, Khan M, et al. RNase MRP is 
required for entry of 35S precursor rRNA into the canonical processing pathway. RNA. 
2009;15(7):1407-16. Epub 2009/05/26. 
7. Oeffinger M, Zenklusen D, Ferguson A, Wei KE, El Hage A, Tollervey D, et al. 
Rrp17p is a eukaryotic exonuclease required for 5' end processing of Pre-60S ribosomal RNA. 
Molecular cell. 2009;36(5):768-81. Epub 2009/12/17. 
8. Sloan KE, Mattijssen S, Lebaron S, Tollervey D, Pruijn GJ, Watkins NJ. Both 
endonucleolytic and exonucleolytic cleavage mediate ITS1 removal during human ribosomal 
RNA processing. The Journal of cell biology. 2013;200(5):577-88. Epub 2013/02/27. 
9. Granneman S, Baserga SJ. Ribosome biogenesis: of knobs and RNA processing. 
Experimental Cell Research. 2004;296(1):43-50. 
10. Gallagher JE, Dunbar DA, Granneman S, Mitchell BM, Osheim Y, Beyer AL, et al. 
RNA polymerase I transcription and pre-rRNA processing are linked by specific SSU 
processome components. Genes & development. 2004;18(20):2506-17. Epub 2004/10/19. 
11. Yeh LC, Thweatt R, Lee JC. Internal transcribed spacer 1 of the yeast precursor 
ribosomal RNA. Higher order structure and common structural motifs. Biochemistry. 
1990;29(25):5911-8. Epub 1990/06/26. 
12. Granneman S, Petfalski E, Tollervey D. A cluster of ribosome synthesis factors 
regulate pre-rRNA folding and 5.8S rRNA maturation by the Rat1 exonuclease. The EMBO 
journal. 2011;30(19):4006-19. Epub 2011/08/04. 
13. Henry Y, Wood H, Morrissey JP, Petfalski E, Kearsey S, Tollervey D. The 5' end of 
yeast 5.8S rRNA is generated by exonucleases from an upstream cleavage site. The EMBO 
journal. 1994;13(10):2452-63. Epub 1994/05/15. 
14. Cote CA, Peculis BA. Role of the ITS2-proximal stem and evidence for indirect 
recognition of processing sites in pre-rRNA processing in yeast. Nucleic acids research. 
2001;29(10):2106-16. Epub 2001/05/23. 
15. van Nues RW, Rientjes JM, Morre SA, Mollee E, Planta RJ, Venema J, et al. 
Evolutionarily conserved structural elements are critical for processing of Internal Transcribed 
113 
Spacer 2 from Saccharomyces cerevisiae precursor ribosomal RNA. Journal of molecular 
biology. 1995;250(1):24-36. Epub 1995/06/30. 
16. Dembowski JA, Ramesh M, McManus CJ, Woolford JL, Jr. Identification of the 
binding site of Rlp7 on assembling 60S ribosomal subunits in Saccharomyces cerevisiae. 
RNA. 2013. Epub 2013/10/17. 
17. Zhang J, Harnpicharnchai P, Jakovljevic J, Tang L, Guo Y, Oeffinger M, et al. 
Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into 
nascent ribosomes. Genes & development. 2007;21(20):2580-92. Epub 2007/10/17. 
18. Lebreton A, Saveanu C, Decourty L, Rain JC, Jacquier A, Fromont-Racine M. A 
functional network involved in the recycling of nucleocytoplasmic pre-60S factors. The 
Journal of cell biology. 2006;173(3):349-60. Epub 2006/05/03. 
19. Claypool JA, French SL, Johzuka K, Eliason K, Vu L, Dodd JA, et al. Tor pathway 
regulates Rrn3p-dependent recruitment of yeast RNA polymerase I to the promoter but does 
not participate in alteration of the number of active genes. Molecular biology of the cell. 
2004;15(2):946-56. Epub 2003/11/05. 
20. Wittner M, Hamperl S, Stockl U, Seufert W, Tschochner H, Milkereit P, et al. 
Establishment and maintenance of alternative chromatin states at a multicopy gene locus. Cell. 
2011;145(4):543-54. Epub 2011/05/14. 
21. Keener J, Josaitis CA, Dodd JA, Nomura M. Reconstitution of yeast RNA polymerase 
I transcription in vitro from purified components. TATA-binding protein is not required for 
basal transcription. The Journal of biological chemistry. 1998;273(50):33795-802. Epub 
1998/12/05. 
22. Beckouet F, Labarre-Mariotte S, Albert B, Imazawa Y, Werner M, Gadal O, et al. Two 
RNA polymerase I subunits control the binding and release of Rrn3 during transcription. 
Molecular and cellular biology. 2008;28(5):1596-605. Epub 2007/12/19. 
23. Aprikian P, Moorefield B, Reeder RH. New model for the yeast RNA polymerase I 
transcription cycle. Molecular and cellular biology. 2001;21(15):4847-55. Epub 2001/07/05. 
24. Albert B, Perez-Fernandez J, Leger-Silvestre I, Gadal O. Regulation of ribosomal RNA 
production by RNA polymerase I: does elongation come first? Genetics research international. 
2012;2012:276948. Epub 2012/05/09. 
25. Perez-Fernandez J, Martin-Marcos P, Dosil M. Elucidation of the assembly events 
required for the recruitment of Utp20, Imp4 and Bms1 onto nascent pre-ribosomes. Nucleic 
acids research. 2011;39(18):8105-21. Epub 2011/07/05. 
26. Jack K, Bellodi C, Landry DM, Niederer RO, Meskauskas A, Musalgaonkar S, et al. 
rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity 
from yeast to human cells. Molecular cell. 2011;44(4):660-6. Epub 2011/11/22. 
27. Nguyen-Lefebvre AT, Leprun G, Morin V, Vinuelas J, Coute Y, Madjar JJ, et al. V-
erbA generates ribosomes devoid of RPL11 and regulates translational activity in avian 
erythroid progenitors. Oncogene. 2013. Epub 2013/04/09. 
28. Komili S, Farny NG, Roth FP, Silver PA. Functional specificity among ribosomal 
proteins regulates gene expression. Cell. 2007;131(3):557-71. Epub 2007/11/06. 
29. Zebarjadian Y, King T, Fournier MJ, Clarke L, Carbon J. Point mutations in yeast 
CBF5 can abolish in vivo pseudouridylation of rRNA. Molecular and cellular biology. 
1999;19(11):7461-72. Epub 1999/10/19. 
114 
30. Cherry JM, Hong EL, Amundsen C, Balakrishnan R, Binkley G, Chan ET, et al. 
Saccharomyces Genome Database: the genomics resource of budding yeast. Nucleic acids 
research. 2012;40(Database issue):D700-5. Epub 2011/11/24. 
31. Perez-Fernandez J, Roman A, De Las Rivas J, Bustelo XR, Dosil M. The 90S 
preribosome is a multimodular structure that is assembled through a hierarchical mechanism. 
Molecular and cellular biology. 2007;27(15):5414-29. Epub 2007/05/23. 
32. Warner JR. Nascent ribosomes. Cell. 2001;107(2):133-6. Epub 2001/10/24. 
33. Henras AK, Soudet J, Gerus M, Lebaron S, Caizergues-Ferrer M, Mougin A, et al. The 
post-transcriptional steps of eukaryotic ribosome biogenesis. Cellular and molecular life 
sciences : CMLS. 2008;65(15):2334-59. Epub 2008/04/15. 
34. Kaberdina AC, Szaflarski W, Nierhaus KH, Moll I. An unexpected type of ribosomes 
induced by kasugamycin: a look into ancestral times of protein synthesis? Molecular cell. 
2009;33(2):227-36. Epub 2009/02/04. 
35. Kinoshita Y, Jarell AD, Flaman JM, Foltz G, Schuster J, Sopher BL, et al. Pescadillo, a 
novel cell cycle regulatory protein abnormally expressed in malignant cells. The Journal of 
biological chemistry. 2001;276(9):6656-65. Epub 2000/11/10. 
36. Oeffinger M, Leung A, Lamond A, Tollervey D. Yeast Pescadillo is required for 
multiple activities during 60S ribosomal subunit synthesis. RNA. 2002;8(5):626-36. Epub 
2002/05/23. 
37. Oeffinger M. Nop7-associated proteins during log phase. Unpublished; 2012. 
38. Krogan NJ, Peng WT, Cagney G, Robinson MD, Haw R, Zhong G, et al. High-
definition macromolecular composition of yeast RNA-processing complexes. Molecular cell. 
2004;13(2):225-39. Epub 2004/02/05. 
39. Tang L, Sahasranaman A, Jakovljevic J, Schleifman E, Woolford JL, Jr. Interactions 
among Ytm1, Erb1, and Nop7 required for assembly of the Nop7-subcomplex in yeast 
preribosomes. Molecular biology of the cell. 2008;19(7):2844-56. Epub 2008/05/02. 
40. Adams CC, Jakovljevic J, Roman J, Harnpicharnchai P, Woolford JL, Jr. 
Saccharomyces cerevisiae nucleolar protein Nop7p is necessary for biogenesis of 60S 
ribosomal subunits. RNA. 2002;8(2):150-65. Epub 2002/03/26. 
41. Xie W, Feng Q, Su Y, Dong B, Wu J, Meng L, et al. Transcriptional regulation of 
PES1 expression by c-Jun in colon cancer. PloS one. 2012;7(7):e42253. Epub 2012/08/04. 
42. Cheng L, Li J, Han Y, Lin J, Niu C, Zhou Z, et al. PES1 promotes breast cancer by 
differentially regulating ERalpha and ERbeta. The Journal of clinical investigation. 
2012;122(8):2857-70. Epub 2012/07/24. 
43. Li J, Yu L, Zhang H, Wu J, Yuan J, Li X, et al. Down-regulation of pescadillo inhibits 
proliferation and tumorigenicity of breast cancer cells. Cancer science. 2009;100(12):2255-60. 
Epub 2009/09/22. 
44. Xie W, Qu L, Meng L, Liu C, Wu J, Shou C. PES1 regulates sensitivity of colorectal 
cancer cells to anticancer drugs. Biochemical and biophysical research communications. 
2013;431(3):460-5. Epub 2013/01/22. 
45. Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF, Koonin EV. A superfamily 
of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB 
journal : official publication of the Federation of American Societies for Experimental 
Biology. 1997;11(1):68-76. Epub 1997/01/01. 
115 
46. Matsumoto S, Yahara I. YTM1, a suppressor of beta-tubulin mutation, encodes a novel 
microtubule-interacting protein and is essential for G1/S transition in Saccharomyces 
cerevisiae. Unpublished1997. 
47. Tecza A, Bugner V, Kuhl M, Kuhl SJ. Pescadillo homologue 1 and Peter Pan function 
during Xenopus laevis pronephros development. Biology of the cell / under the auspices of the 
European Cell Biology Organization. 2011;103(10):483-98. Epub 2011/07/21. 
48. Holzel M, Rohrmoser M, Schlee M, Grimm T, Harasim T, Malamoussi A, et al. 
Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for 
ribosome biogenesis and cell proliferation. The Journal of cell biology. 2005;170(3):367-78. 
Epub 2005/07/27. 
49. Yu Y, Hirsch JP. An essential gene pair in Saccharomyces cerevisiae with a potential 
role in mating. DNA and cell biology. 1995;14(5):411-8. Epub 1995/05/01. 
50. Kim J, Hirsch JP. A nucleolar protein that affects mating efficiency in Saccharomyces 
cerevisiae by altering the morphological response to pheromone. Genetics. 1998;149(2):795-
805. Epub 1998/06/11. 
51. Bogengruber E, Briza P, Doppler E, Wimmer H, Koller L, Fasiolo F, et al. Functional 
analysis in yeast of the Brix protein superfamily involved in the biogenesis of ribosomes. 
FEMS yeast research. 2003;3(1):35-43. Epub 2003/04/19. 
52. Eisenhaber F, Wechselberger C, Kreil G. The Brix domain protein family -- a key to 
the ribosomal biogenesis pathway? Trends Biochem Sci. 2001;26(6):345-7. Epub 2001/06/19. 
53. Wehner KA, Baserga SJ. The sigma(70)-like motif: a eukaryotic RNA binding domain 
unique to a superfamily of proteins required for ribosome biogenesis. Molecular cell. 
2002;9(2):329-39. Epub 2002/02/28. 
54. Fatica A, Cronshaw AD, Dlakic M, Tollervey D. Ssf1p prevents premature processing 
of an early pre-60S ribosomal particle. Molecular cell. 2002;9(2):341-51. Epub 2002/02/28. 
55. Chatr-Aryamontri A, Breitkreutz BJ, Heinicke S, Boucher L, Winter A, Stark C, et al. 
The BioGRID interaction database: 2013 update. Nucleic acids research. 2013;41(Database 
issue):D816-23. Epub 2012/12/04. 
56. Kaluarachchi Duffy S, Friesen H, Baryshnikova A, Lambert JP, Chong YT, Figeys D, 
et al. Exploring the yeast acetylome using functional genomics. Cell. 2012;149(4):936-48. 
Epub 2012/05/15. 
57. Gray JV, Petsko GA, Johnston GC, Ringe D, Singer RA, Werner-Washburne M. 
"Sleeping beauty": quiescence in Saccharomyces cerevisiae. Microbiology and molecular 
biology reviews : MMBR. 2004;68(2):187-206. Epub 2004/06/10. 
58. Martinez MJ, Roy S, Archuletta AB, Wentzell PD, Anna-Arriola SS, Rodriguez AL, et 
al. Genomic analysis of stationary-phase and exit in Saccharomyces cerevisiae: gene 
expression and identification of novel essential genes. Molecular biology of the cell. 
2004;15(12):5295-305. Epub 2004/10/01. 
59. Catala M, Tremblay M, Samson E, Conconi A, Abou Elela S. Deletion of Rnt1p alters 
the proportion of open versus closed rRNA gene repeats in yeast. Molecular and cellular 
biology. 2008;28(2):619-29. Epub 2007/11/10. 
60. Wang Y, Zhang X, Zhang H, Lu Y, Huang H, Dong X, et al. Coiled-coil networking 
shapes cell molecular machinery. Molecular biology of the cell. 2012;23(19):3911-22. Epub 
2012/08/10. 
116 
61. Suarez-Huerta N, Boeynaems JM, Communi D. Cloning, genomic organization, and 
tissue distribution of human Ssf-1. Biochemical and biophysical research communications. 
2000;275(1):37-42. Epub 2000/08/17. 
62. Bugner V, Tecza A, Gessert S, Kuhl M. Peter Pan functions independently of its role in 
ribosome biogenesis during early eye and craniofacial cartilage development in Xenopus 
laevis. Development. 2011;138(11):2369-78. Epub 2011/05/12. 
63. Communi D, Suarez-Huerta N, Dussossoy D, Savi P, Boeynaems JM. Cotranscription 
and intergenic splicing of human P2Y11 and SSF1 genes. The Journal of biological chemistry. 
2001;276(19):16561-6. Epub 2001/03/30. 
64. Naji S, Ambrus G, Cimermancic P, Reyes JR, Johnson JR, Filbrandt R, et al. Host cell 
interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus 
production. Molecular & cellular proteomics : MCP. 2012;11(4):M111 015313. Epub 
2011/12/17. 
65. Askjaer P, Jensen TH, Nilsson J, Englmeier L, Kjems J. The specificity of the CRM1-
Rev nuclear export signal interaction is mediated by RanGTP. The Journal of biological 
chemistry. 1998;273(50):33414-22. Epub 1998/12/05. 
66. Daugeron MC, Kressler D, Linder P. Dbp9p, a putative ATP-dependent RNA helicase 
involved in 60S-ribosomal-subunit biogenesis, functionally interacts with Dbp6p. RNA. 
2001;7(9):1317-34. Epub 2001/09/22. 
67. Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, et al. Functional 
organization of the yeast proteome by systematic analysis of protein complexes. Nature. 
2002;415(6868):141-7. Epub 2002/01/24. 
68. Collins SR, Miller KM, Maas NL, Roguev A, Fillingham J, Chu CS, et al. Functional 
dissection of protein complexes involved in yeast chromosome biology using a genetic 
interaction map. Nature. 2007;446(7137):806-10. Epub 2007/02/23. 
69. Wilmes GM, Bergkessel M, Bandyopadhyay S, Shales M, Braberg H, Cagney G, et al. 
A genetic interaction map of RNA-processing factors reveals links between Sem1/Dss1-
containing complexes and mRNA export and splicing. Molecular cell. 2008;32(5):735-46. 
Epub 2008/12/09. 
70. Gilmore JM, Sardiu ME, Venkatesh S, Stutzman B, Peak A, Seidel CW, et al. 
Characterization of a highly conserved histone related protein, Ydl156w, and its functional 
associations using quantitative proteomic analyses. Molecular & cellular proteomics : MCP. 
2012;11(4):M111 011544. Epub 2011/12/27. 
71. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, et al. The 
genetic landscape of a cell. Science. 2010;327(5964):425-31. Epub 2010/01/23. 
72. Kushnirov VV. Rapid and reliable protein extraction from yeast. Yeast. 
2000;16(9):857-60. Epub 2000/06/22. 
73. Bellemer C, Chabosseau P, Gallardo F, Gleizes PE, Stahl G. Genetic interactions show 
the importance of rRNA modification machinery for the role of Rps15p during ribosome 
biogenesis in S. cerevisiae. PloS one. 2010;5(5):e10472. Epub 2010/05/11. 
74. Mansour FH, Pestov DG. Separation of long RNA by agarose-formaldehyde gel 
electrophoresis. Analytical biochemistry. 2013;441(1):18-20. Epub 2013/06/27. 
75. Ying BW, Fourmy D, Yoshizawa S. Substitution of the use of radioactivity by 
fluorescence for biochemical studies of RNA. RNA. 2007;13(11):2042-50. Epub 2007/09/13. 
117 
76. Longtine MS, McKenzie A, 3rd, Demarini DJ, Shah NG, Wach A, Brachat A, et al. 
Additional modules for versatile and economical PCR-based gene deletion and modification in 
Saccharomyces cerevisiae. Yeast. 1998;14(10):953-61. Epub 1998/08/26. 
77. Janke C, Magiera MM, Rathfelder N, Taxis C, Reber S, Maekawa H, et al. A versatile 
toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and 
promoter substitution cassettes. Yeast. 2004;21(11):947-62. Epub 2004/08/31. 
78. Oeffinger M, Wei KE, Rogers R, DeGrasse JA, Chait BT, Aitchison JD, et al. 
Comprehensive analysis of diverse ribonucleoprotein complexes. Nature methods. 
2007;4(11):951-6. Epub 2007/10/09. 
79. Zhang Y, Cremer PS. Interactions between macromolecules and ions: The Hofmeister 
series. Current opinion in chemical biology. 2006;10(6):658-63. Epub 2006/10/13. 
80. Dokudovskaya S, Williams R, Devos D, Sali A, Chait BT, Rout MP. Protease 
accessibility laddering: a proteomic tool for probing protein structure. Structure. 
2006;14(4):653-60. Epub 2006/04/18. 
81. Teste MA, Duquenne M, Francois JM, Parrou JL. Validation of reference genes for 
quantitative expression analysis by real-time RT-PCR in Saccharomyces cerevisiae. BMC 
molecular biology. 2009;10:99. Epub 2009/10/31. 
82. Bondos SE, Bicknell A. Detection and prevention of protein aggregation before, 
during, and after purification. Analytical biochemistry. 2003;316(2):223-31. Epub 2003/04/25. 
83. Damodaran S, Kinsella JE. Dissociation of nucleoprotein complexes by chaotropic 
salts. FEBS letters. 1983;158(1):53-7. Epub 1983/07/11. 
84. Meyer AE, Hoover LA, Craig EA. The cytosolic J-protein, Jjj1, and Rei1 function in 
the removal of the pre-60 S subunit factor Arx1. The Journal of biological chemistry. 
2010;285(2):961-8. Epub 2009/11/11. 
85. Kressler D, Hurt E, Bassler J. Driving ribosome assembly. Biochimica et biophysica 
acta. 2010;1803(6):673-83. Epub 2009/11/03. 
86. Milkereit P, Gadal O, Podtelejnikov A, Trumtel S, Gas N, Petfalski E, et al. Maturation 
and intranuclear transport of pre-ribosomes requires Noc proteins. Cell. 2001;105(4):499-509. 
Epub 2001/05/24. 
87. Underbakke ES, Zhu Y, Kiessling LL. Protein footprinting in a complex milieu: 
identifying the interaction surfaces of the chemotaxis adaptor protein CheW. Journal of 
molecular biology. 2011;409(4):483-95. Epub 2011/04/06. 
88. Fernandez-Martinez J, Phillips J, Sekedat MD, Diaz-Avalos R, Velazquez-Muriel J, 
Franke JD, et al. Structure-function mapping of a heptameric module in the nuclear pore 
complex. The Journal of cell biology. 2012;196(4):419-34. Epub 2012/02/15. 
89. Dokudovskaya S, Waharte F, Schlessinger A, Pieper U, Devos DP, Cristea IM, et al. A 
conserved coatomer-related complex containing Sec13 and Seh1 dynamically associates with 
the vacuole in Saccharomyces cerevisiae. Molecular & cellular proteomics : MCP. 
2011;10(6):M110 006478. Epub 2011/04/02. 
90. Krogan NJ, Cagney G, Yu H, Zhong G, Guo X, Ignatchenko A, et al. Global landscape 
of protein complexes in the yeast Saccharomyces cerevisiae. Nature. 2006;440(7084):637-43. 
Epub 2006/03/24. 
91. Venema J, Vos HR, Faber AW, van Venrooij WJ, Raue HA. Yeast Rrp9p is an 
evolutionarily conserved U3 snoRNP protein essential for early pre-rRNA processing 
cleavages and requires box C for its association. RNA. 2000;6(11):1660-71. Epub 2000/12/06. 
118 
92. Kufel J, Allmang C, Petfalski E, Beggs J, Tollervey D. Lsm Proteins are required for 
normal processing and stability of ribosomal RNAs. The Journal of biological chemistry. 
2003;278(4):2147-56. Epub 2002/11/20. 
93. Allmang C, Mitchell P, Petfalski E, Tollervey D. Degradation of ribosomal RNA 
precursors by the exosome. Nucleic acids research. 2000;28(8):1684-91. Epub 2000/03/29. 
94. Tafforeau L, Zorbas C, Langhendries JL, Mullineux ST, Stamatopoulou V, Mullier R, 
et al. The Complexity of Human Ribosome Biogenesis Revealed by Systematic Nucleolar 
Screening of Pre-rRNA Processing Factors. Molecular cell. 2013;51(4):539-51. Epub 
2013/08/27. 
 
 
